Cintas má 15. července před otevřením trhu oznámit výsledky za 4. fiskální čtvrtletí; tržby se čekají na 2,88 miliardy USD, tedy o 7,8 % meziročně výše.
Key Takeaways Cintas is expected to report fiscal Q4 revenues of $2.88 billion, up 7.8% year over year. CTAS may benefit from customer retention, AED Rentals demand and gains from recent acquisitions. Cintas faces margin pressure from higher SG&A costs and potential foreign exchange headwinds. Cintas Corporation (CTAS - Free Report) is scheduled to release fourth-quarter fiscal 2026 (ended May 2026) results on July 15, before market open.
The Zacks Consensus Estimate for CTAS’ fiscal fourth-quarter revenues is pegged at $2.88 billion, indicating growth of 7.8% from the prior-year quarter’s figure. The consensus mark for earnings is pinned at $1.24 per share, which has been stable in the past 60 days. The figure indicates growth of 13.8% from the year-ago quarter's figure.
The company has a stellar earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average beat being 1.3%. In the last reported quarter, its earnings of $1.24 per share beat the consensus estimate of $1.23 by 0.8%.
Let’s see how things have shaped up before Cintas’ fiscal fourth-quarter earnings release.
Factors to Note Ahead of CTAS’ ResultsStrong customer retention and penetration of additional products and services into existing customers are expected to have driven the Uniform Rental and Facility Services segment’s performance in the fiscal fourth quarter. The Zacks Consensus Estimate for the segment’s revenues is pegged at $2.17 billion, indicating a 7% jump from the year-ago reported number.
Solid demand for the company’s AED Rentals is likely to have supported the performance of the First Aid and Safety Services segment. Also, strong customer retention levels and an improved sales mix are likely to have boded well for the segment. The consensus mark for the segment’s revenues is pegged at $358 million, which implies a 10.5% increase from the year-ago reported figure.
Also, synergistic gains from the acquisitions of Paris Uniform Services (March 2024) and SITEX (February 2024) are expected to have boosted Cintas’ top line in the to-be-reported quarter. While the Paris Uniform Services buyout has strengthened CTAS’ market presence in Pennsylvania, New York, Maryland and West Virginia, the SITEX acquisition has enhanced its footprint in the U.S. central Midwest region.
However, the escalating selling, general and administrative (SG&A) expenses pose a threat to CTAS’ bottom line. Increase in employee-partner related expensesare expected to have pushed up the SG&A expenses, which are likely to have impacted the company’s margins in the fiscal fourth quarter.
Given Cintas’ extensive geographic presence, its operations are subject to global political risks and foreign exchange headwinds. A stronger U.S. dollar is likely to have hurt CTAS’ overseas business in the quarter.
Earnings WhispersOur proven model predicts an earnings beat for CTAS this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here, as elaborated below.
Earnings ESP: CTAS has an Earnings ESP of +0.58% as the Zacks Consensus Estimate is pegged at $1.25 per share, higher than the Most Accurate Estimate of $1.24. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: CTAS currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Other Stocks to ConsiderHere are some other companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Ingersoll Rand Inc. (IR - Free Report) has an Earnings ESP of +0.61% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on July 30.
Ingersoll Rand’s earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters while matching the mark in two, the average surprise being 2.4%.
Crane Company (CR - Free Report) has an Earnings ESP of +4.73% and a Zacks Rank of 2 at present. The company is scheduled to release second-quarter 2026 results on July 28.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 11.3%.
Illinois Tool Works Inc. (ITW - Free Report) has an Earnings ESP of +0.31% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on July 28.
Illinois Tool’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.8%.
Na společnost Lucid byla podána hromadná žaloba kvůli údajným zavádějícím tvrzením o výrobě a dodávkách. Firma uvedla, že v 1. čtvrtletí vyrobila 5 500 vozů, ale dodala jen 3 093.
New York, New York--(Newsfile Corp. - July 13, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Lucid Group, Inc. ("Lucid" or the "Company") (NASDAQ: LCID) on behalf of investors that purchased or otherwise acquired Lucid Group securities between February 25, 2026 and April 13, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Lucid and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than July 28, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
On Friday April 3, 2026, at the close of the market, Lucid issued in a press release stating that the Company "produced 5,500 vehicles" during the first quarter of 2026, while only "deliver[ing] 3,093 vehicles." The press release further stated that "[d]uring the quarter, deliveries of the Lucid Gravity were disrupted for 29 days due to a supplier quality issue with the second-row seats" and, "[a]s result of this, the [C]ompany's ability to meet customer demand was impacted." That same day, Reuters published an article entitled "Lucid misses first-quarter vehicle delivery estimates on supplier disruptions." According to the article Chief Executive Officer Marc Winterhoff, said "[d]eliveries were particularly hit in February" when the Company "paused to reverse the change and inspect vehicles already produced."
In the first two trading sessions following the news, the price of Lucid shares declined by $1.13 per share, or 11.35%, to close at $8.83 per share on April 7, 2026.
Then, on April 14, 2026, Lucid announced preliminary first quarter 2026 financial results, including revenue in the range of $280 million to $284 million, well below the consensus estimate of $433.8 million according to the complaint, and loss from operations in the range of $985 million to $1.005 billion.
Following this news, the price of Lucid stock fell $0.44 per share, or 4.76%, to close at $8.80 per share on April 14, 2026.
The complaint alleges, among other things, that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (i) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (ii) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (iii) accordingly, the Defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America-the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act-$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Lam Research míří na rekordní tržby ve 4. fiskálním čtvrtletí 2026 ve výši 6,6 mld. USD, tažené poptávkou po AI čipech. Ve 3. čtvrtletí tržby meziročně vzrostly o 24 % na rekordních 5,84 mld. USD.
Key Takeaways Lam Research targets record Q4'26 revenues of $6.6B after posting $5.84B in the third quarter.AI chip demand is driving investments in advanced DRAM, HBM and leading-edge foundry technologies.LRCX's advanced packaging sales are expected to grow by over 50% in 2026 as AI processors become more complex. Lam Research Corporation (LRCX - Free Report) is slated to report its fourth-quarter fiscal 2026 results in late July, and investors must be wondering if the company will reach its record revenue target of $6.6 billion. We believe that the ongoing boom in artificial intelligence (AI) chips could help Lam Research achieve that goal. Demand for advanced semiconductor equipment continues to rise as chipmakers expand capacity for AI processors, high-bandwidth memory (HBM) and next-generation logic devices.
Lam Research delivered strong momentum in the third quarter of fiscal 2026. Revenues increased 24% year over year to a record $5.84 billion, while systems revenues climbed to $3.73 billion. Non-GAAP earnings per share jumped 41% and reached a record $1.47, while non-GAAP gross margin improved 90 basis points to 49.9%, reflecting a favorable product mix and operational execution. These results provide a solid foundation for another quarter of growth.
AI is becoming LRCX’s biggest growth engine. The company is benefiting from rising investments in advanced DRAM, HBM and leading-edge foundry technologies, all of which require Lam Research’s etch and deposition equipment. Management also expects advanced packaging revenues to grow more than 50% in calendar year 2026 as AI processors become more complex and require sophisticated chip integration technologies.
Industry conditions remain favorable. Lam Research estimates global wafer fabrication equipment spending of approximately $140 billion in calendar year 2026, reflecting stronger AI-related investments across memory and logic markets. The company also expects industry growth to continue into 2027.
If AI infrastructure spending remains robust and customers continue expanding advanced chip production, Lam Research appears well-positioned to achieve its record fourth-quarter sales target and sustain its strong growth momentum. The Zacks Consensus Estimate for fourth-quarter fiscal 2026 revenues is currently pegged at $6.67 billion, higher than the midpoint of management’s guidance range and indicating a year-over-year increase of more than 29%.
Lam Research’s Rivals Also Benefit From AI Chip DemandLRCX’s main competitors, Applied Materials, Inc. (AMAT - Free Report) and KLA Corporation (KLAC - Free Report) , are also benefiting from the AI chip boom. Both companies have broad exposure to advanced semiconductor manufacturing and are seeing strong demand from AI-related investments.
Applied Materials is Lam Research’s closest rival in wafer fabrication equipment. The company generated revenues of $7.91 billion in the second quarter of fiscal 2026, with its Semiconductor Systems segment contributing the majority of sales. Applied Materials reported record DRAM revenue and continues to benefit from growing demand for advanced logic, HBM and advanced packaging solutions used in AI servers. Its broad product portfolio positions it to capture a significant share of rising semiconductor capital spending.
KLA Corporation competes through inspection and process control equipment, which are essential for manufacturing advanced AI chips. The company’s third-quarter fiscal 2026 revenues increased 11.5% year over year to $3.42 billion as it continues to benefit from increasing process complexity at leading-edge nodes. As AI processors and HBM stacks require tighter quality control and higher production yields, KLAC's inspection tools are becoming increasingly important.
For Lam Research, sustaining record quarterly revenues will depend on maintaining its leadership in etch and deposition technologies while competing effectively with Applied Materials and KLA Corporation across the rapidly expanding AI semiconductor ecosystem.
LRCX’s Share Price Performance, Valuation and EstimatesShares of Lam Research have surged 104.6% year to date compared with the Zacks Electronics – Semiconductors industry’s rise of 50.3%.
Lam Research YTD Price Return Performance
Image Source: Zacks Investment Research
From a valuation standpoint, Lam Research trades at a forward price-to-earnings ratio of 43.81, significantly higher than the industry’s average of 33.34.
Lam Research Forward 12-Month P/E Ratio
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Lam Research’s fiscal 2026 and 2027 earnings implies a year-over-year increase of approximately 37.2% and 39.6%, respectively. Estimates for fiscal 2026 have been revised upward over the past 30 days, while estimates for fiscal 2027 have been raised northward over the past seven days.
Image Source: Zacks Investment Research
Lam Research currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Summit NATO přinesl zhruba 50 miliard USD nových obranných zakázek, které mohou postupně plnit backlogy firem jako Northrop Grumman, Lockheed Martin a General Dynamics. Klíčové ale bude, zda se sliby promění ve skutečné kontrakty.
Jerry McGinn, who runs the Center for the Industrial Base at CSIS, went on CNBC with a number that will define the defense trade for the rest of the year. Roughly $50 billion in deal announcements have come out of the NATO summit in recent days, as allies convert last year’s pledge to reach 5% of GDP defense spending by 2030 into actual purchase orders. Canada, Germany, and Norway are lining up behind U.S. primes. McGinn’s message to investors was blunt about what to trust and what to discount.
The $50 Billion in Fresh Deals The headline transaction is NATO buying the Triton unmanned surveillance aircraft from Northrop Grumman, alongside deals featuring European firms like Saab on ISR systems (Saab trades in Stockholm, not on a U.S. exchange, so American investors get the theme through the primes). Northrop Grumman (NYSE:NOC | NOC Price Prediction) already booked $400 million in Triton awards in Q1 and is expanding B-21 production capacity with the Air Force. Its backlog stands at $95.6 billion, and management reaffirmed FY26 sales of $43.5 to $44.0 billion.
The stock is down 7.5% year to date, which tells you the market has not fully priced the NATO order book. Analyst consensus target is $689.33, against a current price near $541, with shares trading at a forward P/E of 19x.
The Commitment-to-Contract Gap Investors Have to Watch McGinn’s investor test is the whole ballgame. “What investors need to be looking at is how does this translate into actual real business contracts?” He flagged three hurdles. U.S. congressional approval comes first, then European parliamentary approval, then actual contracting. Pledges are cheap. Contracts show up in backlog.
Lockheed Martin (NYSE:LMT) is the clearest example of pledge-to-paper conversion. In its Q1 filing, CEO Jim Taiclet said the company signed framework agreements for advanced Patriot Missile, THAAD, and PrSM that will support raising production rates to 3 to 4 times current levels. That is a multi-year purchase commitment. Lockheed’s backlog closed 2025 at a record $194 billion. General Dynamics (NYSE:GD) shows the same conversion, with a consolidated Q1 book-to-bill of 2-to-1 and total estimated contract value climbing to $188.4 billion from $178.9 billion. GD shares are up 9.75% YTD and 23% over the past year, so much of the good news is already in.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Lockheed Martin didn't make the cut. Grab the names FREE today.
New Money Spigots and Where Munitions Cash Lands The financing side is where things get interesting. McGinn pointed to Canadian Prime Minister Carney’s newly announced defense bank and the expanded U.S. loan authority as tools designed to attract private capital to the industrial base. The Pentagon’s FY2027 request backs this up with real dollars. The DoW budget book earmarks $20.2 billion for the Defense Credit Account and over $100 billion in Defense Industrial Base investments, including $72.3 billion for Industrial Base Analysis and Sustainment and Defense Production Act Title III. That is munitions and hypersonics money.
Which brings you to Kratos Defense & Security Solutions (NASDAQ:KTOS), the pure-play beneficiary. CEO Eric DeMarco told investors on the Q1 call that “Fiscal 2027 National Security spend is currently projected to be $1.5 trillion, an approximate $400 billion increase above Fiscal Year 2026” and that the Department plans to spend the entire $156 billion Reconciliation Bill defense funding in fiscal 2026, covering Kratos’ Valkyrie CCA, solid rocket motors, and hypersonics.
Kratos beat Q1 EPS estimates by 23%, raised FY26 revenue guidance to $1.70-$1.76 billion, and announced a 100,000-square-foot expansion in Oklahoma City to boost Valkyrie production. The catch is valuation. The stock trades at a forward P/E of 62x and is down 39% YTD from its highs.
McGinn’s framework is the right one. Watch backlogs. Congressional and parliamentary votes come first, then contracts, then revenue. That sequence decides whether $50 billion of headlines becomes real EPS.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Lockheed Martin didn't make the cut. Grab the names FREE today.
Amcor zahájil rozšíření závodu v čínském Dongguanu o 7 000 m² a výstavbu automatizovaného skladu. Dokončení se očekává do července 2027, kapacita i odolnost dodavatelského řetězce mají vzrůst.
Key Takeaways Amcor is expanding its Dongguan facility with a 7,000-square-meter manufacturing site and automated warehouse.AMCR will add advanced automated equipment to boost production capacity and improve operational efficiency.Amcor expects the China facility expansion to complete by July'27 and strengthen supply-chain resilience. Amcor plc (AMCR - Free Report) announced that it started an expansion project at its flexible packaging solutions facility in Dongguan, China. This move will boost AMCR’s manufacturing network to better support its customers across the Asia Pacific region.
Details of Amcor’s Facility Expansion in ChinaAmcor has a 30-year history of operating in China, with 23 manufacturing sites and two research and development centers nationwide. The investment in Dongguan expansion underscores Amcor's commitment to a key growth market.
As part of the expansion project, the company will add a 7,000-square-meter manufacturing facility and an automated warehouse to its existing campus. This will take the total campus to more than 38,000 square meters, boosting Amcor’s production capacity and supply-chain resilience in a key South China industrial hub.
The expanded facility will employ automated solvent-free laminators, high-speed bag-making machines and automated bag arranging systems, aiding increased production capacity and improved operational efficiency. These technologies will further support the production of recyclable packaging for food, home and personal care applications.
The company expects the construction of the facility to be completed by July 2027.
AMCR’s Focus to Advance Sustainable Packaging SolutionsOn June 29, Amcor announced a partnership with Kelpi to develop advanced coating technologies that will boost the company’s performance and sustainability of packaging materials. This move is in sync with AMCR’s strategy to focus on developing sustainable packaging solutions with high functional standards.
Kelpi’s proprietary coating technology platform, which is a bio-based seaweed material designed to deliver high barrier performance. It is also compatible with recycling streams for fiber-based packaging.
Amcor is testing the technology to expand its AmFiber portfolio, ensuring these fiber-based solutions meet strict requirements for barrier performance, high running speeds and circularity. By using bio-based coatings, Amcor will gain from the reduced reliance on fossil fuel-derived feedstocks and greater use of renewable resources. This will result in a lower carbon footprint.
Amcor’s Q3 PerformanceAMCR delivered third-quarter fiscal 2026 adjusted earnings of 96 cents per share, rising 6% year over year and meeting the Zacks Consensus Estimate. Reported net sales climbed 77% from the year-ago quarter to $5.91 billion and beat the consensus mark of $5.69 billion.
Results reflected the first full year of the Berry combination and continued integration progress, including $77 million of acquisition synergies in the quarter, along with cost and productivity actions that supported profitability.
AMCR’s Price PerformanceOver the past year, the company’s shares have lost 4.7% compared with the industry’s 4.3% decline.
Image Source: Zacks Investment Research
Amcor’s Zacks Rank & Stocks to ConsiderAMCR currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks from the Industrial Products sector are Helios Technologies, Inc (HLIO - Free Report) , Fastenal Company (FAST - Free Report) and Tennant Company (TNC - Free Report) . HLIO flaunts a Zacks Rank #1 (Strong Buy), and FAST and TNC carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Helios Technologies’ 2026 earnings is pegged at $2.89 per share. The company has a trailing four-quarter average earnings surprise of 15.7%. Helios Technologies’ shares have soared 134% in a year.
Fastenal has an average trailing four-quarter earnings surprise of 0.1%. The Zacks Consensus Estimate for FAST’s 2026 earnings is pinned at $1.23 per share, which indicates year-over-year growth of 13.1%. The company’s shares have grown 5.3% in a year.
Tennant has an average trailing four-quarter earnings surprise of 40.8%. The Zacks Consensus Estimate for TNC’s 2026 earnings is pinned at $5.12 per share. The company’s shares have gained 5.3% in a year.
Wall Street čeká, že BOK Financial vykáže zisk 2,56 USD na akcii, meziročně o 16,9 % více, při výnosech 558,9 milionu USD. Analytici mu dávají Earnings ESP +3,52 %.
Wall Street expects a year-over-year increase in earnings on higher revenues when BOK Financial (BOKF - Free Report) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 20. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis Regional banking operator is expected to post quarterly earnings of $2.56 per share in its upcoming report, which represents a year-over-year change of +16.9%.
Revenues are expected to be $558.9 million, up 4.4% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for BOK Financial?For BOK Financial, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +3.52%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that BOK Financial will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that BOK Financial would post earnings of $2.3 per share when it actually produced earnings of $2.58, delivering a surprise of +12.17%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
BOK Financial appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsFirst Horizon National (FHN - Free Report) , another stock in the Zacks Banks - Southwest industry, is expected to report earnings per share of $0.52 for the quarter ended June 2026. This estimate points to a year-over-year change of +15.6%. Revenues for the quarter are expected to be $873.47 million, up 5.2% from the year-ago quarter.
The consensus EPS estimate for First Horizon has been revised 0.2% higher over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -2.19%.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that First Horizon will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
SPX Technologies zvýšila výhled růstu v datových centrech pro rok 2026 zhruba z 50 % na 70 % díky silné poptávce po chlazení a vzduchotechnice. Zisk segmentu vzrostl o 22 % na 135 milionů USD.
Key Takeaways SPX Technologies' stock gained 26.1% in a year, outpacing the Construction sector and the S&P 500 Index.SPXC raised its 2026 data center growth outlook to 70% as cooling and air-handling demand accelerated.Segment income rose 22% to $135 million, while margin expanded 100 basis points to 23.9%. SPX Technologies, Inc. (SPXC - Free Report) has delivered a strong share price performance, reflecting solid execution, resilient demand across its key end markets and growing confidence in its long-term growth strategy. Momentum in its HVAC and Detection & Measurement businesses, accelerating demand for data center cooling solutions and disciplined acquisitions have strengthened the company's growth outlook. SPXC stock has climbed 26.1% over the past year, broadly matching the Zacks Building Products - Air Conditioner and Heating industry’s 27% rise while outperforming the Construction sector’s 14.6% gain and the S&P 500 Index’s 24.2% increase.
The outlook remains encouraging. Management raised its full-year guidance after a stronger-than-expected first quarter of 2026, citing robust execution, sustained demand across key markets and additional data center-related volumes expected in the second half of 2026. Continued investments in manufacturing capacity, product innovation and strategic acquisitions should further strengthen SPX Technologies' competitive position.
SPXC’s 1-Year Price Performance
Image Source: Zacks Investment Research
Over the past year, SPX Technologies has substantially outperformed several industry peers. While Carrier Global Corporation (CARR - Free Report) and Pentair plc (PNR - Free Report) posted declines of 9.5% and 28.7%, respectively, Trane Technologies plc (TT - Free Report) gained 9.2%.
SPXC's Data Center Strategy Continues to Drive Long-Term GrowthSPX Technologies continues to benefit from one of the strongest structural growth trends in industrial markets: data center infrastructure. Management noted that demand for its cooling systems and custom air-handling solutions remains exceptionally strong, prompting the company to increase its 2026 data center growth outlook from approximately 50% to 70%. SPXC also emphasized that demand continues to accelerate, supported by increasing activity from hyperscale and colocation customers.
To support this opportunity, SPX Technologies is expanding production capacity across multiple facilities. New manufacturing lines at its Tennessee and Kansas plants have already begun production, while the Alabama expansion remains on schedule to add additional assembly and manufacturing capacity through 2027. Management believes these investments, together with strong customer visibility and a diversified customer base, position the company for sustained growth beyond 2026.
SPXC's Operational Execution Continues to Support Profit GrowthSPX Technologies continues to execute well across both operating segments despite ongoing investments in capacity expansion. Consolidated segment income rose 22% year over year to $135 million, while segment margin expanded 100 basis points to 23.9%, supported by higher volumes, a favorable product mix and increased software revenues within Detection & Measurement.
HVAC segment’s income increased 20% to $88.6 million, benefiting from organic growth and acquisition contributions. Segment margin declined 40 basis points to 22.5%, mainly due to planned start-up costs associated with new production capacity. Management expects most of the estimated $8-$9 million in start-up expenses to be incurred during the first half of 2026. As the new facilities ramp up, operating leverage is expected to improve and support stronger profitability over time.
The company's disciplined acquisition strategy also continues to enhance its growth profile. Recent additions such as Thermolec and Crawford's commercial air-handling business expand SPX Technologies' HVAC capabilities, while the divestiture of Crawford United's non-core industrial and transportation businesses sharpens management's focus on higher-growth markets.
SPXC's Financial Strength Supports Future GrowthSPX Technologies maintains a healthy balance sheet that provides ample flexibility to invest in organic growth and pursue strategic acquisitions. The company ended the first quarter with approximately $158 million in cash and a leverage ratio of roughly 0.9x, well below its long-term target range. This financial strength provides significant capacity to pursue additional value-enhancing acquisitions while continuing to invest in manufacturing expansion and innovation.
The company also continues to generate positive operating cash flow while actively reshaping its portfolio. During the quarter, SPX Technologies completed the divestiture of Crawford United's non-core industrial and transportation businesses, allowing management to sharpen its focus on higher-growth HVAC and Detection & Measurement markets. Combined with a robust acquisition pipeline and raised full-year guidance, the balance sheet positions SPXC to continue executing its long-term growth strategy.
Earnings Estimate Revision of SPXC StockSPXC’s earnings outlook has improved over the past 60 days, with the Zacks Consensus Estimate for 2026 rising to $7.98 per share. The consensus estimate for 2027 has remained unchanged over the same period, as shown below. The current projections imply earnings growth of 18.1% in 2026, followed by an additional 12.9% increase in 2027.
Image Source: Zacks Investment Research
SPXC's earnings growth outlook also compares favorably with its peers. Carrier Global is expected to grow earnings by 7.7% this year, while Pentair and Trane Technologies are projected to deliver growth of 8.7% and 13.6%, respectively.
SPXC Stock Trades at a DiscountSPX Technologies trades at a forward 12-month P/E ratio of 25.77X, below the industry average. The valuation reflects investor confidence in the company's disciplined execution, expanding data center opportunity, resilient demand across key end markets and continued investments in manufacturing capacity, product innovation and strategic acquisitions. These initiatives are expected to support long-term earnings growth.
However, following the stock's strong run, execution remains critical. Delays in ramping new manufacturing capacity, slower-than-expected data center demand, integration challenges related to recent acquisitions or a greater-than-expected impact from tariffs could pressure margins and weigh on investor sentiment.
SPXC P/E Ratio (Forward 12 Months) Vs Industry
Image Source: Zacks Investment Research
Among peers, Carrier Global trades at a forward 12-month P/E multiple of 23.27X, while Pentair trades at 13.57X. Trane Technologies carries a higher valuation of 30.06X on the same basis. SPXC therefore trades at a premium to Carrier and Pentair but at a discount to Trane Technologies, placing it within the broader peer valuation range.
Is SPXC Stock Still a Buy After Its Strong Run?SPX Technologies remains well positioned to benefit from structural growth trends across data centers, HVAC and Detection & Measurement markets. The company continues to execute its value creation strategy through capacity expansion, product innovation and disciplined acquisitions, while its raised guidance and robust backlog underscore confidence in long-term growth. These initiatives, combined with resilient demand across key end markets, should support sustained earnings growth over time.
SPXC also maintains financial flexibility to invest in organic expansion and pursue strategic acquisitions. However, risks remain from delays in ramping new manufacturing capacity, slower-than-expected data center demand, acquisition integration challenges and tariff-related pressures. While the stock trades at a discount to the broader peer group, sustained execution will be important to justify its valuation. Encouragingly, rising earnings estimates suggest analysts remain confident in the company's growth prospects.
SPXC stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
EMCOR zvýšil výhled tržeb i EPS na rok 2026 díky rekordním RPO ve výši 15,62 miliardy USD a silné poptávce po infrastrukturních projektech. Jacobs mezitím oznámil rekordní backlog ve výši 27 miliard USD.
Key Takeaways EMCOR raised 2026 guidance as record RPOs and infrastructure demand support long-term growth.Jacobs posted a record backlog, expanded AI and consulting capabilities, and increased expected PA synergies.EME's 35.19% trailing ROE exceeds Jacobs', reflecting stronger shareholder return efficiency. The demand for mission-critical industrial, government, healthcare and data center projects has ramped up across the United States over the past few years and is currently reaching its peak, given the public funding growth and market trends. Firms like EMCOR Group, Inc. (EME - Free Report) and Jacobs Solutions, Inc. (J - Free Report) sit at the juncture and are currently gaining from these market tailwinds.
EMCOR offers mechanical and electrical construction, industrial and energy infrastructure services for a diverse range of businesses, serving commercial, industrial, utility and institutional clients in the United States. Meanwhile, Jacobs offers professional, technical and construction services to industrial, commercial and governmental clients.
Let’s closely compare the fundamentals of the two infrastructure stocks to determine which one is a better investment now.
The Case for EMCOR StockFederal and state investments in water infrastructure, transportation, healthcare modernization, institutional facilities and energy-related projects are creating a healthy pipeline of opportunities for EMCOR. At the same time, AI-driven data center expansion and broader digital transformation continue to fuel commercial construction demand. Owing to these robust trends, EMCOR’s record remaining performance obligations (RPOs) reached $15.62 billion as of March 31, 2026, up 32.9% year over year and nearly 18% sequentially, providing exceptional visibility into future revenue generation. RPOs in the construction segments highlighted contributions of $8.56 billion in U.S. mechanical construction and $5.61 billion in U.S. electrical construction, with additional contributions from building services.
Management emphasized that it continues to see no signs of slowing demand as customers expand data center capacity and adopt advanced liquid cooling technologies. Reflecting this confidence, EME raised its full-year 2026 revenue guidance to $18.5-$19.25 billion from $17.75-$18.5 billion and increased its EPS guidance to $28.25-$29.75 from $27.25-$29.25 expected earlier. Supported by disciplined project selection, execution capabilities and broad market diversification, the company appears well-positioned to capitalize on multi-year infrastructure investment trends.
Meanwhile, strategic acquisitions remain an important pillar of EMCOR's long-term growth strategy, complementing its strong organic expansion. The company's acquisition of Miller Electric has strengthened its electrical construction capabilities, expanded its geographic presence and increased exposure to attractive end markets. Rather than pursuing scale for its own sake, EMCOR prioritizes disciplined capital deployment and integration, preserving its operational culture while creating cross-selling opportunities across its construction and services platforms.
EME ended the first quarter of 2026 with approximately $916 million in cash and about $1.25 billion in working capital, supporting organic investments, strategic acquisitions and operational needs. Management expects full-year 2026 operating cash flow to remain broadly in line with net income, reflecting the underlying strength of the business despite quarterly working-capital fluctuations.
The Case for Jacobs StockJacobs continues to benefit from long-term structural demand across data centers, semiconductors, water infrastructure, transportation and energy & power, reporting more than 100% year-over-year growth in its data center business, supported by accelerating AI investments and strong hyperscaler demand. PA Consulting acquisition is further enhancing growth through advisory, digital transformation and national security opportunities, creating meaningful cross-selling potential. Management has already increased expected annual cost synergies from the acquisition to more than $20 million within 24 months.
These demand drivers helped Jacobs deliver a record backlog of $27 billion, up 22% year over year, with a strong trailing 12-month book-to-bill ratio of 1.4x, providing excellent revenue visibility and supporting confidence in sustained long-term growth. The company is executing a strategy focused on expanding higher-margin consulting, digital and lifecycle solutions while strengthening its leadership in resilient infrastructure markets. Jacobs continues to invest in AI-enabled engineering solutions, including digital twins developed with NVIDIA Omniverse, reinforcing its competitive positioning in rapidly expanding AI infrastructure, advanced manufacturing and mission-critical facilities.
Besides, Jacobs continues to strengthen its global footprint through expanding operations across North America, Europe and the United Kingdom. Recent project wins with Ofwat, Scottish Hydro Electric Transmission and global hyperscale data center customers further demonstrate growing international opportunities. With diversified end markets, strong bookings, improving margins and an upgraded fiscal 2026 outlook, Jacobs appears well-positioned to capture expanding global infrastructure and digital transformation spending, even though execution risks and macroeconomic uncertainties pose a near-term threat.
Notably, Jacobs maintains a balanced capital allocation strategy that simultaneously funds long-term growth while delivering substantial shareholder returns. It repurchased $472 million of shares during the first half of fiscal 2026 and increased its quarterly dividend by 12.5%, reflecting confidence in future cash generation.
Stock Performance & ValuationAs witnessed from the chart below, in the past six months, EMCOR’s share price performance has been above Jacobs’ and the broader Construction sector.
Image Source: Zacks Investment Research
Considering valuation, over the last five years, EMCOR has been trading above Jacobs on a forward 12-month price-to-earnings (P/E) ratio basis.
Image Source: Zacks Investment Research
Overall, from these technical indicators, it can be deduced that EME stock offers an increasing growth trend but with a premium valuation, while J stock offers a declining growth trend with a discounted valuation.
Comparing EPS Estimate Trends: EME vs. JThe Zacks Consensus Estimate for EME’s 2026 and 2027 earnings has moved upward in the past 60 days. The revised estimates for 2026 and 2027 imply year-over-year growth of 13.5% and 11.8%, respectively.
EME's EPS Trend
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for J’s fiscal 2026 earnings has increased in the past 30 days, while the same for fiscal 2027 has edged down during the same time frame. The revised estimates for fiscal 2026 and fiscal 2027 imply year-over-year growth of 18.1% and 14.5%, respectively.
J's EPS Trend
Image Source: Zacks Investment Research
Return on Equity (ROE) of EME & J StocksEMCOR’s trailing 12-month ROE of 35.19% significantly exceeds Jacobs’ average, underscoring its efficiency in generating shareholder returns.
Image Source: Zacks Investment Research
Investment Decision: Should Investors Choose EME Stock or J Stock?EMCOR combines record remaining performance obligations, raised 2026 revenue and earnings guidance, disciplined acquisitions and broad exposure across mechanical, electrical, healthcare, institutional and industrial construction, providing exceptional earnings visibility. Its superior execution and industry-leading 35.2% ROE further strengthen the investment case. Although the stock trades at a premium, its recent price momentum, upward earnings estimate revisions and improving fundamentals justify the higher valuation.
Jacobs remains an attractive long-term infrastructure play, supported by record backlog, rapid data center growth, AI-enabled engineering capabilities and expanding consulting opportunities through PA Consulting. However, mixed earnings estimate revisions, greater exposure to consulting execution and slower share price momentum make its near-term outlook comparatively less compelling.
With a current Zacks Rank #1 (Strong Buy) compared with J stock’s Zacks Rank #2 (Buy), stronger technical indicators and more consistent operational momentum, EME stock stands out as the better investment choice for investors looking to capitalize on the current infrastructure and AI-driven construction cycle. You can see the complete list of today’s Zacks #1 Rank stocks here.
Alcon a RxSight budou společně vyvíjet nastavitelné nitrooční čočky pro pacienty po operaci šedého zákalu. RxSight dostane předem 60 milionů USD a může získat až dalších 140 milionů USD na milnících.
Key Takeaways Alcon and RxSight will develop adjustable PCIOLs that surgeons can fine-tune after cataract surgery.RxSight will receive $60M upfront and may earn up to $140M in development and regulatory milestones.Alcon will lead global commercialization, while RxSight will handle development and manufacturing. Alcon (ALC - Free Report) recently entered into a non-exclusive collaboration with RxSight (RXST - Free Report) to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) for cataract patients. The partnership will combine Alcon’s advanced PCIOL optical designs with RxSight’s post-operative light-adjustable technology, enabling surgeons to fine-tune patients’ visual outcomes after surgery.
The collaboration reflects both companies’ commitment to advancing customized vision care and expanding access to innovative cataract treatment solutions that improve patient outcomes.
Per management, Alcon’s leading PCIOLs have helped millions of cataract patients reduce or eliminate their dependence on glasses after surgery. By combining these lenses with RxSight’s technology, the company aims to develop tunable PCIOLs that will give surgeons greater confidence to refine post-surgery outcomes.
Likely Trend of ALC Stock Following the NewsShares of ALC have lost 0.8% since the announcement on July 6. Year to date, the stock has lost 14% compared with the industry’s 13.2% decline. However, the S&P 500 has risen 10.7% in the same timeframe.
The collaboration is expected to strengthen Alcon's position in the premium cataract surgery market by combining its PCIOL expertise with RxSight's light-adjustable technology. The partnership expands Alcon's innovation pipeline and supports the growing demand for personalized vision correction. With Alcon leading global commercialization and RxSight handling development and manufacturing, the companies can leverage their respective strengths. If successfully commercialized, the co-developed technology could accelerate the adoption of adjustable PCIOLs and support Alcon's long-term growth in advanced cataract care.
ALC currently has a market capitalization of $33.54 billion.
Image Source: Zacks Investment Research
More on the NewsUnder the agreement, RxSight will receive an upfront payment of $60 million to initiate development and may earn up to an additional $140 million upon achieving specified development and regulatory milestones. Alcon will oversee the global commercialization of the co-developed technology, while RxSight will be responsible for product development and manufacturing and will receive royalties based on future net sales.
RxSight expects its collaboration with Alcon to broaden patient access to customized visual outcomes after cataract surgery. The company believes the partnership highlights the importance of adjustable lens technology and will help accelerate its adoption among a larger patient population.
Industry Prospects Favoring the MarketGoing by data provided by Future Market Report, the presbyopia corrective intraocular lens (PCIOL) market is anticipated to be valued at $320.75 million in 2026 and is expected to witness a CAGR of 12.96% through 2033.
Factors like the rising prevalence of presbyopia and cataracts among aging populations, technological advancements in PCIOLs, growing adoption of cataract surgeries worldwide and increasing healthcare investments, favorable reimbursement policies and higher disposable incomes are driving the market’s growth.
Other NewsIn April, Alcon launched Clareon TruPlus, an enhanced monofocal and toric intraocular lens available in both standard and toric versions. The lens is designed to increase depth of focus while preserving high-quality distance vision. TruPlus demonstrated improved distance image quality, better simulated visual acuity at intermediate distances, lower glare and halo profiles and strong performance across varying pupil sizes and lighting conditions.
ALC’s Zacks Rank & Other Key PicksCurrently, ALC carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the broader medical space are Veracyte (VCYT - Free Report) and West Pharmaceutical (WST - Free Report) .
Veracyte, currently sporting a Zacks Rank #1 (Strong Buy), reported first-quarter 2026 adjusted earnings of 52 cents per share, which beat the Zacks Consensus Estimate by 52.9%. Revenues of $139.1 million surpassed the Zacks Consensus Estimate by 6.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Veracyte has an estimated earnings growth rate of 5.1% for 2026. VCYT’s earnings surpassed estimates in the trailing four quarters, the average surprise being 45.9%.
West Pharmaceutical, currently carrying a Zacks Rank #2, reported first-quarter 2026 earnings per share of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%.
West Pharmaceutical has an estimated long-term earnings growth rate of 13.9%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 19.4%.
Analytici čekají, že Alcoa vykáže zisk 2,41 USD na akcii, meziročně o 518 % více, při tržbách 3,93 miliardy USD, což je meziročně o 30,2 % více. Odhad EPS za posledních 30 dní klesl o 14 %.
Wall Street analysts expect Alcoa (AA - Free Report) to post quarterly earnings of $2.41 per share in its upcoming report, which indicates a year-over-year increase of 518%. Revenues are expected to be $3.93 billion, up 30.2% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 14% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Alcoa metrics that Wall Street analysts commonly model and monitor.
The consensus among analysts is that 'Total sales- Aluminum' will reach $3.34 billion. The estimate indicates a change of +70.4% from the prior-year quarter.
Analysts' assessment points toward 'Total sales- Alumina' reaching $975.67 million. The estimate indicates a change of -35.7% from the prior-year quarter.
The combined assessment of analysts suggests that 'Third-party sales- Aluminum' will likely reach $3.40 billion. The estimate indicates a year-over-year change of +73.8%.
Analysts forecast 'Third-party sales- Alumina' to reach $489.67 million. The estimate indicates a change of -41.9% from the prior-year quarter.
It is projected by analysts that the 'Average realized third-party price per metric ton of alumina' will reach $319.06 . Compared to the present estimate, the company reported $378.00 in the same quarter last year.
Based on the collective assessment of analysts, 'Average realized third-party price per metric ton of aluminum' should arrive at $5009.54 . The estimate compares to the year-ago value of $3143.00 .
The consensus estimate for 'Average cost per metric ton of aluminum shipped' stands at $2578.81 . Compared to the present estimate, the company reported $2718.00 in the same quarter last year.
Analysts expect 'Third-party alumina shipments in Tons' to come in at 1569 thousands metric tons. The estimate compares to the year-ago value of 2195 thousands metric tons.
The average prediction of analysts places 'Alumina production in Tons' at 2351 thousands metric tons. Compared to the present estimate, the company reported 2351 thousands metric tons in the same quarter last year.
The collective assessment of analysts points to an estimated 'Aluminum production in Tons' of 619 thousands metric tons. Compared to the present estimate, the company reported 572 thousands metric tons in the same quarter last year.
According to the collective judgment of analysts, 'Bauxite production in Tons' should come in at 9 millions of metric ton. Compared to the current estimate, the company reported 9 millions of metric ton in the same quarter of the previous year.
Analysts predict that the 'Intersegment Alumina Shipments' will reach 1241 thousands metric tons. Compared to the present estimate, the company reported 1089 thousands metric tons in the same quarter last year.
View all Key Company Metrics for Alcoa here>>>
Over the past month, shares of Alcoa have returned -29.2% versus the Zacks S&P 500 composite's +4.3% change. Currently, AA carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Keurig Dr Pepper v 1. čtvrtletí zvýšil tržby o 9,4 % na 3,98 miliardy USD a upravený EPS byl 0,39 USD. Firma zároveň připravuje rozdělení na dvě samostatně zaměřené společnosti.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Keurig Dr Pepper (NASDAQ: KDP | KDP Price Prediction) and Coca-Cola (NYSE: KO) both delivered Q1 2026 beats, but the businesses are moving in opposite directions. KDP just absorbed JDE Peet’s on April 1, 2026 and is preparing to split in two. Coke is defending a fortress.
Cold Beverages Carry KDP. Zero Sugar Carries Coke. Keurig Dr Pepper posted $3.98 billion in revenue, up 9.4% YoY, with adjusted EPS of $0.39. U.S. Refreshment Beverages grew 11.9% on Dr Pepper, GHOST energy, and sports hydration share gains. U.S. Coffee volume fell 8.2%, which is why management wants to isolate it in a separate coffee company.
Coca-Cola pulled $12.47 billion in revenue, +12.1% YoY, and EPS of $0.86, its fourth straight beat. Coca-Cola Zero Sugar grew volume 13% across every geography, and comparable operating margin expanded 70 bps to 34.5%. Global unit case volume rose only 3%, and Q1 benefited from six extra calendar days.
Business Driver KDP KO Main growth engine Cold beverages, GHOST energy Zero Sugar, premium packaging Weakest link U.S. Coffee volume (-8.2%) Asia Pacific OI (-17%) Forward P/E 14 26 Transformation Story Versus Fortress Story KDP is the more interesting business right now. CEO Tim Cofer called the quarter a milestone toward “standing up two pure-play companies”, backed by roughly $400M in projected cost savings. Principal debt sits at $25.9B, with interest expense nearly doubling to $281M. Any integration stumble bites hard.
Coke is executing what it already knows. Fairlife is accelerating, innocent and Santa Clara just joined the billion-dollar club, and 2025 marked the 63rd consecutive year of dividend increases. Trefis flagged a concern: management is shifting from aggressive pricing to a “balanced” approach, hinting that pricing power has a ceiling. The CFO also warned that consumers earning under $50K-$60K are strained.
What Decides the Next Six Months For KDP, watch GHOST-driven energy share (currently 8%, targeting 10%+) and whether the coffee spin timeline stays clean. Barclays flagged a potential 40% undervaluation post-financing. For Coke, the swing factor is volume in China and India holding up while the ~4% M&A headwind from the Africa divestiture flows through.
Why KDP Screens Better Than Coke Right Now Paying 14 times forward earnings for a business shedding its weakest segment and guiding to low-double-digit constant currency EPS growth looks like better math than paying 26 times for Coke’s 8-9% guided EPS growth. KDP is up 21.76% YTD, roughly matching KO’s 21.97%, so the discount has not closed yet. For investors seeking structural alpha at a cheaper multiple, KDP screens more favorably on valuation, provided the debt load behaves.
Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
Wintrust Financial čeká za čtvrtletí zisk 3,17 USD na akcii, meziročně o 14 % více, při výnosech 737,16 mil. USD. Odhady EPS byly za 30 dní sníženy o 0,2 %.
Wintrust Financial (WTFC - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on July 20, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis bank holding company is expected to post quarterly earnings of $3.17 per share in its upcoming report, which represents a year-over-year change of +14%.
Revenues are expected to be $737.16 million, up 9.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.2% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Wintrust?For Wintrust, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.58%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Wintrust will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Wintrust would post earnings of $2.96 per share when it actually produced earnings of $3.22, delivering a surprise of +8.78%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Wintrust doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Banks - Midwest industry, Commerce Bancshares (CBSH - Free Report) , is soon expected to post earnings of $1.04 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of -8.8%. This quarter's revenue is expected to be $488.01 million, up 9.5% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Commerce has been revised 1% up to the current level. Nevertheless, the company now has an Earnings ESP of +3.37%, reflecting a higher Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Commerce will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
BioLargo uvádí CupriDyne pro produkty pro domácí mazlíčky pod dosud neoznámenou značkou po úspěchu Pooph, které pod licencí vygenerovaly přes 125 milionů USD v tržbách. Firma začne v oblasti péče o domácí mazlíčky a poté se rozšíří do domácích odor a čisticích produktů.
BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo.
WESTMINSTER, CA / ACCESS Newswire / July 13, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that it is preparing to relaunch CupriDyne®-based consumer pet products under a yet-to-be-announced brand. Targeting pets first, the new consumer products subsidiary will eventually expand into household odor and cleaning products. Formed to fill the gap left by Pooph's ongoing withdrawal from the market, BioLargo will sell direct to consumers and through online marketplaces such as Amazon, leveraging a "digital-first" strategy that allows for hyper-specific audience targeting, real-time performance tracking, and flexible budgets, rather than depending on expensive television campaigns.
CupriDyne-based pet products generated over $125 million in sales while under license and marketed under the Pooph brand. Unfortunately, a series of business decisions by Pooph's management later culminated in its abandonment of CupriDyne-formulated products, the foreclosure of their assets by their lender, board and CEO resignations, and what appears to be the cessation of business operations. BioLargo always owned the CupriDyne technology and had to revoke Pooph's license. Now, the ownership of the Pooph brand is embroiled in litigation. "As a result, we have an opportunity to leverage the prior marketing success by introducing our own brand" said Joseph Provenzano, who will lead the new BioLargo consumer products subsidiary as CEO.
BioLargo's launch brings the CupriDyne® technology and BioLargo's original products back to consumers who loved them. According to Grand View Research1, the U.S. pet odor control and clean-up products market was valued at approximately $6.47 billion in 2023 and is projected to reach approximately $8.87 billion by 2030. BioLargo's initial launch into pet odor control is part of a much larger home and pet cleaning opportunity. The company views pet care as a proven, well-defined category where the difference between masking and eliminating odors is immediately obvious to consumers. Unlike the Pooph brand, BioLargo's new brand will not be limited to pets, and will use the pet product launch to anchor a broader expansion of CupriDyne products across the home.
BioLargo has assembled a team of branding, marketing, creative, and channel-sales experts with proven track records building and growing consumer brands nationally in the pet and household categories. It plans to release additional information, including the product line, the brand name, and key team members, as the product nears its formal launch.
"It will be great to get back into the pet odor control and consumer products business", said Dennis Calvert, BioLargo CEO. "We have seen what can be done, and this time we will own the brand and control the marketing and distribution."
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
CONTACT:
Investor Relations
Matt Kreps
Darrow Associates, Inc.
214-597-8200 [email protected]
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863 [email protected]
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
1 Grand View Research (2004), U.S. Pet Odor Control & Clean-up Products Market(2024 - 2030) https://www.grandviewresearch.com/industry-analysis/us-pet-odor-control-clean-up-products-market-report
AeroVironment získal od italské Directorate of Aeronautical Armaments and Airworthiness (DAAA) označení MQ-31A pro systém JUMP 20, který nyní Itálie uznává za oficiální vojenskou schopnost. To navazuje na dubnovou smlouvu na dodávku těchto dronů italské armádě.
ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a global defense technology leader, today announced that it has received an MQ-31A military designation from Italy’s Directorate of Aeronautical Armaments and Airworthiness (DAAA) to deliver the JUMP® 20 unmanned aircraft system (UAS) to the Italian Army.
The MQ‑31A designation confirms that the Italian Ministry of Defence now recognizes JUMP 20 as an official military capability.
ShareThe MQ-31A designation confirms that the Italian Ministry of Defence now recognizes JUMP 20 as an official military capability.
“This designation validates that JUMP 20 meets the standards of a modern European military and underscores the system’s ability to deliver actionable intelligence and persistent overwatch in highly contested environments,” said Shane Hastings, Vice President and General Manager, Medium Unmanned Aircraft Systems at AV. “It also signals that Italy is treating JUMP 20 as an integrated element of its formal military inventory, rather than a limited trial or off-the-shelf experiment.”
The MQ-31A designation is the next step following AV’s April 2025 contract to deliver JUMP 20 VTOL aircraft systems, sustainment, engineering, and support, replacing Italy’s legacy unmanned ISR fleet while enhancing NATO interoperability, expeditionary operations, and operational readiness.
The JUMP 20 was selected over multiple bidders through a competitive procurement process and continues to grow in popularity among NATO forces in Europe.
“Across Europe, JUMP 20 continues to gain traction with allied forces, including Italy, Denmark, Lithuania, and the Czech Republic, reinforcing its position as a trusted and rapidly adopted medium UAS platform,” said Hastings.
Designed for simplicity and adaptability, JUMP 20 is a vertical takeoff and landing (VTOL), fixed-wing unmanned aircraft system with more than 13 hours of endurance and an operational range of 185 km (115 mi). Runway-independent, the system is built for rapid, safe deployment, launching and landing autonomously without the need for personnel intervention. Its rugged, easily transportable design makes it ideal for dynamic, on-the-move operations. The system offers best-in-class open system architecture, with more than 70 integrated payloads and over 500,000 flight hours in operational environments.
Engineered with a 30-pound modular payload capacity, JUMP 20 easily adapts to evolving concepts of operations (CONOPS) and multi-domain mission demands. Its modular design ensures seamless integration of next-generation sensors, communication tools and advanced autonomy, helping Italian forces maintain an edge in UAS battlefield innovation.
About AV
AeroVironment (“AV”) (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo™, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. For more information, visit www.avinc.com.
Safe Harbor Statement
Certain statements in this press release may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties, which could cause actual results to differ materially. Factors that may cause such differences include, but are not limited to, our ability to perform under existing contracts and obtain new ones; regulatory changes; competitor activities; market growth; product development challenges; and general economic conditions. For a more detailed discussion of these risks, please refer to AeroVironment’s filings with the Securities and Exchange Commission. We undertake no obligation to update forward-looking statements as a result of new information or future events.
Freedom Holding Corp. dokončila nabídku kmenových akcií a získala hrubý výnos 300 milionů USD. Peníze chce použít na další expanzi a mezinárodní investice.
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Freedom Holding Corp. (Nasdaq: FRHC), an international financial technology group, today announced that aggregate gross proceeds from its offering of ordinary shares were US$300 million. In the offering, the company sold 2,374,356 ordinary shares, at a price of approximately US$126.35 per share.
Freedom Holding Corp. plans to use the proceeds to support its continued expansion and international investment program.
“The proceeds from this offering will support the development of our ecosystem in international markets,” said Timur Turlov, founder and chief executive officer of Freedom Holding Corp. “I believe the ecosystem our team has built in Kazakhstan can be competitive not only in these markets, but also in the United States, where we intend to introduce it in due course,” he added.
Freedom is developing a unified digital ecosystem that brings together banking, brokerage, insurance, and lifestyle services. At the core of this model is the Freedom SuperApp, which provides access to financial products, payments, insurance, investments, ticketing, travel, and e-commerce services.
International Expansion
International growth is a key element of Freedom’s strategy. The company plans to develop digital financial services in Europe by drawing on its experience in building an integrated financial ecosystem in Kazakhstan.
Earlier in June 2026, Freedom Holding Corp. applied for a banking license in France. The company has also stated that it aims to attract 50 million new clients in Europe.
Freedom Finansal Hizmetler A.Ş., a subsidiary of Freedom, recently received approval from Türkiye’s Banking Regulation and Supervision Agency to acquire a 99.32% stake in Turkish Bank A.Ş. The approval marks a key regulatory step toward completing the transaction. Upon completion, Turkish Bank would provide Freedom with an established banking platform from which to develop financial services in the country.
In November 2025, Freedom Holding Corp. received approval to open a bank in Georgia, further expanding the geographic reach of its financial ecosystem.
The company views Kazakhstan as the foundation for developing and refining its digital model for international markets. In 2025, Freedom’s ecosystem-building case was included in the MBA program at Stanford Graduate School of Business. The case became part of the school’s educational library and was prepared for use by students, faculty, and participants in international business programs.
Business and Financial Performance
As of March 31, 2026, Freedom’s ecosystem served more than 14 million customers across its banking, brokerage, insurance, lifestyle, and other business lines. The Freedom SuperApp had more than 5.2 million registered users.
The number of brokerage clients increased by 26%, from 683,000 to 858,000, while banking clients grew by approximately 100%, from 2.52 million to 5.03 million. The company’s other services segment had 1.105 million clients as of March 31, 2026.
For the fiscal year ended March 31, 2026, Freedom Holding Corp.’s revenue increased to US$2.19 billion, compared with US$2.0 billion a year earlier. Net income rose to US$153.3 million from US$76.2 million in the previous fiscal year. Basic earnings per share were US$2.56, and diluted earnings per share were US$2.51.
The company’s total assets reached US$13.16 billion as of March 31, 2026, while shareholders’ equity amounted to US$1.49 billion.
In June 2026, S&P Global Ratings upgraded the ratings of JSC Freedom Finance, Freedom Finance Europe Ltd., Freedom Finance Global PLC, and JSC Freedom Bank Kazakhstan to ‘BB-’ with a stable outlook. Freedom Holding Corp.’s issuer credit rating was affirmed at ‘B-’.
About Freedom Holding Corp.
Freedom Holding Corp. provides financial services in 22 countries, including Kazakhstan, the United States, Cyprus, Poland, Spain, Uzbekistan, and Armenia. The Company’s principal executive office is located in New York City. In Kazakhstan, Freedom is actively developing its financial and digital ecosystem, which includes Freedom Bank, Freedom Broker, the insurance companies Freedom Life and Freedom insurance, as well as a lifestyle segment that features Arbuz.kz, Freedom Ticketon, and Aviata.
Freedom Holding Corp. shares are traded on the U.S. technology exchange NASDAQ, the Kazakhstan Stock Exchange (KASE), and the Astana International Exchange (AIX) under the ticker symbol FRHC. Freedom Holding Corp. is regulated by the U.S. Securities and Exchange Commission (SEC) and the common stock is included in Russell 3000 Index.
Contact
Head of Public Relations
Natalia Kharlashina
Freedom Holding Corp. [email protected]
+77013641454
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/689175a0-3261-419d-9add-54b7426fd415
Crescent Energy čeká v roce 2026 téměř 1 mld. USD levered free cash flow a FCF yield nad 25 %. Firma už získala asi 120 mil. USD synergií z akvizice Vital Energy.
Key Takeaways Crescent Energy targets nearly $1B in 2026 levered free cash flow with a projected FCF yield above 25%.CRGY exceeded its Vital Energy synergy target, boosting efficiency and supporting debt reduction and returns.CRGY maintains about $2B in liquidity and a long-term leverage target of about 1x for financial flexibility. Crescent Energy Company (CRGY - Free Report) has built its strategy around generating sustainable free cash flow (FCF) rather than pursuing production growth at any cost. This disciplined approach is helping the company strengthen its financial position while creating opportunities for long-term expansion.
CRGY's latest performance highlights the effectiveness of this model. In the first quarter of 2026, the company generated $690 million in adjusted EBITDAX and $192 million in levered free cash flow despite reporting a net loss driven by non-cash derivative mark-to-market adjustments. Management expects to generate nearly $1 billion in levered FCF in 2026, supported by a projected FCF yield of more than 25%.
Image Source: Crescent Energy Company
Operational execution has further strengthened the business. Crescent Energy has already captured approximately $120 million in synergies from the Vital Energy acquisition, exceeding its original target through improved drilling efficiency, infrastructure optimization and lower development costs. These efficiencies allow the company to reinvest selectively while directing excess cash toward debt reduction, dividends, share repurchases and value-accretive acquisitions. With roughly $2 billion of liquidity, no near-term debt maturities and a long-term leverage target of about 1x, Crescent Energy remains financially flexible.
Although cash flow remains exposed to oil and natural gas price volatility, Crescent Energy's focus on capital discipline, operational efficiency and strong cash generation provides a solid foundation for future growth. If management continues to execute effectively and commodity markets remain supportive, the company's cash flow-centric business model should remain a key driver of long-term shareholder value.
How Does Crescent Energy Compare With Peers?Several U.S. exploration and production companies have recently been following a cash flow and capital discipline-centric theme, translating it into concrete financial targets and operational decisions.
EOG Resources, Inc. (EOG - Free Report) continues to demonstrate strong cash flow generation through disciplined capital allocation and low-cost operations. In the first quarter of 2026, EOG generated $1.5 billion in free cash flow and expects a record FCF of $8.5 billion for full-year 2026 while maintaining its $6.5 billion capital budget. The company is also committed to returning at least 70% of annual FCF to its shareholders through dividends and share repurchases. With a low breakeven below $50 WTI, a pristine balance sheet and a flexible multi-basin portfolio, EOG Resources remains well positioned to sustain strong free cash flow generation across commodity cycles.
SM Energy Company (SM - Free Report) demonstrated resilient cash flow generation in the first quarter despite its expenses related to the Civitas merger. The company reported adjusted FCF of $20 million, even after absorbing nearly $180 million in one-time integration and transaction costs. SM expects FCF to accelerate significantly through the remainder of 2026, supported by higher production, disciplined capital spending and growing merger synergies. Rising free cash flow is expected to support faster debt reduction, increased share repurchases and enhanced shareholder returns, positioning SM Energy for stronger financial performance in the second half of the year.
The Zacks Rundown on Crescent EnergyShares of Crescent Energy have gained nearly 8.1% in a year compared with the Oil/Energy sector’s growth of 24.1%.
Image Source: Zacks Investment Research
From a valuation perspective — in terms of the forward 12-month Price/Sales (P/S F12M) ratio — Crescent Energy is trading at a discount compared with the industry average, making it attractive for investors as more upside is still left in the stock.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate implies about 25.6% year-over-year growth in Crescent Energy’s 2026 earnings per share. In other words, investors are paying up for CRGY at a point when the fundamentals of the company are expected to accelerate.
Image Source: Zacks Investment Research
CRGY stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Niagen Bioscience získala od FDA označení pro vzácné pediatrické onemocnění a od EMA orphan medicinal product designation pro NB4168 na léčbu ataxie-telangiektázie. Firma říká, že jde o potvrzení vývoje kandidáta bez schválené léčby.
Regulatory recognition in the United States and Europe supports the development of NB4168, a novel small molecule candidate for a rare pediatric disease with no approved treatments
LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure than conventional NR while maintaining a differentiated pharmacokinetic and safety profile. In addition, the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation (OMPD) to NB4168 for the treatment of A-T, providing regulatory recognition in the European Union and further supporting the Company's plans to advance the program globally.
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
Share The FDA granted RPD Designation based on its determination that A-T is a serious and life-threatening disease that primarily affects individuals from birth through adolescence and meets the statutory definition of a rare disease. The EMA's Committee for Orphan Medicinal Products similarly concluded that NB4168 met the criteria for orphan designation for the treatment of A-T. Together, these regulatory designations recognize the significant unmet medical need in A-T and provide development incentives intended to support and accelerate the advancement of promising therapies for rare diseases.
NB4168 is the first investigational therapeutic candidate to emerge from Niagen Bioscience's recently announced wholly owned subsidiary focused on developing therapies for rare genetic diseases and age-related disorders, NAD Pharmaceuticals Corp. NB4168 is designed to have significantly higher bioavailability and increase NAD+, a coenzyme essential for DNA repair, mitochondrial function, cellular energy production, and stress responses—biological pathways disrupted in A-T. As A-T is categorized as a rare genetic premature aging disease, NB4168 may translate to other age-related diseases.
“Receiving RPD Designation from the U.S. FDA and OMPD from the EMA represents meaningful regulatory validation of NB4168 and our strategy to develop therapies for patients with serious rare diseases,” said Rob Fried, CEO of Niagen Bioscience. “These milestones strengthen our path toward clinical development and reinforce the opportunity to extend our leadership in NAD+ science into regulated medicines.”
About Ataxia Telangiectasia (A-T)
A-T is a rare genetic disease caused by mutations in the ATM gene. The disease typically presents in early childhood and is characterized by progressive loss of motor coordination, impaired immune function, increased susceptibility to infections, pulmonary complications, a substantially elevated risk of cancer, and premature aging. Children living with A-T often experience worsening neurological disability over time, with many requiring wheelchair assistance as the disease progresses. There are currently no FDA-approved therapies for A-T, and treatment is largely limited to supportive care. A-T impacts roughly 1 in 40,000 people in the U.S. (Riboldi et al., 2023; Teive et al., 2015) and 1 in 150,000 people in Europe (Bhatt et al., 2015).
About the U.S. FDA RPD and EMA OMPD
The FDA's RPD Designation is intended to encourage the development of therapies for serious and life-threatening diseases that primarily affect children. The designation provides certain regulatory and development incentives intended to support the advancement of promising therapies for rare pediatric conditions.
The EMA's OMPD is granted to therapies intended to diagnose, prevent, or treat life-threatening or chronically debilitating rare diseases affecting fewer than five in 10,000 people in the European Union. Orphan designation provides access to regulatory support and other development incentives designed to facilitate treatment development for rare diseases.
About NB4168
NB4168 is a distinct, proprietary small molecule designed for oral pharmaceutical development. It is not commercially available as a supplement or approved drug and has robust coverage by Niagen Bioscience's patent portfolio, including a composition-of-matter patent. After oral administration, NB4168 is designed to deliver significantly increased doses of NR to the bloodstream. NR enters cells directly, where it is converted through the nicotinamide riboside kinase pathway into NAD+. Because NAD+ supports DNA repair, mitochondrial function and cellular resilience, increasing intracellular NAD+ may represent a novel therapeutic approach for rare genetic diseases such as A-T in which these biological pathways are impaired.
The compound was designed to build upon Niagen Bioscience's extensive expertise in NR and NAD+ biology. The Company is currently advancing preclinical development activities and plans to submit an Investigational New Drug (IND) application to the FDA in anticipation of initiating human clinical studies, representing another step in Niagen Bioscience's strategy to translate decades of NAD+ science into proprietary medicines for serious rare genetic diseases.
“A-T is characterized by defects in DNA damage repair, mitochondrial dysfunction and chronic cellular stress, all biological processes that rely on adequate NAD+ availability,” said Vilhelm Bohr, M.D., Ph.D., D.Sc., formerly at the National Institute on Aging, NIH, and currently a Professor (AFL) in Molecular Aging at the University of Copenhagen. “The absence of effective treatment options underscores the urgent need for new therapeutic approaches. It is encouraging to see scientific advances in NAD+ biology translated into investigational medicines such as NB4168, as this intervention has implications for similar accelerated aging diseases.”
Niagen Bioscience, Inc. is a publicly traded bioscience company focused on NAD+ science and healthy aging research. The Company's product portfolio includes its flagship patented NR ingredient, Niagen®, Tru Niagen®, Niagen™ Plus and a pharmaceutical development effort focused on proprietary NAD+ precursors. Niagen Bioscience maintains a portfolio of over 50 patents protecting NR and other NAD+ precursors.
For additional information on the Pharmaceutical Program for rare genetic diseases and age-related disorders and NB4168, visit www.niagenbioscience.com/nad-pharmaceuticals.
About Niagen Bioscience
Niagen Bioscience, Inc. (NASDAQ: NAGE) is the global authority in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions.
The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality.
Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There’s a better way to age.
At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, and high-quality NAD+ booster available. Niagen powers the Company’s consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at www.truniagen.com), and Niagen™ Plus, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products (www.niagenplus.com). Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. NAD Pharmaceuticals Corp., the Company’s wholly owned subsidiary focused on developing therapies for rare genetic diseases and age-related disorders, is conducting research on NB4168, a differentiated molecule.
Niagen Bioscience’s robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at www.niagenbioscience.com, where copies of press releases, news, and financial information are regularly published.
†Based on revenue per largest U.S. e-commerce marketplace (Jan. 2025 – Dec. 2025)
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “anticipates,” “intends” “estimates,” “plans,” “potential,” “possible,” “probable,” “believes,” “seeks,” “may,” “will,” “should,” “could,” “predicts,” “projects,” “continue,” “would” or the negative of such terms or other similar expressions.
Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those described. These risks and uncertainties include, but are not limited to, statements regarding Niagen Bioscience's NB4168 pharmaceutical development program; planned preclinical, IND-enabling and clinical development activities; the potential timing of an IND submission or first-in-human study; the potential bioavailability, exposure, safety, tolerability, efficacy, pharmacodynamic or clinical profile of NB4168; and the Company's ability to translate its NAD+ platform into pharmaceutical products; inflationary conditions and adverse economic conditions; our history of operating losses; the growth and profitability of our product sales; our ability to maintain and grow sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; risks of conducting business in China; including unanticipated developments in and risks related to the Company’s ability to secure adequate quantities of pharmaceutical-grade Niagen in a timely manner; the Company’s ability to obtain appropriate contracts and arrangements with U.S. FDA-registered 503B outsourcing facilities required to compound and distribute pharmaceutical-grade Niagen to clinics; the Company’s ability to remain on the U.S. FDA Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Category 1 list; the Company’s ability to maintain and enforce the Company’s existing intellectual property and obtain new patents; whether the potential benefits of NRC can be further supported; further research and development and the results of clinical trials possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials; determinations made by the FDA and other governmental authorities, including with respect to products seeking to compete in our market; mislabeling or other misleading marketing practices by competitors; economic and market instability, including as a result of tariffs or trade conflicts; and the risks and uncertainties associated with our business and financial condition in general, described in our filings with the Securities and Exchange Commission (SEC), including, without limitation, our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q as filed with the SEC.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and Niagen Bioscience undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
Onto Innovation těží ze silné poptávky po AI čipech a čeká ve 2Q tržby 320–330 milionů USD, tedy zhruba o 28 % meziročně více. Pro celý rok 2026 míří tržby nad 1,3 miliardy USD.
Key Takeaways Onto exceeded Q1 guidance and projected stronger Q2 revenue on sustained AI semiconductor demand.ONTO expects advanced packaging revenue to grow more than 50% in 2026, backed by AI capacity expansion.Onto expects 2026 revenue above $1.3B as backlog, new products and customer expansions drive growth. Onto Innovation Inc. (ONTO - Free Report) is benefiting from strong demand for AI compute, which is driving momentum across both front-end semiconductor manufacturing and advanced packaging. During the first quarter of 2026, the company delivered revenue above its original guidance and expects this momentum to continue with a stronger second-quarter outlook. Management expects growth to continue through the second half of the year, supported by customer capacity expansions, increasing adoption of new products and a growing backlog. This demand is being fueled by the need for high-performance computing and enabling technologies such as silicon photonics.
The company continues to expand its process control capabilities through its broad portfolio of optical metrology solutions. Onto Innovation recently announced a collaboration with Rigaku to combine optical and X-ray technologies through its Ai Diffract software. The company stated that this combination addresses process metrology challenges involving advanced materials and complex 3D structures. The partnership has already resulted in competitive wins and additional customer evaluations across memory and logic manufacturers, while also creating opportunities for software licensing and future hybrid metrology solutions.
Growing AI semiconductor demand is also supporting Onto Innovation’s advanced packaging business. The company announced the qualification of its Dragonfly G5 inspection system at a leading 2.5D logic customer following earlier wins in high-bandwidth memory applications. Dragonfly G5 offers improved sensitivity, higher throughput and multiple sensor capabilities, and shipments are ahead of schedule. The company is actively working with additional customers across more than 15 applications and over 10 customers. At the same time, shrinking interconnect dimensions have increased demand for the company's 3DI technology, leading to additional customer orders.
Onto Innovation also highlighted that AI-driven packaging capacity constraints are encouraging the adoption of panel-level packaging, where its JetStep platform has secured qualifications with packaging suppliers. Based on these factors, the company expects advanced packaging revenue to grow more than 50% in 2026 while its advanced nodes business is projected to increase approximately 25%, supported by continued demand across logic, DRAM and an early recovery in NAND.
The company anticipates second-quarter revenues of $320–$330 million, implying about 10% rise from prior estimates at the midpoint and 28% year-over-year growth. Momentum is set to build in the second half, with at least 15% growth over the first half, putting full-year 2026 revenue above $1.3 billion.
Taking a Look at ONTO’s CompetitorsApplied Materials (AMAT - Free Report) is benefiting from AI-driven demand that is shifting wafer fabrication equipment spending toward leading-edge foundry-logic, DRAM and advanced packaging, where it holds leading process positions. In the second quarter of fiscal 2026, the company delivered record revenue and the highest gross margin in more than two decades, and management sees better multi-quarter visibility as customers share longer-range forecasts. New gate-all-around and packaging products, expanding EPIC collaborations and a growing services attach rate support value-based pricing and operating leverage. For the third quarter of fiscal 2026, Applied Materials expects total revenues of $8.95 billion plus or minus $500 million. Within that outlook, Semiconductor Systems revenues are projected at about $6.90 billion, Applied Global Services at about $1.75 billion and Other at about $300 million.
KLA Corporation (KLAC - Free Report) continues to benefit from AI-driven spending in leading-edge foundry/logic, high-bandwidth memory and advanced packaging, supporting market share gains in process control and steady services growth that helps anchor cash generation. Management expects its advanced packaging portfolio revenue to rise to about $1 billion in 2026 and sees wafer equipment demand strengthening into 2027, with June quarter guidance implying another step up in revenue. For the fourth quarter of fiscal 2026, KLA expects revenues of $3.575 billion plus or minus $200 million. KLA expects foundry/logic to represent approximately 82% of Semiconductor Process Control systems revenue to semiconductor customers in the June quarter, with memory at about 18%, reflecting a mix shift that could influence both revenue composition and near-term margin dynamics.
ONTO Price Performance, Valuation and EstimatesONTO’s shares have soared 22.9% in the past three months, outperforming the Zacks Nanotechnology industry’s growth of 19.9% and surpassing the Zacks Computer and Technology sector and the S&P 500 composite’s growth of 14.2% and 9%, respectively.
Image Source: Zacks Investment Research
In terms of forward price/earnings, ONTO’s shares are trading at 37.14X, higher than the industry’s 7.19X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ONTO has moved up for both 2026 and 2027 over the past 60 days.
Image Source: Zacks Investment Research
Onto Innovation currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
AST SpaceMobile plánuje na začátek srpna společný start tří satelitů BlueBird 11, 12 a 13. Firma tím míří k cíli mít do konce roku 45 satelitů BlueBird na oběžné dráze.
Midland, Texas-based AST SpaceMobile NASDAQ: ASTS has been a battleground for bulls and bears this year.
Among space stocks, it has been one of the most volatile, seeing its fair share of ups and downs throughout 2026 including a 59% run-up to its all-time high on May 28 and a series of double-digit peaks and troughs mixed in.
That trend has continued over the past month. Shares pushed up more than 35% from their one-month low June 25 through June 30. But since the calendar turned to July, the stock has given back nearly half of those gains, with ASTS now down more than 17% from that recent high.
Get AST SpaceMobile alerts:
AST SpaceMobile, Inc. (ASTS) Price Chart for Monday, July, 13, 2026
With its beta now up to 2.69, the SpaceX NASDAQ: SPCX rival and space-based direct-to-device (D2D) cellular broadband provider is likely positioned for more of the same as. But a combination of potential catalysts and inhibitors will ultimately decide whether AST SpaceMobile is able to break back into the green during the second half of the year.
This is a fair market value price provided by Massive. Learn more.
52-Week Range$36.08▼
$133.86Price Target$85.09
AST SpaceMobile’s bull case remains largely intact in large part due to maintaining its first-mover advantage in the space-based D2D market.
That has resulted in a myriad of formal strategic agreements that have cemented the company’s status.
Most recently, ASTS received a bump from Japan's $912 million satellite communications push. That put AST SpaceMobile’s existing partnership with Tokyo-based Rakuten OTCMKTS: RKUNY back into the spotlight while raising hopes for a major D2D rollout. The two companies are forming a joint venture that is targeting regulatory approval for D2D operations in Japan, with initial commercial services expected to begin later in 2026.
The company also has agreements with nearly 60 global mobile network providers, totaling more than three billion subscribers, and strategic partnerships in place with AT&T NYSE: T, Verizon NYSE: VZ, Vodafone NASDAQ: VOD, Rakuten, Alphabet NASDAQ: GOOGL, and real estate investment trust American Tower NYSE: AMT, among others. Over the long term, those relationships should continue to drive AST SpaceMobile's top-line growth, translating into strong earnings for patient investors.
An accelerated launch schedule for the company’s low Earth orbit (LEO) BlueBird satellites—the largest commercial arrays currently in operation—serves as another catalyst. A simultaneous launch of the next three, including BlueBirds 11, 12, and 13, is scheduled for early August from Cape Canaveral, Florida, aboard a Falcon 9 rocket.
The bundled launches should go a long way in AST SpaceMobile meeting its 2026 launch target of having 45 BlueBirds in LEO. According to president Scott Wisniewski, the company is in the process of producing and assembling satellites through BlueBird 37.
Headwinds: Mounting Costs, Launch Targets, Earnings MissesScaling at the pace and size that the company is comes at a steep cost. AST SpaceMobile posted a net loss of $342 million in 2025, which was nearly 969% higher than its net loss in 2022 after its first full year of operation as a publicly traded company. However, in Q1, that loss significantly accelerated to $191 million.
As the company ramps up its launch production and launch schedule, analysts are forecasting a full-year cash burn rate between $1.5 billion and $1.8 billion.
Another potential headwind is AST SpaceMobile’s lofty BlueBird launch target. While that also serves as a near-term headwind, longer term, it could present issues. Unforeseen launch complications and mishaps—like the Blue Origin deployment of BlueBird 7 at an insufficient orbit back in April—could adversely impact AST SpaceMobile’s ability to meet its year-end launch target. BlueBird 7 was subsequently deorbited, yet the company has maintained that it can reach its goal of having 45 LEO satellites deployed by the end of 2026.
Meanwhile, sentiment has been negatively impacted by a series of consecutive earnings per share (EPS) misses. AST SpaceMobile remains unprofitable, but its negative EPS has missed the analyst mark for five straight quarters, with only two beats in the past 11 quarters. This has played a major role in outflows driven by impatient investors who have been waiting for the stock—which had its IPO in April 2021—to finally turn a corner.
Where Wall Street StandsAST SpaceMobile Stock Forecast Today12-Month Stock Price Forecast:
$85.09
21.63% Upside
Reduce
Based on 10 Analyst Ratings
Current Price$69.95High Forecast$108.00Average Forecast$85.09Low Forecast$45.60AST SpaceMobile Stock Forecast Details
The smart money appears to be erring on the side of caution when it comes to ASTS.
Sentiment is tepid, with just one of the 10 analysts covering the stock assigning it a Buy rating.
Overall, it holds a consensus Reduce rating despite a 12-month price target implying about 16% potential upside from current levels.
In the past year, insider selling has muted insider buying by a ratio of more than $451 million to just over $187,000.
But institutional investors are evidently taking a longer-term approach, with buyers injecting $2.34 billion over the past 12 months compared to outflows of just over $487 million.
Still, as previously mentioned, more volatility is likely ahead, as reflected by current short interest of 21% of the float, which equates to $5.45 billion worth of shares.
Should You Invest $1,000 in AST SpaceMobile Right Now?Before you consider AST SpaceMobile, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AST SpaceMobile wasn't on the list.
While AST SpaceMobile currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Ondas po akvizici DZYNE Technologies zvýšila výhled tržeb pro rok 2026 na nejméně 525 milionů USD z 390 milionů USD. Zároveň rozšiřuje AI obranné systémy prostřednictvím IRON-WAVE a Palantir SkyWeaver.
Key Takeaways Ondas expanded AI defense with IRON-WAVE, integrating autonomous systems for military missions.ONDS raised 2026 revenue guidance to at least $525M after acquiring DZYNE Technologies.Ondas and Palantir's SkyWeaver aim to unify ISR data and support mission autonomy across platforms. Ondas Inc. (ONDS - Free Report) is strengthening its position in autonomous defense systems by expanding its AI-powered technologies, strategic partnerships and integrated defense platform. The company continues to execute its Core + Strategic Growth strategy, building a global operating platform for unmanned and autonomous systems serving defense, security, industrial and critical infrastructure markets. Through internal innovation, disciplined execution and acquisitions, Ondas has expanded its technology portfolio, customer relationships and global reach while increasing its backlog and pursuing larger defense opportunities. The company is also advancing multi-domain intelligence, surveillance and reconnaissance (ISR) capabilities through its partnership with Palantir, which provides access to AI software and operational tools designed to enhance mission autonomy and integrated defense solutions.
A key part of this strategy is the development of AI-enabled Systems of Systems platforms that combine aerial and ground technologies with integrated sensors and command-and-control capabilities. The newly introduced IRON-WAVE platform is designed as a multilayered robotic solution that integrates multiple autonomous systems to support military operations. Powered by an AI-assisted mobile command-and-control center, the platform enables coordinated multi-domain missions, combines counter-drone detection with offensive capabilities and has already been deployed with military units in active combat environments. Ondas noted that the system has received positive feedback for improving mission effectiveness, force protection and frontline operations.
The company is also expanding its ISR capabilities through the acquisition of World View and its partnership with Palantir. SkyWeaver, Palantir's AI platform deployed across the Ondas portfolio, is designed to connect data from stratospheric platforms, unmanned aerial systems and ground-based systems into a unified intelligence network. The platform continuously processes information, reasons across multiple domains, plans missions, coordinates autonomous actions and adapts to changing operational conditions. By automating intelligence collection, processing and dissemination, SkyWeaver is intended to deliver integrated, decision-ready intelligence while supporting mission autonomy across multiple defense platforms.
Ondas believes these AI-enabled capabilities strengthen its broader defense portfolio and support future growth opportunities. The company expects SkyWeaver to expand software content across its platforms while creating additional software licensing opportunities. Also, Ondas continues to invest in integrated command-and-control systems and AI-driven software as part of its Systems of Systems strategy. Management expects these technologies, together with expanding defense programs, acquisitions and a growing global pipeline, to support the continued scaling of its autonomous defense platform.
Recently, Ondas announced the acquisition of DZYNE Technologies, expanding its autonomous defense capabilities with long-endurance ISR, Counter-UAS, autonomous strike and logistics platforms while forming the new OndasSentinel division to strengthen integrated AI-driven defense solutions. The buyout also prompted management to raise its 2026 revenue guidance to at least $525 million from $390 million, supported by contributions from DZYNE, Omnisys and a stronger backlog and contract pipeline.
Taking a Look at ONDS Competitors’Red Cat Holdings, Inc. (RCAT - Free Report) is strengthening its position in the defense market by expanding its portfolio of unmanned aerial and surface systems while targeting growing military demand. The company is advancing its FANG, Black Widow, FlightWave and Blue Ops platforms to support defense missions across multiple domains. Black Widow has been deployed in multiple operational theaters and is being integrated with targeting, GPS-denied navigation and military command systems, while the company continues to pursue opportunities with the U.S. Army, Marines, Air Force, Ukraine and allied nations. Red Cat is also increasing manufacturing capacity, strengthening its supply chain and expanding production to support anticipated defense contracts and military requirements.
Draganfly (DPRO - Free Report) is strengthening its position in the defense market by expanding its military-focused operations, strategic partnerships and drone platform capabilities. During the first quarter of 2026, the company secured military orders from the U.S. Army, international customers and special operations units, while also supporting Air Force swarming technology initiatives and border security applications. It further enhanced its defense business by adding experienced military leadership, pursuing opportunities tied to growing defense spending and establishing partnerships with Global Ordnance and Babcock. Draganfly continues to focus on delivering interoperable drone platforms that support a wide range of defense missions and evolving operational requirements.
ONDS’ Price Performance, Valuation and EstimatesShares of ONDS have gained a whopping 214.3% in the past year compared with the Zacks Wireless-National industry’s growth of 102.6%.
Image Source: Zacks Investment Research
ONDS seems overvalued, as suggested by the Value Score of F. In terms of the forward 12-month Price/Sales ratio, ONDS is trading at 4.86, considerably lower than the industry’s multiple of 8.87.
Image Source: Zacks Investment Research
For ONDS, earnings estimates for the current year have been revised downward in the past 60 days.
Image Source: Zacks Investment Research
ONDS currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Skupina generálních prokurátorů jednotlivých států má už v pondělí podat žalobu proti plánované akvizici Warner Bros. Discovery společností Paramount Skydance kvůli antimonopolním obavám. Federální ministerstvo spravedlnosti USA už transakci schválilo.
A group of state attorneys general is expected to file a lawsuit as soon as Monday challenging Paramount Skydance's proposed acquisition of Warner Bros. Discovery, CNBC's David Faber reported.
The lawsuit, which will be brought by a group including California Attorney General Rob Bonta, is expected to try to block the merger on antitrust grounds, Faber reported.
The deal would combine two storied film studios — Paramount and Warner Bros. — as well as streaming platforms Paramount+ and HBO Max. Paramount CEO David Ellison has previously said the streaming services would become one following the merger.
It would also mean the formation of the largest portfolio of TV networks in the U.S., bringing together Paramount's broadcast network CBS and pay TV channels like MTV and BET with WBD's CNN, TNT and others.
The merger won approval from WBD shareholders in April, and Ellison said in a recent earnings call that it was on track to close by September.
The deal came under scrutiny from lawmakers in both the U.S. and Europe, including related to foreign funding that was part of Paramount's offer. In mid-June, the U.S. Department of Justice signed off on the tie-up, clearing it of federal antitrust concerns.
"The Division has completed its analysis of the proposed merger of Paramount and Warner Bros. and determined based on the evidence received in its investigation that the transaction is not likely to result in harm to competition or American consumers," the department said in its determination.
The merger has also won approval from several global jurisdictions as it moves toward a potential close.
However, the the European Union is still reviewing the deal for approval , with a new provisional deadline set for July 22. The European Commission said in a public filing this month that Paramount has submitted concessions in a bid to smooth over concerns regarding the deal.
Hollywood has previously expressed concerns about the combination, citing the likelihood for fewer film releases and the potential for job losses in the industry. Ellison has promised that once combined the film studios would put out a slate of 30 movies per year and has said he's committed to protecting jobs.
Ellison first set his sights on WBD last September. Just weeks after Paramount and Ellison's Skydance completed its merger, the company made its initial run for WBD, resulting in several bids and a formal sale process.
WBD ultimately signed a deal to sell its film studio and streaming assets to Netflix. However, Paramount launched a hostile takeover offer and subsequently amended its bid. Netflix ditched its deal, and Paramount walked away with an agreement to buy the entirety of WBD for $31 per share.
Application based on long-term safety and efficacy data from three ongoing studies, including adult height and additional clinical outcomes beyond linear growth, including body proportionality and arm span evaluated over long-term follow-up
FDA PDUFA target action date of Feb. 28, 2027
, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) for full approval in children with achondroplasia. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of Feb. 28, 2027.
"This submission for VOXZOGO is supported by the largest body of evidence for any medicine in achondroplasia, reflecting BioMarin's long-standing commitment to advancing the science of skeletal growth. The clinical data demonstrate meaningful improvements across multiple skeletal growth-related measures beyond annualized growth velocity in children with this condition," said Greg Friberg, M.D., Executive Vice President and Chief Research & Development Officer at BioMarin. "If approved, VOXZOGO would be the first therapy for achondroplasia to convert from accelerated approval to traditional approval based on a comprehensive clinical data package, including adult height outcomes and other clinical measures evaluated over extended follow-up."
The sNDA submission was supported by substantial long-term safety and efficacy data from three ongoing studies (111-205, 111-208 and 111-302), including clinically meaningful results in growth and improvements across key skeletal growth-related measures, including proportionality and arm span. The full package submitted to the FDA included the longest efficacy and safety data of any medicine studied in achondroplasia.
VOXZOGO received FDA accelerated approval in 2021, a pathway enabling faster patient access based on measures reasonably likely to predict clinical benefit. This sNDA is intended to fulfill the postmarketing requirement to confirm that benefit and convert to full approval, supported by long-term data from three ongoing studies demonstrating clinically meaningful improvements in growth and skeletal health outcomes in children with achondroplasia.
About Achondroplasia
Achondroplasia, the most common form of skeletal dysplasia leading to disproportionate short stature in humans, is characterized by slowing of endochondral ossification, which results in disproportionate short stature and disordered architecture in the long bones, spine, face and base of the skull. This condition is caused by a change in the FGFR3 gene, a negative regulator of bone growth.
More than 80% of children with achondroplasia have parents of average stature and have the condition as the result of a spontaneous gene mutation. The worldwide incidence rate of achondroplasia is about one in 25,000 live births. VOXZOGO is being tested in children whose growth plates are still "open," typically those under 18 years of age. Approximately 25% of people with achondroplasia fall into this category.
For more information about our clinical trials in achondroplasia, hypochondroplasia and other skeletal conditions, please visit clinicaltrials.biomarin.com.
About VOXZOGO (vosoritide)
In children with achondroplasia, endochondral bone growth, an essential process by which bone tissue is created, is negatively regulated due to a gain of function mutation in FGFR3. VOXZOGO, a C-type natriuretic peptide (CNP) analog, acts as a positive regulator of the signaling pathway downstream of FGFR3 to promote endochondral bone growth.
VOXZOGO is the only approved medicine to support the growth of children with achondroplasia starting from birth, with international consensus guidelines recommending initiation of VOXZOGO as early as possible. First approved in 2021, VOXZOGO has helped more than 5,000 infants and children in more than 50 countries. Through our ongoing studies, BioMarin continues to evaluate VOXZOGO on key clinical endpoints relevant for achondroplasia patients, such as arm span, tibial bowing (leg bowing), body proportionality, spinal morphology (including spinal stenosis) and quality of life measures.
VOXZOGO is approved in the U.S., Japan and Australia to increase linear growth in children of all ages with achondroplasia with open epiphyses, and VOXZOGO is indicated in the EU for the treatment of achondroplasia in children 4 months of age and older whose epiphyses are not closed, as confirmed by appropriate genetic testing. In the U.S., this indication is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trial(s). To fulfill this post-marketing requirement, BioMarin intends to use the ongoing open-label extension studies compared to available natural history.
Patient Support Accessing VOXZOGO
BioMarin's robust support services have ensured a seamless treatment experience, spearheaded by Clinical Coordinators, who have conducted hundreds of trainings for families with achondroplasia since approval. BioMarin provides resources to support families navigating achondroplasia, including a caregiver mentorship program that connects parents with other caregivers, and a U.S. doctor directory that helps families and healthcare professionals identify clinicians experienced in achondroplasia care.
To reach a BioMarin RareConnections® Case Manager, please call, toll-free, 1-833-VOXZOGO (1-833-869-9646) or e-mail [email protected]. For more information about VOXZOGO, please visit www.voxzogo.com. For additional information regarding this product, please contact BioMarin Medical Information at [email protected].
VOXZOGO U.S. Important Safety Information
What is VOXZOGO used for?
VOXZOGO is a prescription medicine used to increase linear growth in children with achondroplasia and open growth plates (epiphyses). VOXZOGO is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials. What is the most important safety information about VOXZOGO?
VOXZOGO may cause serious side effects including a temporary decrease in blood pressure in some patients. To reduce the risk of a decrease in blood pressure and associated symptoms (dizziness, feeling tired, or nausea), patients should eat a meal and drink 8 to 10 ounces of fluid within 1 hour before receiving VOXZOGO. What are the most common side effects of VOXZOGO?
The most common side effects of VOXZOGO include injection site reactions (including redness, itching, swelling, bruising, rash, hives, and injection site pain), high levels of blood alkaline phosphatase shown in blood tests, vomiting, joint pain, decreased blood pressure, and stomachache. These are not all the possible side effects of VOXZOGO. Ask your healthcare provider for medical advice about side effects, and about any side effects that bother the patient or that do not go away. How is VOXZOGO taken?
VOXZOGO is taken daily as an injection given under the skin, administered by a caregiver after a healthcare provider determines the caregiver is able to administer VOXZOGO. Do not try to inject VOXZOGO until you have been shown the right way by your healthcare provider. VOXZOGO is supplied with Instructions for Use that describe the steps for preparing, injecting, and disposing VOXZOGO. Caregivers should review the Instructions for Use for guidance and any time they receive a refill of VOXZOGO in case any changes have been made. Inject VOXZOGO 1 time every day, at about the same time each day. If a dose of VOXZOGO is missed, it can be given within 12 hours from the missed dose. After 12 hours, skip the missed dose and administer the next daily dose as usual. The dose of VOXZOGO is based on body weight. Your healthcare provider will adjust the dose based on changes in weight following regular check-ups. Your healthcare provider will monitor the patient's growth and tell you when to stop taking VOXZOGO if they determine the patient is no longer able to grow. Stop administering VOXZOGO if instructed by your healthcare provider. What should you tell the doctor before or during taking VOXZOGO?
Tell your doctor about all of the patient's medical conditions including If the patient has heart disease (cardiac or vascular disease), or if the patient is on blood pressure medicine (anti-hypertensive medicine). If the patient has kidney problems or renal impairment. If the patient is pregnant or plans to become pregnant. It is not known if VOXZOGO will harm the unborn baby. If the patient is breastfeeding or plans to breastfeed. It is not known if VOXZOGO passes into breast milk. Tell your doctor about all of the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. You may report side effects to BioMarin at 1-866-906-6100. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see additional safety information in the full Prescribing Information and Patient Information.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.
Forward-Looking Statements
This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. (BioMarin), including without limitation, statements about: BioMarin's expectations regarding the submission of its supplemental New Drug Application (sNDA) for VOXZOGO (vosoritide) for full approval in children with achondroplasia, including expectations regarding the Prescription Drug User Fee Act (PDUFA) target action date; the safety profile and potential benefits of VOXZOGO for children with achondroplasia, including benefits beyond height; and the development of BioMarin's VOXZOGO program generally and the continued clinical development of VOXZOGO, including in achondroplasia, hypochondroplasia and other skeletal conditions. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: results and timing of current and planned preclinical studies and clinical trials of VOXZOGO; any potential adverse events observed in the continuing monitoring of the patients in the clinical trials; the content and timing of decisions by the U.S. Food and Drug Administration, the European Medicines Agency, the European Commission and other regulatory authorities; and those factors detailed in BioMarin's filings with the Securities and Exchange Commission (SEC), including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, as such factors may be updated by any subsequent filings with the SEC. Investors are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.
BioMarin®, BioMarin RareConnections® and VOXZOGO® are registered trademarks of BioMarin Pharmaceutical Inc.
Apple od minima z 25. června vzrostl o 15 % a přidal téměř 600 miliard USD tržní kapitalizace. Investoři dávají přednost jeho silnému cash flow před vysokými výdaji do AI.
Apple's 15% rebound reflects investor preference for stronger cash flow over AI infrastructure spending. Summary
Apple outperforms AI peers as investors reassess AI spending returns.
Investors have moved back into Apple AAPL , the iPhone maker, as growing concerns about returns from artificial intelligence spending weigh on chipmakers and cloud-computing companies. Apple shares have climbed 15% since reaching a low on June 25, adding nearly $600 billion in market value and returning to record territory. Over the same period, the Philadelphia Stock Exchange Semiconductor Index declined 7%, while the S&P 500 advanced 3% and the Nasdaq 100 gained 1.3%. Investors increasingly appear to view Apple's decision to avoid the data-center spending race as an advantage, particularly as the market questions how much return large technology companies may generate from their AI investments. Mark Bronzo, chief investment strategist at Rye Strategic Partners, said Apple is benefiting from being outside the pressure facing the broader AI trade, where concerns have emerged over hyperscaler spending and semiconductor valuations.
Apple's 16% gain in 2026 has made it the strongest performer among the Magnificent Seven technology companies, even though the semiconductor index remains 83% higher this year. Alphabet GOOGL , a technology company investing heavily in cloud computing and AI, and Amazon AMZN , a technology company operating a major cloud-computing business, are both more than 10% below their May peaks, while Microsoft MSFT , a technology company with a large cloud-computing operation, has fallen 20% in 2026. Apple has also faced pressure from rising memory-chip prices, which could affect profit margins and prompted the company to increase prices across Macs, iPads and home devices on June 25. JPMorgan analyst Samik Chatterjee suggested that Apple's past pricing increases have had limited effects on longer-term sales volumes, supporting the view that its customers may be more willing than other hardware buyers to accept higher prices.
Investors may also see a potential catalyst in Apple's foldable iPhone, which is expected to be released in September and carry a premium price. Apple reportedly asked suppliers to prepare production for approximately 10 million foldable iPhones this year, above an earlier projection of seven million to eight million units. The company's fiscal 2026 revenue is expected to increase nearly 15%, representing its fastest annual growth since 2021, while net income is projected to rise 17%. Apple's free cash flow is forecast to reach a record $140 billion this year, more than 40% above 2025, while Alphabet's free cash flow is expected to decline about 67% to $21 billion. However, Apple trades at 33 times projected earnings for the next 12 months, compared with its 10-year average of 23 times, and only 61% of analysts tracked by Bloomberg recommend buying the stock, suggesting investors are paying a substantial valuation premium for its cash generation, more conservative spending approach and possible new iPhone upgrade cycle.
Apple žaluje OpenAI kvůli údajnému zneužití obchodního tajemství a chce soudně zakázat používání svých důvěrných informací. Spor míří na hardware a může zbrzdit ambice OpenAI v AI zařízeních.
Apple's decision to sue OpenAI marks one of the biggest legal confrontations yet in the artificial intelligence industry, transforming what was once a strategic partnership into an increasingly bitter rivalry.
The iPhone maker alleges that OpenAI systematically acquired Apple trade secrets to accelerate its ambitions in AI hardware, accusing the ChatGPT creator of using former employees, recruiting tactics, and supplier relationships to gain access to confidential information.
The lawsuit filed on Friday comes at a time when the battle in artificial intelligence is expanding beyond software models into consumer devices, making hardware the next major competitive frontier.
Here is a closer look at what Apple's lawsuit is about, why it matters, and what it could mean for the AI industry.
Apple's complaint alleges that OpenAI orchestrated a broad campaign to obtain confidential information relating to Apple's unreleased technologies, manufacturing processes, and products.
According to the lawsuit, OpenAI relied heavily on former Apple employees and supplier relationships to accelerate development of its own hardware products.
"Recently, significant evidence has emerged suggesting individuals employed by OpenAI wrongfully took Apple's secret and confidential information regarding our unreleased technologies, processes, and products," an Apple spokesperson said.
OpenAI has denied the allegations.
"We have no interest in other companies' trade secrets," OpenAI spokesperson Drew Pusateri said.
"We remain focused on building innovative technology that empowers people everywhere."
Apple is seeking a court order preventing OpenAI from possessing or using its confidential information and wants the AI company to return any Apple intellectual property it may possess.
The lawsuit represents a remarkable reversal in the relationship between the two companies.
In 2024, Apple announced a major partnership with OpenAI that integrated ChatGPT into iPhones, iPads, and Macs as part of its Apple Intelligence initiative.
That alliance, however, has steadily weakened.
Last month, Apple unveiled a revamped Siri powered by Google's Gemini AI model rather than ChatGPT, signalling a shift in its AI strategy.
Meanwhile, OpenAI has increasingly moved toward building its own consumer hardware ecosystem.
The turning point came when OpenAI agreed to acquire io Products, the hardware startup founded by legendary former Apple designer Jony Ive, in a deal valued at $6.4 billion.
The acquisition made clear that OpenAI intended to compete directly in hardware rather than simply provide AI software.
"OpenAI's nascent hardware business now rests on the shakiest of foundations, rotten to its core by its illegal reliance on misappropriated trade secrets," Apple said in its complaint.
Much of Apple's complaint focuses on former executives who later joined OpenAI.
Among those named is Tang Tan, OpenAI's chief hardware officer and a former Apple vice president.
Apple alleges Tan directed Apple employees interviewing with OpenAI to disclose confidential information.
"He has directed job candidates still working for Apple to bring 'actual parts' from Apple to their interviews for 'show and tell' sessions in which he and his team at OpenAI can elicit still more Apple confidential information," Apple alleged.
The lawsuit also names former Apple employee Chang Liu, alleging he stole an Apple laptop before joining OpenAI.
According to the lawsuit, Liu allegedly left Apple with three key assets: a company-issued MacBook that was never returned, an ongoing relationship with an Apple employee who continued sharing internal information, and, most significantly, knowledge of a software flaw that gave him continued access to Apple's internal file servers.
"LOL, I found out I can access the (network storage), so funny," Liu allegedly wrote to his former Apple colleague, Alyssa Peng, Bloomberg reported.
Liu then used that access to download presentations, hardware designs, manufacturing details and testing procedures – while already working at OpenAI, Apple alleges.
According to Apple, OpenAI also coached departing employees on how to avoid Apple's internal security procedures when leaving the company.
The complaint notes that more than 400 former Apple employees now work at OpenAI.
"That OpenAI now employs people who were once entrusted with Apple's trade secrets does not entitle OpenAI to use that information to jumpstart its hardware efforts," Apple wrote.
The complaint goes beyond employee recruitment.
Apple alleges OpenAI sought confidential information from Apple's manufacturing partners and suppliers.
One allegation claims OpenAI asked a hardware supplier to reproduce a proprietary metal-finishing technique developed by Apple while leading the supplier to believe Apple had authorised the work.
The company also claims that Tang Tan carried confidential information relating to Apple suppliers after leaving the company.
Apple said it first raised concerns with OpenAI in February, writing to the company about what it believed was the misuse of confidential information.
According to the complaint, OpenAI did not respond.
The lawsuit reflects a broader shift underway in artificial intelligence.
While AI companies initially competed by building increasingly powerful language models, attention is now turning toward dedicated AI devices that could reduce dependence on smartphones.
OpenAI's acquisition of Jony Ive's startup signalled ambitions to create new categories of AI hardware.
For Apple, whose business remains centred around the iPhone, such efforts represent a potential long-term competitive threat.
"Apple sees OpenAI moving from partner to potential rival, while OpenAI is trying to reduce its dependence on the iPhone and build a direct relationship with consumers," PP Foresight analyst Paolo Pescatore told Reuters.
"Even if the allegations are not proven, the lawsuit could delay OpenAI's hardware ambitions and further weaken what is already becoming an increasingly fragile partnership."
Does Apple have a history of such lawsuits?Yes.
Apple has previously taken legal action against former employees whom it believed misused confidential information.
In 2019, it sued former chief chip architect Gerard Williams III after he left to establish semiconductor startup Nuvia.
Apple eventually dropped that case in 2023.
The current lawsuit also recalls one of the company's most famous legal battles under Steve Jobs.
Jobs famously described Google's Android operating system as "a stolen product" and vowed to wage "thermonuclear war" against it.
According to accounts published at the time, Jobs said he would "spend every penny of Apple's $40 billion in the bank, to right this wrong."
Some observers see Apple's action against OpenAI as a similar attempt to slow an emerging competitor before it can reshape the consumer technology landscape.
Legal experts say Apple has raised serious allegations, but proving them may not be straightforward.
Mark Lemley, a professor at Stanford Law School, said the case could become significant if Apple can demonstrate that confidential documents were actually taken and used.
"But if Apple's claims that the employees took confidential documents with them — and that OpenAI is using those documents — are true, that is a problem for OpenAI," Lemley said in a Reuters report.
At the same time, he noted that hiring former employees is not illegal in California, where employment laws have historically encouraged labour mobility.
Rutgers Law School professor Camilla Hrdy said the dispute could prove unusually complex because most previous AI trade-secret cases have focused on software rather than hardware.
"These trade secret lawsuits are frequently brought in the tech space, and we usually learn much, much more as the case develops. OpenAI is not a defendant that can't afford to defend itself," Hrdy said.
Regardless of the eventual outcome, the lawsuit underscores how the AI race is rapidly expanding beyond algorithms into hardware, manufacturing and intellectual property, making the competition between technology giants increasingly resemble the smartphone wars that defined the previous decade.
Uber ve Washingtonu, D.C. lobbuje za pravidla, která by robotaxi musela fungovat v hybridní síti s lidskými řidiči, a tím se dostává do sporu s Waymo. Návrh zákona zároveň počítá s poplatkem 0,15 USD za míli.
A proposed bill that would allow autonomous vehicles to operate in Washington, D.C. has become a test case for Uber’s broader robotaxi strategy. Instead of simply partnering with, and investing in, robotaxi developers, Uber is also trying to shape the rules that govern them, an effort that puts it in direct opposition with its business partner, Waymo.
Uber, which opposes the bill, argues the proposed rule would displace for-hire human drivers and hand Waymo a de facto monopoly. It has lobbied instead for a system that would require robotaxis to operate on a ride-hailing network that also uses human drivers, according to public records viewed by TechCrunch and interviews with industry and company sources.
“We have already seen in other jurisdictions how a flawed, first-party only regulatory approach can disrupt a city,” Javi Correoso, who leads U.S. policy and federal affairs for Uber, said in May during a D.C. Council roundtable on a separate, existing statute regulating for-hire drivers. Correoso argued at the time that robotaxis create congestion by idling or cruising empty, cannot provide the kind of physical assistance to older or disabled adults that human drivers can, and cited data that states one AV displaces roughly four drivers.
When asked about the hybrid model, Correoso shared Uber’s regulatory vision.
“Hybrid model means that consumers should have the ability to access both. If a consumer is on the app, they should be able to choose,” he said, according to a publicly available recording and transcript. “I would go a step further: I think it should be part of the regulatory framework for the industry. There should be a requirement for consumers to be able to take an Uber that’s driven by a human.”
Alphabet-owned Waymo contends the bill, which it backs, will allow for the safe deployment of autonomous vehicles while supporting public transit, equitable access, and workers without restricting companies like Uber.
The two companies will pitch their positions on Monday during a day-long hearing. The bill’s passage is not imminent — many parties told TechCrunch they hope legislation is approved before the end of the year, and before Washington, D.C. Mayor Muriel Bowser leaves office in January. Still, the arguments and lobbying efforts surrounding the bill reflect a broader debate that stretches beyond Washington, D.C.
The proposed AV bill The bill, which was introduced by Councilmember Charles Allen in May, would update the existing Autonomous Vehicle Act of 2012 to allow for driverless testing and commercial driverless operations within the district. Today, companies like Waymo and Zoox can test autonomous vehicles, but only with a human safety operator behind the wheel.
The proposed bill would give the District Department of Transportation (DDOT) the authority to issue driverless testing and deployment permits to AV developers that meet certain requirements. Such requirements include holding a minimum of $5 million in liability insurance, and agreeing to report crash data within either eight hours or 72 hours, depending on whether the vehicle is part of a commercial fleet or a privately owned AV (which doesn’t yet exist in the market).
The bill would also charge robotaxi operators a $0.15 per mile tax, a proposal that robotaxi advocates have argued is too expensive. Revenue from the “vehicles miles traveled” (VMT) tax would be split, with 50% going toward public transit and the remaining used to support education and workforce development for rideshare and taxi drivers at risk of losing their jobs to robot cars.
Uber and Waymo are not the only parties interested in the bill. Numerous organizations and companies, including representatives from Tesla, Lyft, the Teamsters and Service Employees International Union labor unions, disability rights and accessibility advocacy groups, local business and industry groups, highway safety proponents, government officials, and think tanks are all scheduled to speak during Monday’s hearing.
The bill has even prompted an anti-robotaxi campaign, launched by a New York-based organization called Coalition for Accountability and Road Safety, which is canvassing voters and posting on social media.
It’s unclear who is funding the organization, which is registered to an employee of Pitta Bishop & Del Giorno LLC, a New York lobbying and government affairs outfit affiliated with labor and employment law firm Pitta LLP. According to publicly available lobbying documents listed by the city, Pitta has been retained over the past year by several labor unions and the New York Black Car Operators’ Injury Compensation Fund.
The stakes are high for all robotaxi developers, human drivers, and the ride-hailing and taxi companies that employ them in D.C. It’s arguably elevated for Uber and Waymo too, given their considerable market positions. Uber is the largest ride-hailing and delivery network in the United States, and Waymo is the largest robotaxi operator, providing more than 500,000 rides each week across 11 cities.
If Uber is successful and its hybrid network idea is adopted in D.C. — or elsewhere — it would leave AV developers like Waymo with two choices: put their robotaxis on ride-hailing apps like Uber’s, or employ human drivers who provide ride-hailing services alongside the robot cars that have taken years and hundreds of millions of dollars to develop.
If Waymo and other supporters of the D.C. bill are successful, Uber argues it will be pushed out altogether.
Protect and expand Image Credits:Uber/Lucid/Nuro The bill is a local policy fight, but it also highlights one prong of Uber’s strategy to protect its leading position in the ride-hailing and delivery market.
Uber is actively investing in and partnering with autonomous vehicle technology companies — more than 30 globally — while also building AV Labs, a new business unit designed to collect and share real-world driving data with AV developers. The company is hiring dozens of engineers for the division, according to job listings and interviews with sources familiar with the effort.
While Uber stakes its claim in the AV market, it is also championing protective policies that would require autonomous vehicles to operate alongside human drivers within a single platform — much like the Uber app.
Uber’s investment and partnership activity has been underway for several years. The company’s push for a hybrid network is recent, first emerging in a white paper published in May. Since then, Uber has ramped up its rhetoric with policymakers, including the D.C. Council roundtable meeting in May to discuss updates to the district’s Vehicle-for-Hire Innovation Amendment Act of 2014. (That law, which regulates ride-hailing and taxi services through the Department of For-Hire Vehicles, is separate from the AV bill, but multiple sources told TechCrunch that the policies overlap.)
Uber submitted a letter to the D.C. Council in June, which TechCrunch has seen, elaborating on Uber’s policy chief Correoso’s earlier comments. The letter stated the hybrid approach would be a single transportation network with traditional drivers that gradually incorporates autonomous vehicles.
“What this means in practice is that if you call an Uber in a market with AVs, you might get matched with an AV or a human driver, depending on the nature of your trip,” the letter reads.
In D.C., Uber is responding to a bill that would effectively ban hybrid networks altogether, company spokesperson Noah Edwardsen told TechCrunch.
Waymo disputes that interpretation, and a representative for the company said Waymo does not support efforts to limit AVs to specific types of networks. “We would welcome changes clarifying that different types of networks can operate in the District,” Waymo spokesperson Ethan Teicher wrote in an emailed statement sent to TechCrunch.
More broadly, Edwardsen said Uber has never taken a one-size-fits-all approach to policy, contrasting it to “advocacy from parts of the AV industry today, where proposals have repeatedly failed to address important issues like labor and transportation equity — or that have tried to cynically lock out competitors and create monopolies — making them largely unworkable.”
While numerous industry insiders have criticized aspects of the D.C. bill — notably the VMT tax and proposed cap on robotaxis — some disagree with Uber’s hybrid proposal.
Greg Rogers, founder and executive director of the nonprofit mobility and tech think tank The Innovation Majority, is scheduled to speak at Monday’s hearing, and he called Uber’s move an attempt at “regulatory capture.”
“Mobility is already a marketplace — people already can make choices on whether to take a bus, or ride a bike, or walk, or take rideshare every day,” Rogers told TechCrunch in an interview. “And any argument that you can improve consumer welfare by forcing certain business models and canceling out others does not improve people’s mobility choices. It does not improve road safety, and what it risks is only further entrenching interests and charging rent on anyone who seeks to operate AVs in the district.”
Uber’s pro-driver, ”let’s compromise” positioning may surprise close followers of the ride-hailing company. The company’s early history was painted by an anti-regulation ethos that sought out loopholes within existing laws, or ignored them altogether.
Uber often opposed union-supported regulations, like AB 5 in California, which would have disrupted its asset-light business model by classifying gig workers as employees. Proposition 22, a 2020 ballot initiative passed by voters and upheld by the California Supreme Court, was backed by Uber, Lyft, and others as a compromise that gave workers access to health insurance and other benefits while maintaining their contractor status.
Those fights, and others like it, have taught Uber that it has to consider human workers, and the power of labor unions that support them, if it wants to play a central role in the robotaxi market, according to sources. Uber’s own chief operating officer Andrew Macdonald struck a similar we-learned-our-lesson tone in a LinkedIn post in May that promoted its white paper.
Macdonald noted that the consequences of the company’s grow-at-all-costs approach led to “regulatory battles and a corporate crisis that damaged trust for years. “
“That experience changed us,” he wrote. “Today, we partner with cities instead of confronting them.”
Uber argues its hybrid network proposal is that compromise — one that allows robotaxis and human drivers to coexist on the same platform while easing labor concerns.
The company is committed to pitching the idea in other cities and states as lawmakers develop new AV laws or update existing ones.
Wired published its own report detailing lobbying efforts in New Jersey and D.C.
Uber’s stance, and its active lobbying, puts it on a collision course with Waymo.
Frenemies Image Credits:Waymo/Uber Waymo and Uber have squared off over autonomous vehicle technology before.
In 2017, Waymo sued Uber over allegations of trade secret theft. The high-profile trial, in which Waymo accused Uber of using trade secrets downloaded by former Google engineer Anthony Levandowski, delivered memorable testimony and evidence, including phrases like “laser is the sauce.” The trial lasted just five days before Uber agreed to settle, and the two companies stopped sparring, at least publicly.
Six years later, with Uber’s in-house AV development program sold off to Aurora, the former courtroom rivals teamed up. Waymo agreed to put its self-driving vehicles on Uber’s app in Phoenix in 2023. That partnership, which quietly ended in May, has been described as limited and as a “pilot.” Waymo also operates its own stand-alone app in Phoenix, its first robotaxi market.
The relationship seemed to solidify by March 2025, when company executives — grasping mugs of prickly pear margaritas and plates of Terry Black’s barbecue at a private party — celebrated the launch of Waymo robotaxis on the Uber app in Austin during the annual music, film, and tech fest, SXSW. The partnership soon expanded to Atlanta. In both of those cities, prospective customers cannot hail a robotaxi directly through Waymo’s app, and have to use the Uber app and hope for a match.
In recent months, the relationship has soured — and publicly.
Earlier this year, Uber chief technology officer Praveen Neppalli openly criticized Waymo on X, posting a video and commentary calling out the unsafe and “scary” behavior of a Waymo robotaxi. During an earnings call in May, Uber chief executive Dara Khosrowshahi directed comments toward Waymo without directly naming the company when he expressed support for regulators.
“They’re asking the right questions, which is how are AVs going to interact with — in situations where the power goes out or interacting in school zones or working with firefighters, etc. in the city,” said Khosrowshahi, referring to recent incidents that involved Waymo robotaxis.
The tension between Waymo and Uber has even gone global, with both companies poised for a looming showdown in London.
As speculation swirls over when Uber and Waymo’s existing partnerships in Austin or Atlanta will implode, both companies are gearing up for a regulatory fight that appears poised to spill into other cities and states.
Uber is betting, and lobbying for, a different future than the one Waymo envisions.
“We think the future of our transportation system will be hybrid,” Uber’s head of AV policy Harry Hartfield said in testimony submitted ahead of Monday’s meeting. “Public policy should be designed around that reality, not around an AV-only future that does not exist.”
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.
Netflix zveřejní výsledky za 2. čtvrtletí po uzavření trhu ve čtvrtek 16. července; analytici čekají zisk 79 centů na akcii a tržby 12,58 miliardy USD.
Netflix, Inc. (NASDAQ:NFLX) will release its second quarter earnings report after the closing bell on Thursday, July 16.
Analysts expect the Los Gatos, California-based company to report quarterly earnings of 79 cents per share, up from 72 cents per share in the year-ago period. The consensus estimate for Netflix’s quarterly revenue is $12.58 billion. It reported $11.08 billion last year, according to Benzinga Pro.
According to the Wall Street Journal, Netflix is exploring options to boost subscriber engagement.
Shares of Netflix fell 2.8% to close at $73.37 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
Considering buying NFLX stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Goldman Sachs před výsledky za 2. čtvrtletí klesl od letošního maxima o více než 6 % a technicky vytváří medvědí formaci. Trh čeká silné výsledky, ale akcie zůstávají zranitelné.
Goldman Sachs stock has pulled back more than 6% from its year-to-date high and has gradually formed a risky chart pattern ahead of its second-quarter earnings on Tuesday. The stock was trading at $1,055 and appears vulnerable to further downside despite expectations for strong earnings.
The GS stock price has pulled back in the past few weeks, moving from a high of $1,125 on June 15 to $1,055. It has formed a head-and-shoulders pattern, a common bearish reversal sign in technical analysis. Its head is at $1,125, while the right and left shoulders are at $1,100. The neckline is at $1,000.
The stock has also formed what looks like a diamond reversal pattern, which normally leads to a bearish breakout over time. At the same time, the two lines of the MACD indicator formed a bearish crossover and are pointing downwards.
Therefore, there is a risk that the stock will retreat in the coming weeks, potentially to the neckline at $1,000. The bearish outlook will become invalid if it jumps above the head section of $1,125.
GS stock chart | Source: TradingView
On the positive side, all signs are that the company will publish strong financial results on Tuesday this week.
All indications are that its business is having one of its best years. For example, data compiled by the Wall Street Journal shows that Goldman Sachs has advised M&A deals worth over $1.2 trillion this year, much higher than JPMorgan’s $843 billion.
Goldman Sachs has also led as the top bookrunner in IPOs this year, with the value of deals rising to over $67.9 billion, higher than last year’s $35 billion. Dealogic estimates that its investment banking revenue jumped to over $5.7 billion, higher than last year’s $4.1 billion.
The most recent results showed that its business boomed in the first quarter, with the Global Banking and Markets division rising by 11% to over $12.7 billion. Its asset and wealth management revenue rose by 10% to $4 billion.
READ MORE: Goldman Sachs stock has soared: here’s why it has more gains ahead
This growth likely continued growing in the second quarter as its investment banking and trading businesses soaring. Its investment banking revenue is benefiting from major deals, including the recent SpaceX IPO and the recent SK Hynix listing. It also took part in the $67 billion deal between NextEra and Dominion Energy.
Trading has also continued booming this year, helped by the US-Iran war that has led to substantial market volatility.
Analysts anticipate that the upcoming results will show that its business continued to boom. The average estimate is that its revenue rose by 12.50% to $16.4 billion, while its guidance for the third quarter will be $16 billion. Goldman has a long history of doing better than expected.
Analysts have a bullish outlook for the company. Bank of America boosted its target from $1,050 to $11,50, while UBS hiked from $940 to $1,120. BMO Capital Markets and Morgan Stanley hiked to $1,070 and $1,099.
Intel investuje kapitálově 5 miliard eur (5,7 miliardy USD) do modernizace irského areálu v Leixlipu a rozšíření evropské výroby pro AI a high-performance computing. Investice má vytvořit několik stovek pracovních míst.
The Intel logo at the 10th edition of the VivaTech technology startups and innovation fair in Paris, France, June 18, 2026. REUTERS/Gonzalo Fuentes/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesInvestment to add several hundred jobs at Irish operationMajority of investment to be deployed by end-2027LEIXLIP, Ireland, July 13 (Reuters) - Intel (INTC.O), opens new tab has begun a €5 billion ($5.7 billion) capital investment to upgrade its Irish campus and expand its European output to meet growing global demand for AI and high-performance computing, the U.S. chipmaker said on Monday.
Intel said the move would upgrade and maximize capacity at its facility in Leixlip outside Dublin that produces Intel 3 silicon wafers, which the company says is the most advanced semiconductor manufacturing facility of its kind in Europe.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
It will also link the facility to other factories at the campus, Intel's European manufacturing base, as well as advance research and development and retrain staff, Naga Chandrasekaran, executive vice president of Intel Foundry, said.
Intel is one of the key multinationals in Ireland's foreign investment-focused economy, having already invested €30 billion in the country since 1989, more than half of which was spent between 2019 and 2023 on the fabrication facility that doubled the available capacity in Ireland.
The leading-edge manufacturing equipment that Intel has begun to install will help deliver Intel Xeon 6 processors and next-generation Intel Xeon built on the group's Intel 3 manufacturing process, the company said.
"The demand for servers, the demand for AI is driving a significant increase in the need for Intel 3 wafers," Chandrasekaran told reporters.
Chandrasekaran said the investment would add "several hundred" more jobs to the 4,900 people Intel employs in Ireland.
The majority of the investment would be made by the end of 2027 and represents about 30% of Intel's $17 billion planned capital expenditure for 2026, he added.
Ireland is hugely reliant on the taxes and jobs of foreign multinationals such as Intel. Foreign-owned firms have almost doubled their Irish workforce in the last decade to make up 11% of the entire labour market.
Irish Prime Minister Micheal Martin said Intel's latest investment was a powerful vote of confidence in Ireland and its position as a location for advanced manufacturing.
($1 = 0.8750 euros)
Reporting by Padraic Halpin; Editing by Sarah Young and Tomasz Janowski
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Adobe (NASDAQ: ADBE | ADBE Price Prediction) has been beaten down while fundamentals improved. Our 24/7 Wall St. price target is $283.39, roughly 26.72% above the current price of $223.64. We rate the stock a buy with 90% model confidence. An $88.9 billion software franchise with AI-first ARR north of $500 million, trading at a forward P/E near 9.
Metric Value Current Price $223.64 24/7 Wall St. Price Target $283.39 Upside 26.72% Recommendation BUY Confidence Level 90% Adobe Was Cut Nearly in Half While Fundamentals Improved ADBE is down 39.79% over the last year and 36.1% year to date, below the 52-week high of $376.16 and just above the $190.12 low.
Q2 FY26, reported June 11, 2026, was a record. Revenue hit $6.62 billion (up 13% YoY), non-GAAP EPS of $5.96 marked a fifth straight beat, and total ARR closed at $27.10 billion. Management raised FY26 non-GAAP EPS guidance to $24.35 to $24.45.
The Case for $322 and Higher Our bull scenario takes ADBE to $322.51, a 44.21% return over 12 months. Firefly ARR is approaching $300 million and grew roughly 50% quarter over quarter, Firefly enterprise ARR is up 4x YoY, and Creative freemium MAU jumped from 50 million to 90 million.
Acrobat AI Assistant paid MAU grew 150%+ YoY. Options positioning skews bullish with a full-chain put/call ratio of 0.46. The Semrush deal adds roughly $480 million in ARR, and consensus of $272.48 implies meaningful upside.
What Could Go Wrong Our bear scenario finishes at $249.71, still an 11.66% return. CEO Shantanu Narayen is transitioning to Board Chair, CFO Dan Durn departed June 15, 2026, and Q2 GAAP EPS of $4.25 was weighed by a $70 million goodwill impairment and a $30 million litigation accrual.
Competition from OpenAI, Canva, Figma, and Microsoft Copilot has crushed the multiple. Recent insider activity skewed to selling. The goodwill charge is a non-cash write-down on a legacy Publishing and Advertising unit. Non-GAAP EPS of $5.96 still grew 18% YoY. The operating engine remains intact.
How Adobe Compares to Salesforce and Autodesk Adobe’s forward P/E near 9 looks cheap against two AI-forward software peers.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Adobe didn't make the cut. Grab the names FREE today.
Salesforce (NYSE: CRM) Salesforce (NYSE: CRM) is the cleanest AI-monetization comparison. Q1 FY27 revenue of $11.13 billion grew 13.3% YoY, with Agentforce plus Data 360 ARR near $3.4 billion, up over 200% YoY. Salesforce trades at a trailing P/E of 18 versus Adobe at 13. On a comparable AI-growth basis, Adobe screens materially cheaper.
Autodesk (NASDAQ: ADSK) Autodesk (NASDAQ: ADSK) is the closest creative and design software analogue. Q1 FY27 revenue of $1.93 billion grew 18.4% YoY with non-GAAP EPS of $2.99. Management guides FY27 non-GAAP EPS of $12.40 to $12.65.
Adobe’s forward EPS of $26.26 and Q2 revenue growth of 13% suggest the market is pricing ADBE like a decelerating incumbent, while the numbers describe a raised-guidance AI beneficiary.
I Would Buy Here, With Eyes Open The 24/7 Wall St. price target of $283.39 with 90% confidence and a buy rating reflects a rare valuation gap in mega-cap software. A forward P/E of 9 attached to a business that just raised guidance and tripled AI-first ARR to over $500 million makes this compelling.
The setup looks attractive for investors who can stomach CEO and CFO succession noise. The thesis weakens if AI-first ARR growth breaks or if the freemium payback (management expects it to play out over 2027) fails to materialize.
Year 24/7 Wall St. Price Target 2026 $251.16 2027 $283.39 2028 $335 2029 $390 2030 $446.28 These projections assume Adobe converts freemium traffic into paid seats and defends its creative moat. Meaningful upside or downside could come from the CEO succession outcome, the pace of AI monetization, or a broad re-rating of the software sector.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Adobe didn't make the cut. Grab the names FREE today.
Merck získal nové schválení FDA pro Keytrudu a Keytrudu QLEX v kombinaci s Padcevem u dospělých se svalově invazivním karcinomem močového měchýře jako léčbu před a po operaci. Akcie MRK byly po zprávě téměř na maximech.
Merck & Co. Inc. (NYSE:MRK) shares are in focus Monday after a wave of analyst activity capped by a new FDA approval for its cancer drug Keytruda.
Merck stock is trading near recent highs. What’s the outlook for MRK shares? Analyst Consensus and Recent Actions The stock carries a Buy rating with an average price target of $133.86. Recent analyst moves include:
Morgan Stanley: Equal-Weight (Raises Target to $113.00) (July 9) RBC Capital: Outperform (Maintains Target to $142.00) (July 8) Wells Fargo: Overweight (Raises Target to $150.00) (July 8) The FDA ApprovalThe week culminated Friday when the U.S. Food and Drug Administration (FDA) approved KEYTRUDA and KEYTRUDA QLEX, Merck’s anti-PD-1 therapies, each in combination with Padcev, as treatment before and after surgery for adults with muscle-invasive bladder cancer.
The approval expands Keytruda’s already dominant position in the immuno-oncology landscape and adds another indication to the drug’s broad label, which already spans multiple cancer types.
Merk Shares Edge HigherMRK Price Action: At the time of publication, Merck shares are trading 0.11% higher at $123.68, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Jim Cramer walked onto CNBC’s Mad Dash last week on Wednesday morning and turned on a company he has championed for years. The target was Palantir (NASDAQ:PLTR | PLTR Price Prediction), a stock he has repeatedly told viewers to own through every valuation panic since the AI trade caught fire. His complaint was about a company-produced NFT video that Palantir made, posted, and then quietly pulled. Cramer wants management to disavow it publicly before market close.
What Cramer Said Cramer opened by re-anchoring his bull case. “I’ve been a big supporter, Palantir, mostly because of what it does in real business, which is really help organizations get their act together,” he said. Then came the pivot. Reacting to a Financial Times piece examining Palantir’s political alignment with Republicans, Cramer zeroed in on the NFT video itself, calling it “one of the most frightening things I’ve seen” and describing it as “a Punisher-like video… on the site of the company made itself, which is subsequently pulled, that I found very disturbing.”
The line that will get replayed all day is his interpretation of the imagery. “It’s basically saying, listen, we’re Satan. Look out!” Cramer said. From a host who has spent two years defending Alex Karp’s leadership and Palantir’s growth story, that is a genuine break.
Why Reputational Risk Matters for a Stock Like Palantir Palantir sells Gotham, Foundry, and AIP to defense agencies, hospital systems, and Fortune 500 boards that require multi-year procurement cycles and internal champions willing to stake their reputations on the vendor choice. The fundamentals have been extraordinary. Q1 2026 revenue landed at $1.63 billion, up 84.7% year over year, with U.S. commercial revenue up 133% to $595 million, and management raised full-year guidance to roughly 71% growth (see the Q1 2026 press release filed with the SEC).
That is the growth profile of a company whose customers are still saying yes. Cramer’s warning is about the second derivative. “A board member might say… maybe we can’t use Palantir because… it shouldn’t be doing these kinds of videos,” he said. Enterprise procurement runs on soft signals as much as on software demos, and a single risk committee memo citing brand-safety concerns can freeze a nine-figure pipeline for a quarter.
July 16 is the Final Day to Tap Into the Lithium Boom (sponsor)
General Motors, POSCO, and 50,000+ everyday investors have already backed lithium producer EnergyX.
Here's why you should do the same before their July 16 investment deadline: lithium prices are up 75% this year, with demand projected to grow a staggering 5X by 2040.
With tech that can recover up to 3X more lithium than traditional methods, EnergyX is preparing to unlock up to 15M+ tons. Become a private-stage EnergyX investor before the July 16 deadline.
The stock is already wobbling. Palantir is down 3.6% in the past five trading sessions and off 23% year to date. At a trailing P/E of 144x and a price-to-sales ratio above 60x, this is a stock priced for perfect execution on both the product and narrative fronts.
What Palantir Did Cramer’s prescription was unusually direct. “They have to distance themselves from this. They have to do it today,” he said. A quiet takedown is not enough when a Financial Times feature is already in circulation, and CNBC’s most-watched personality is telling his audience the imagery evokes Satan.
Palantir indeed removed that video after Cramer’s warning.
The Palantir bull case has always rested on hard product wins and a founder-led mystique that made customers feel they were joining a movement. Movements attract iconography, and iconography can go wrong. The video did not spiral into a bigger deal due to its quick removal.
Meet America's Newest $1b Unicorn (Sponsor) A US startup just passed a $1 billion private valuation, joining billion-dollar private companies like OpenAI and ByteDance. Unlike those other unicorns, you can invest in EnergyX right now; but only until July 16.
Over 50,000 people already have, along with global giants like General Motors and POSCO.
Here's why there's so much interest: EnergyX's patented tech can recover up to 3X more lithium than traditional methods. That's a big deal, as demand for lithium is expected to 5X current production levels by 2040. Become an early-stage EnergyX shareholder before the 7/16 investment deadline.
Micron ve 4. fiskálním čtvrtletí 2026 očekává tržby kolem 50 miliard USD a upravený zisk na akcii (EPS) 31 USD, oba údaje nad odhady. Firma zároveň oznámila investice v USA přes 250 miliard USD do roku 2035.
Key Takeaways Micron's AI memory business is benefiting from strong demand, supply shortages and rising HBM pricing.MU forecast fiscal Q4 2026 revenue of about $50B and adjusted EPS of $31, above consensus estimates. Micron plans major U.S. investments through 2035 to expand AI memory capacity and secure silicon supply. Micron Technology Inc. (MU - Free Report) witnessed a meteoric rise in its stock price in the first half of 2026, rallying nearly 340%. On June 24, the company posted blockbuster third-quarter fiscal 2026 earnings results, crushing all estimates.
As a result, on June 25, shares of MU touched an all-time high of $1,255. Thereafter, the stock has seen a gradual decline and is currently in the bear-market territory plunging 22% from its all-time high. However, the recent softness in the stock price has opened a tremendous opportunity for both short and long-term investors.
The chart below shows the price performance of MU in the past month.
Image Source: Zacks Investment Research
Excellent Business Opportunity Micron has been benefiting tremendously from the enormous application of AI in day-to-day life, which has pushed up the demand for memory chips. The four major hyperscalers raised their AI capital expenditure budget to $750 billion for 2026. This figure is set to cross $1 trillion next year and is likely to rise further beyond 2027.
This has resulted in more AI semiconductor sales, implying the need for multiple AI memory chips to operate. Flash memory technologies like DRAM and NAND are used in AI chips, enabling them to perform optimally.
This has pushed up the demand for AI-enabled memory chips. In their last earnings reports, all four major hyperscalers highlighted a shortage of memory and storage chips, resulting in soaring prices of these products. As a result, MU benefits significantly.
Micron’s CEO, Sanjay Mehrotra, said, “Our customers are recognizing that supply shortages in memory and storage will take considerable time to improve, even as we expect industry supply to improve gradually in 2028.”
Solid Estimate RevisionsMicron has an expected revenue and earnings growth rate of more than 100% each, for the current year (ending August 2026). The Zacks Consensus Estimate for the current year’s earnings has improved 22.6% over the last 30 days.
MU has an expected revenue and earnings growth rate of 87.8% and more than 100%, for the next year (ending August 2027). The Zacks Consensus Estimate for next year’s earnings has improved 44.3% over the last 30 days.
Image Source: Zacks Investment Research
Image Source: Zacks Investment Research
Micron’s gross margin climbed to 84.9% in the third quarter from 74.9% in the prior quarter and 39% in the year-ago period. This proved how high-bandwidth memory (HBM) shortage is helping these high-end memory developers to increase prices in a world of AI-powered data center boom. Likewise, the Zacks Consensus Estimate for 2027 EBITDA margin has shown steady improvement since mid-May.
Image Source: Zacks Investment Research
New Tech Trends to Drive ProspectsThe performance of any AI model depends on memory performance and capacity. MU’s HBM is a highly sought-after product for NVIDIA Corp. (NVDA - Free Report) , Advanced Micro Devices Inc. (AMD - Free Report) and Alphabet Inc. (GOOGL - Free Report) to name a few, for their AI-enabled chipsets.
Micron has meaningful exposure to AI, cloud data centers, industrial IoT and autonomous vehicles, all of which require increasingly advanced memory solutions. As AI adoption accelerates, demand for DRAM and NAND products continues to rise.
NVIDIA identified Micron as a key HBM supplier for its GeForce RTX 50 Blackwell GPUs, reinforcing its importance within the AI supply chain. Demand for HBM4 is also benefiting from next-generation AI infrastructure deployments, including NVIDIA’s Vera Rubin platform.
On July 8, Reuters reported that Micron has decided to invest more than $250 billion in the United States through 2035. The company’s original investment plan was $170 billion, which it raised to $200 billion in June.
Moreover, MU also unveiled its plan to invest $3 billion in GlobalWafers' silicon wafer manufacturing operations in Texas. The two companies plan to enter a 10-year deal to ensure a long-term supply of raw silicon wafer capacity to the AI memory chip behemoth.
Strong Guidance Micron anticipates revenues of $50 billion (+/1 billion) in the fiscal fourth quarter of 2026. Operating expenses on a non-GAAP basis are estimated to be approximately $1.65 billion. Adjusted EPS is anticipated to be $31.00 (+/- $1.00).
Attractive Valuation Despite a robust rally, the MU stock still looks very attractive. It trades at a forward 12-month price-to-earnings (P/E) multiple of 13.43, which is significantly lower than the industry average of 27.73. This discount adds to the appeal for long-term investors.
MU trades at a price-to-sales (P/S) multiple of 12.41, compared with the industry average of 10. Further, it trades at a price-to-book (P/B) multiple of 11.12, compared with the industry average of 8.40. These two multiples warrant premiums due to the company’s dominant position in the AI HBM and DRAM markets.
Huge Price Upside PotentialThe current Zacks Consensus average price for Micron is based on short-term price targets offered by 33 analysts. The short-term average price target of brokerage firms represents an increase of 52.2% from the last closing price of $979.30.
The brokerage target price is currently in the range of $2,000-$470. This indicates a maximum upside of 104.2% and a maximum downside of 52%. The risk/reward ratio is highly favorable 1:2.
Image Source: Zacks Investment Research
What Next for MU?Micron currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
MU has invested heavily in next-generation memory technologies, positioning itself to meet the growing performance and efficiency requirements of AI ecosystems. MU’s position in the AI ecosystem continues to strengthen.
Micron Technologies represents an opportunity to invest in a company with substantial unrealized potential in the AI revolution. At this stage, it will be prudent to buy MU on every dip. Hold this stock for the long term as the astonishing growth potential of the global AI-powered data centers and MU’s strong guidance and business visibility are likely to generate more value.
Micron, SanDisk a Western Digital v pondělí ráno klesly o 6 % poté, co slabý výhled zisku SK Hynix za 2. čtvrtletí otřásl akciemi firem z oblasti pamětí. Korejský broker KIS snížil odhad o 8 % pod konsensus.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Memory and storage stocks are selling off sharply Monday morning as a weak second-quarter profit estimate for South Korea’s SK Hynix rattled the AI memory trade. Micron Technology (NASDAQ:MU | MU Price Prediction) stock, SanDisk (NASDAQ:SNDK) shares, and Western Digital (NASDAQ:WDC) stock were each down 6% a few minutes after the day’s session started.
The moves come after historic runs. Micron stock was up 243% year to date (YTD) through Friday’s close, SanDisk shares had climbed 707%, and Western Digital stock was higher by 238%. Today’s 5% pullback trims only a small slice of those gains.
Renewed U.S.-Iran headlines and the ongoing debate about the payoff on AI capital spending sit in the background of these stock declines. However, specific events surrounding SK Hynix are hitting memory/storage stocks particularly hard.
Weak SK Hynix Estimate Triggers a Memory Reset The trigger came from Seoul. South Korean brokerage KIS published a Q2 2026 profit estimate for SK Hynix 8% below consensus, citing slower-than-expected HBM4 (high-bandwidth memory) shipments and heavy reliance on HBM contracts. That call cut into the core bull thesis for the entire memory complex.
SK Hynix stock fell 15% in Asia, its largest single-day drop ever, a stunning reversal from its strong U.S. NASDAQ debut on Friday. Samsung slid alongside it and the KOSPI dropped 9%, triggering a 20-minute trading halt. U.S.-listed SK Hynix shares were set to open sharply lower after Friday’s debut.
U.S. memory names sold in sympathy. SK Hynix is Micron’s most direct competitor in DRAM and high-bandwidth memory, so any signal that HBM4 shipments are slipping raises questions about pricing power across the group. The reaction reads as profit-taking plus a scare that the memory super-cycle‘s momentum may be cooling.
Peers and the Memory ETF Feel the Ripple Seagate Technology (NASDAQ:STX) stock is down 4% to $869 this morning after a YTD run of 231% through Friday’s close of $910.34. The hard-disk maker trades on similar AI storage tailwinds as Western Digital, and both are moving in tandem with the DRAM and NAND names. Seagate stock also carries a beta of 2.07, so its swings have tended to run larger than the broader tape in both directions.
The Roundhill Memory ETF (NYSEARCA:DRAM) is taking a bigger hit than the U.S. constituents, with the ETF down 9% to $57.52. That reflects concentration: the top three holdings, Samsung Electronics, SK Hynix, and Micron, account for 73% of net assets, and the Korean names are leading the losses. The ETF is a narrow, non-leveraged thematic fund, and today’s move highlights its single-region concentration risk.
Sell-side conviction hasn’t evaporated, though. Citi recently reaffirmed a Buy on Western Digital with an $800 target, well above Friday’s close. That constructive analyst view is being overshadowed by sector-wide selling this morning.
What to Watch Now The bull case for Micron rests on durable AI-driven memory demand. Micron’s recent Q3 FY2026 results showed revenue of $41.5 billion, up 346% year over year (YoY), with non-GAAP EPS of $25.11 and gross margin expanding to 85%. CEO Sanjay Mehrotra guided Q4 FY2026 revenue to $50 billion, plus or minus $1 billion, citing multi-year Strategic Customer Agreements and HBM4 already in high-volume shipments. The bear case is memory cyclicality, the HBM4 shipment and pricing concern flagged for SK Hynix, and rich valuations after a massive run. Investors should consider keeping their position sizes modest given the volatility.
SanDisk’s own Q3 FY2026 report was similarly outsized. Revenue jumped 251% YoY to $5.9 billion, non-GAAP EPS came in at $23.41, and management guided Q4 revenue between $7.75 billion and $8.25 billion. The company also cleared $650 million in debt to reach a zero-debt balance sheet, giving it flexibility to weather any near-term memory pricing wobble.
Prediction market participants are leaning cautious near term. Polymarket odds place the highest conviction on Micron trading in the $930 to $960 range this week, with a 0.865 probability that shares finish today lower. Upside conviction above $1,020 drops sharply.
Still, Reddit sentiment tells a more bullish story. Aggregate sentiment on Micron scored 66 (bullish) as of Monday morning, and SanDisk sentiment on WallStreetBets held between 58 and 75 through the initial selloff, indicating retail dip-buyers stayed engaged. Traders can watch for whether the $920 level holds on Micron stock and whether the DRAM ETF stabilizes once U.S.-listed SK Hynix shares find a level after their delayed open, and could look for any updated commentary from Korean analysts later this week.
Intuitive Surgical rozšiřuje robotický ekosystém o AI a digitální nástroje; v 1. čtvrtletí 2026 hlásila širší adopci da Vinci, Ion i digitálních platforem.
Key Takeaways ISRG expands its robotic ecosystem with AI, digital tools and minimally invasive platforms. TER, CDNS, MCHP and FTV are advancing robotics through AI, automation and data center innovation.The picks are set to benefit from rising robotics adoption despite industry dynamics and regulatory risks. Robotics companies are at the forefront of innovation, driving efficiency and productivity across industries such as manufacturing, healthcare and logistics. The global robotics market is poised for significant growth, fueled by technological breakthroughs, and rising demand for automation and advancements in artificial intelligence (AI) and machine learning.
This potential for high growth promises substantial returns to investors. Also, robotics can address labor shortages and enhance precision in tasks, thereby reducing operational costs and improving quality. This space includes companies that integrate hardware, software and AI to build intelligent machines capable of performing complex tasks autonomously or semi-autonomously.
Pros and Cons of Robotics ApplicationDespite the rapid growth and transformative potential of this space, the investment landscape is not without risks. Robotics technology is still evolving, and companies in this space often face high research and development costs with no guaranteed success. Regulatory challenges, market volatility, concerns about job displacement and data privacy, along with the societal impact of automation add to the uncertainty.
At this stage, we recommend five robotics stocks for investment in second-half 2026. These are: Intuitive Surgical Inc. (ISRG - Free Report) , Teradyne Inc. (TER - Free Report) , Cadence Design Systems Inc. (CDNS - Free Report) , Microchip Technology Inc. (MCHP - Free Report) and Fortive Corp. (FTV - Free Report) . Each of our picks currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
The chart below shows the price performance of our five picks in the past three months.
Image Source: Zacks Investment Research
Intuitive Surgical Inc.Intuitive Surgical is increasingly embedding AI and digital tools into its robotic ecosystem. ISRG operates in the robotic surgery market for soft tissue procedures, where adoption is supported by the shift toward minimally invasive care. The company’s platforms include the da Vinci surgical system and the Ion endoluminal system.
ISRG continues to add digital capabilities that can improve training, workflow and program management for hospitals. These efforts include software and analytics that connect systems, instruments and services and can deepen customer engagement over time.
In the first quarter of 2026, ISRG highlighted expanded adoption of its da Vinci, Ion and digital platforms, which support continued investment in the connected ecosystem. Over time, digital features can differentiate the installed base and support incremental service and software revenues as hospitals focus on standardizing surgical programs.
Intuitive Surgical has an expected revenue and earnings growth rate of 16.5% and 16.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.1% over the last 30 days.
Teradyne Inc.Teradyne benefits from strong AI-related demand that is driving significant investments in cloud AI build-out as customers accelerate the production of a wide range of AI accelerators, networking, memory, and power devices. AI computing is witnessing technological progress, which is bringing rapid transformation to design, process, and packaging technologies.
Robotics delivered $91 million of first-quarter 2026 revenues, up 32% year over year, and management highlighted a fourth consecutive quarter of sequential growth. The company cited customer engagement across e-commerce, electronics manufacturing, and semiconductor end markets, and noted that AI-related revenues in Robotics increased to 15% of quarterly sales with emerging data center applications.
TER continues to expect its large e-commerce customer to triple its revenue contribution in 2026 versus 2025, which, if executed, would improve scale and utilization in the Robotics segment. Over time, the use of robots in assisted assembly, test and data center operations could broaden the installed base beyond traditional factory automation deployments.
Teradyne has an expected revenue and earnings growth rate of 42.1% and 81.8%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 1.6% over the last 30 days.
Cadence Design Systems Inc.Cadence Design Systems is benefiting from higher design complexity and rising customer spend on AI-driven automation. CDNS’ efforts to unify EDA, IP, 3D-IC, PCB and system analysis are aiding in capitalizing on the opportunity presented by the AI super cycle. The focus on generative AI, agentic AI and physical AI is leading to an exponential increase in computing demand and semiconductor innovation.
Amid rapid AI proliferation, the Cadence.ai portfolio has been gaining strength and new product launches (like AgentStack along with ChipStack, ViraStack and InnoStack AI Super Agents) are expected to aid in sustaining the momentum.
CDNS’ hardware systems continue to gain traction from AI, HPC, robotics and automotive companies. The inorganic strategy is the calculated execution of its Intelligent System Design vision. Backlog stood at $8 billion. CDNS now expects 2026 revenues to be between $6.125-$6.225 billion compared with $5.3 billion in 2025.
Cadence Design Systems has an expected revenue and earnings growth rate of 17.1% and 11.2%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has remained the same over the last 30 days.
Microchip Technology Inc.Microchip Technology benefits from growing AI investments. The company’s Gen 4 and Gen 5 data center products are witnessing strong sales growth. MCHP’s new products are expected to gain traction with the launch of the industry's first 3-nanometer-based PCIe Gen 6 switch that powers modern AI infrastructure.
These switches offer double bandwidth, lower latency, advanced security and high-density AI connectivity for next-generation cloud and data center performance. The success of the restructuring plan also bodes well for MCHP’s prospects. The company also entered the PCIe retimer market in the June 2026 quarter as a companion device for Gen6 switches, and disclosed an OEM design win that displaced a competitor.
MCHP has expanded connectivity, storage and compute offerings for AI and data center applications, as well as intelligent power modules for AI at the edge. These factors are expected to drive top-line growth in the long term.
Microchip Technology has an expected revenue and earnings growth rate of 31.7% and 88.4%, respectively, for the current year (ending March 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 0.3% in the last 30 days.
Fortive Corp.Fortive has been benefiting from productivity actions and reinvestment in innovation and commercial initiatives. FTV is benefiting from steady demand across Intelligent Operating Solutions and Advanced Healthcare Solutions. The company’s Fortive Accelerated strategy bodes well.
FTV is building the new Fortive around faster, profitable organic growth, disciplined capital allocation and consistent delivery. In first-quarter 2026, the company cited higher innovation velocity with several hardware milestones and AI-enhanced launches.
In healthcare, FTV’s Provation Mira Documentation Assist was introduced as a real-time, AI-powered, voice-driven documentation capability embedded into GI procedural workflows, which can reduce administrative burden and support continued software adoption.
FTV’s commercial efforts are increasingly targeted at higher-growth verticals such as AI data centers, defense and distributed energy, alongside made-in-region actions in India and China and a European launch of STERRAD ULTRA GI.
Fortive has an expected revenue and earnings growth rate of -6.9% and 9.6%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.3% in the last 30 days.
Hyperscalery letos utratí za kapitálové výdaje asi 750 miliard USD, což dál podporuje poptávku po AI čipech pro datová centra. Z toho těží hlavně Micron Technology a Taiwan Semiconductor.
In the third quarter of 2025, Goldman Sachs analysts were trying to estimate just how much the technology hyperscalers (Alphabet, Meta, Amazon, Microsoft, and others) would spend in 2026 to build out data centers.
Their estimate at the time: $465 billion.
That was supposed to account for all the monumental spending on artificial intelligence(AI) infrastructure. But even after they revised their estimate to $527 billion just three months later, they still missed the mark.
Hyperscalers now are forecast to devote about $750 billion to capital expenditures (capex) this year -- and the number could go higher next year.
That's fantastic news for Micron Technology (MU 1.05%) and Taiwan Semiconductor Manufacturing (TSM 0.55%), also called TSMC. These two companies are leading pick-and-shovel investments in the enormous AI data center build-out that's currently underway, and they could benefit for years to come. Here's why.
Image source: Getty Images.
Hyperscalers can't get enough of Micron Technology's memory So called pick-and-shovel companies benefit from selling the tools that help other companies build what they need. In the current AI gold rush, Micron is a great pick-and-shovel play because it sells much-needed memory chips to tech companies.
With AI data center spending surging, hyperscalers are buying up as many memory processors as they can get. Artificial intelligence uses a lot of it, and that's driving memory prices higher and leading to much higher profits for Micron.
Consider that in the third quarter of fiscal 2026 (ended May 28), Micron's sales jumped 345% to $41.5 billion, and adjusted earnings per share spiked more than 1,300% to $24.67. The company's management believes this growth isn't anywhere near finished yet. Just read what Micron Chief Executive Officer Sanjay Mehrotra said on the Q3 earnings call: "The memory industry has been structurally transformed by the proliferation of AI. We are only in the early innings of the significant innovation and productivity that can be unleashed in every part of the global economy over time."
And the company likely isn't exaggerating the shift toward long-term memory demand. Alphabet's capex spending will reach as much as $190 billion this year, and management said that next year's spending is likely to "significantly increase." In short, AI spending is still accelerating.
That's one of the reasons three analysts recently raised their price target for Micron stock to $1,500, representing a 51% increase from its current price.
Today's Change
(
-1.05
%) $
-10.39
Current Price
$
981.25
Taiwan Semiconductor could be the ultimate pick-and-shovel AI play As the world's leading semiconductor manufacturer, TSMC is arguably one of the best ways for investors to play long-term demand in AI data center infrastructure. The company makes an estimated 70% of the world's processors and 90% of the most advanced processors (including those for AI).
This means that no matter which company leads the AI gold rush, TSMC benefits. If Nvidia loses ground to a competitor, Taiwan Semiconductor still wins. If Alphabet outpaces OpenAI and Anthropic to take the crown for the top AI model, TSMC still wins as long as they all need lots of processors.
And they all need lots of processors.
TSMC's revenue jumped about 41% in the first quarter to nearly $36 billion, and adjusted earnings (not in accordance with generally accepted accounting principles, or GAAP) popped 58% to $3.49 per American depositary receipt (ADR). It's worth mentioning that TSMC's gross margin is very impressive, too, reaching 66% in the quarter and helping the company's bottom-line growth as processor demand heats up.
And more growth is likely on the way. Taiwan Semiconductor Chief Executive Officer C.C. Wei said on the first-quarter earnings call: "The shift from generative AI and the query mode to agentic AI and the command and action mode is leading to another step up in the amount of tokens being consumed. This is driving the need for more and more computation, which supports the robust demand for leading-edge silicon."
For investors looking to tap into the AI data center boom and benefit regardless of which hyperscaler leads the pack, Micron Technology and Taiwan Semiconductor are two fantastic choices right now.
Chris Neiger has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Goldman Sachs Group, Meta Platforms, Micron Technology, Microsoft, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.
CANADA - 2026/07/03: In this photo illustration, the AMD (Advanced Micro Devices) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
SOPA Images/LightRocket via Getty Images
This article was written by Doug Nathman, with research by his team at Trefis.
AMD (AMD) has nearly quadrupled its value in the last year, with its market capitalization nearing $900 billion.
The factors driving this surge are quite evident.
EPYC CPUs are capturing significant server market share from Intel (INTC), with proactive AI workloads fostering a structural recovery in CPU demand that extends beyond normal cycles. On the GPU front, the MI400 series represents the most formidable product AMD has ever released, so much so that its specifications compelled Nvidia (NVDA) to enhance memory bandwidth and power capacity just to maintain competitiveness. Commitments from hyperscalers are genuine and expanding, with Meta alone intending to deploy up to 6 gigawatts of AMD Instinct GPUs, all amidst over $700 billion in AI infrastructure capital expenditures pledged by hyperscalers this year.
The bullish outlook is credible.
The chips are increasingly attractive. The clientele is dedicated. The CPU segment is concurrently experiencing a structural rebound. With the stock trading at over 70x projected 2026 earnings, the market is aware of all these factors. (See AMD valuation multiples)
What it might be neglecting is an issue unrelated to demand.
The Constraint Is PhysicalIn contrast to conventional CPUs, AI accelerators achieve a significant portion of their performance through the close integration of processing dies and high-bandwidth memory. Advanced packaging is essential for facilitating that integration. Specifically, TSMC's CoWoS technology is what enables the binding of chiplets into a complete AI accelerator. Without it, the silicon in a fabrication plant is essentially useless. Presently, no other manufacturer can provide advanced packaging at a level comparable to TSMC's leading edge. TSMC's CEO informed shareholders on June 4, 2026, that CoWoS capacity remains exceptionally limited and fully booked through 2026, with lead times varying from 52 to 78 weeks.
MORE FOR YOU
This is not a fleeting bottleneck. The machinery necessary for expansion requires years for acquisition and installation, indicating that the limitation will mainly remain fixed for the upcoming years.
Evaluating how this limited capacity is allocated reveals that Nvidia commands approximately 60% of the overall CoWoS production, around 595,000 wafers, and has already secured more than half of TSMC's expansion capacity for 2026-2027. The top three clients together account for over 85% of total output. AMD possesses about 105,000 wafers, roughly 11% of total need. However, in AI, the scarcity is no longer in demand. It resides in packaging capacity.
Intel has directed substantial investments towards developing a foundry business, which has contributed to the stock's appreciation. The more pressing question is whether Intel's capacity is supported by committed external clients.
AMD Is Competing With Itself For What Limited Capacity ExistsAMD's collaboration with TSMC encompasses both SoIC-X and CoWoS-L packaging across its complete data center range, including CPUs and GPUs. These advanced packaging solutions are employed in the assembly of AMD's most intricate server processors and AI accelerators. The Venice EPYC CPU, which is transitioning to 2nm, shares the same restricted resource pool as the MI400 GPU. Each EPYC slot utilized cannot be allocated to an Instinct GPU. Thus, AMD is allocating capacity between its two rapidly expanding product lines at the same time.
Nvidia does not experience this issue. Its CoWoS allocation is dedicated to one product family. More critically, packaging capacity is reserved several years in advance, which means AMD cannot simply acquire additional capacity if demand for the MI400 surpasses expectations. AMD is the only significant entity simultaneously scaling both its server CPU and AI GPU franchises through the same bottleneck.
The ConclusionAI investors frequently engage in discussions about chips, benchmarks, and clients. For AMD, a more crucial question may be whether it can acquire adequate advanced packaging capacity to convert that demand into shipments.
With the current valuation exceeding 70x forward earnings, even a minor execution error could translate into a substantial investment error. A single-stock strategy at these valuations is inherently unstable. As historical volatility illustrates, depending on the perfect pricing assumptions of a single position ignores the structural risks that high-multiple stocks face during broader market shifts. The remedy is a rule-based portfolio strategy.
The Trefis High Quality (HQ) Portfolio merges analytical precision with a forward-looking perspective spanning 30 stocks, utilizing a consistent selection framework and sizing/rebalancing protocols formulated to provide upside without the risks associated with individual stocks you have just reviewed.
By selecting 30 high-conviction stocks, the HQ strategy has historically outperformed a benchmark that encompasses the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.
Eli Lilly and Company (NYSE:LLY) shares are in the spotlight Monday as the company presents new data at the Alzheimer’s Association International Conference in London. Wall Street weighed in on the stock last week.
Eli Lilly stock is trading flat. What’s next for LLY stock? The AAIC PresentationEli Lilly is presenting 16 abstracts at the 2026 Alzheimer’s Association International Conference, running July 12-15 in London, with significant new data expected on its Alzheimer’s treatment Kisunla. The presentations could help clarify Kisunla’s competitive standing in a market where diagnosis bottlenecks, required scans, and monitoring requirements remain key hurdles to broader adoption.
Kisunla at a GlanceAnalyst Consensus & Recent Actions The stock carries a Buy rating with an average price target of $1293.73. Recent analyst moves include:
B of A Securities: Buy (Raises Target to $1334.00) (July 10) Truist Securities: Buy (Raises Target to $1370.00) (July 8) Morgan Stanley: Overweight (Raises Target to $1347.00) (July 8) Eli Lilly Shares Trade FlatLLY Price Action: At the time of publication, Eli Lilly shares are edging 0.01% higher at $1,188.75, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Key Takeaways MS' Q2 revenues are projected to rise 15.4%, while earnings are expected to jump 35.7%.Strong advisory and underwriting fees are expected to drive a 40% increase in MS' IB income.Higher client activity and volatility may lift MS' equity and fixed-income trading revenues. Morgan Stanley (MS - Free Report) is scheduled to announce second-quarter 2026 earnings on July 15 before market open. The company’s financial results and subsequent management conference call are expected to attract significant attention from analysts and investors seeking insights into how it is navigating the current operating environment.
Morgan Stanley’s first-quarter 2026 performance was impressive, driven by robust trading and deal-making activities. The company’s results in the to-be-reported quarter are likely to have benefited from similar positive factors. The Zacks Consensus Estimate for second-quarter revenues of $19.38 billion suggests 15.4% year-over-year growth.
In the past seven days, the consensus estimate for earnings for the to-be-reported quarter has been revised 4% upward to $2.89. The figure indicates a 35.7% jump from the prior-year quarter.
Estimate Revision Trend
Image Source: Zacks Investment Research
MS has an impressive earnings surprise history. The company’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average beat being 17.07%.
Earnings Surprise History
Image Source: Zacks Investment Research
Factors to Influence Morgan Stanley’s Q2 ResultsIB Income: After an impressive first-quarter performance, global deal-making activity moderated as geopolitical uncertainty, persistent valuation gaps, slowing economic growth, elevated inflation and interest rates, and a stubbornly high backlog of private equity exits weighed on transaction value. However, strategic buyers remained active, targeting deals that could expand scale, bolster resilience and strengthen supply chain security amid the challenging operating environment.
So, while global mergers and acquisitions (M&As) volume improved year over year, deal value fell as only a handful of big transactions dominated the space. This, along with Morgan Stanley’s position as one of the leading players in the space, is expected to have driven advisory fees in the second quarter. The Zacks Consensus Estimate for advisory fees is pegged at $684.6 million, indicating a year-over-year jump of 34.8%.
The quarter witnessed strong IPO activity and equity issuances. Morgan Stanley’s prominent underwriting role in SpaceX’s mega IPO is likely to have boosted its equity underwriting fees. Further, global bond issuance volume was solid, driven by corporate refinancing and infrastructure builds. So, Morgan Stanley’s equity and fixed income underwriting fees are expected to have increased on a year-over-year basis.
The Zacks Consensus Estimate for equity underwriting fees of $554.4 million suggests year-over-year growth of 10.9%. The consensus estimate for fixed-income underwriting fees is pegged at $704.9 million, indicating a surge of 32.5%. The consensus estimate for total underwriting fees of $1.26 billion implies a jump of 22%.
The Zacks Consensus Estimate for IB income of $2.3 billion indicates a year-over-year jump of 40%.
Trading Revenues: The performance of Morgan Stanley’s trading business (constituting a significant portion of its top line) is expected to have been solid in the second quarter of 2026, supported by increased client activity and market volatility. Trading conditions were shaped by evolving expectations surrounding artificial intelligence, ongoing geopolitical tensions, persistent inflationary pressures and a more hawkish Federal Reserve. These factors contributed to heightened volatility across equities and other asset classes, including commodities, fixed income and foreign exchange.
The Zacks Consensus Estimate for the company’s equity trading revenues is pegged at $4.42 billion, suggesting a rise of 18.7% from the prior-year quarter. The consensus estimate for fixed-income trading revenues of $2.31 billion indicates a gain of 6%.
Net Interest Income (NII): In the to-be-reported quarter, the Fed kept interest rates unchanged, while signaling a hike later in the year because of persistently high inflation. This created a favorable backdrop for Morgan Stanley.
Further, the lending scenario is likely to have improved in the second quarter, which, along with stabilizing funding/deposit costs, is expected to have offered much-needed support. Hence, Morgan Stanley’s NII is likely to have witnessed a decent improvement in the quarter.
The Zacks Consensus Estimate for net interest revenues is pegged at $2.62 billion, suggesting a rise of 11.5% on a year-over-year basis.
For the wealth management segment, management expects NII to rise modestly on a sequential basis.
Expenses: Cost reduction, which has long been Morgan Stanley's primary strategy for remaining profitable, is unlikely to have provided much support in the June-ended quarter. As the company has been investing in franchises, overall costs are likely to have been elevated.
What Our Quantitative Model Unveils for MSMorgan Stanley’s Price PerformanceIn the second quarter, Morgan Stanley’s share performance was impressive as the operating backdrop turned favorable. The stock fared better than the industry as well as its peers, Goldman Sachs (GS - Free Report) and JPMorgan (JPM - Free Report) .
2Q26 Price Performance
Image Source: Zacks Investment Research
Goldman and JPMorgan are scheduled to announce second-quarter 2026 numbers tomorrow.
Over the past seven days, the Zacks Consensus Estimate for Goldman’s second-quarter 2026 earnings has been revised north to $14.47. The consensus estimate for JPMorgan’s second quarter 2026 earnings has been revised upward to $5.59 over the past week. At present, both GS and JPM carry a Zacks Rank #2 (Buy).
PENN Entertainment spustila v Albertě theScore Bet Sportsbook & Casino i samostatné aplikace theScore Casino a Hollywood Casino. Tím rozšiřuje své kanadské online herní působení.
- Expands PENN's Canadian online gaming footprint, bringing premier sportsbook and online casino experiences to players across Alberta -
TORONTO & WYOMISSING, Pa.--(BUSINESS WIRE)--PENN Entertainment (Nasdaq: PENN) (“PENN” or the “Company”) today announced the launch of theScore Bet Sportsbook & Casino in Alberta, as well as theScore Casino and Hollywood Casino standalone apps, further expanding the Company’s Canadian online gaming footprint and bringing its leading digital gaming brands to players across the province. These apps are now available across Alberta on iOS, Android, and are also available on the web.
The Alberta launch marks the next chapter in theScore Bet’s continued growth in Canada, building on its success in Ontario. Players in Alberta can now enjoy the uniquely integrated sports media and betting experience from two of Canada’s most trusted brands, theScore and theScore Bet, bringing live scores, news, stats and betting together in one connected ecosystem.
In addition to sports betting, theScore Bet Sportsbook & Casino gives Alberta players access to a comprehensive online casino experience featuring hundreds of slots, table games, live dealer experiences and exclusive games, including Blue Jays Blackjack.
Complementing theScore Bet Sportsbook & Casino experience, PENN is also launching standalone Hollywood Casino and theScore Casino apps in Alberta. Hollywood Casino, a popular online and retail casino brand, delivers a casino-first experience featuring an extensive portfolio of slots, table games and live dealer content. For players who prefer a dedicated casino app, theScore Casino offers the same premium gaming experience, providing additional choice alongside the all-in-one theScore Bet Sportsbook & Casino app.
“Alberta has an incredible sports culture, and we’re excited to bring theScore Bet Sportsbook & Casino to players across the province,” said Aaron LaBerge, Chief Technology Officer and Head of Interactive at PENN Entertainment. “Fans already know and trust theScore, and with theScore Bet, we’re extending that connection into a seamless sportsbook and casino experience. Whether you’re following your favorite team, placing a bet, or enjoying casino games, we’ve built the experience around the way fans naturally engage with sports. We commend the Alberta government for introducing a regulated online gaming market for private operators and look forward to serving fans in one of Canada’s great sports markets.”
As Canada’s sportsbook, theScore Bet is proud to partner with Canada’s most iconic sports organizations as the exclusive official gaming partner of the Toronto Blue Jays, the exclusive gaming partner of Golf Canada and an official gaming partner of the NHL and PGA Tour.
Alberta customers can now enjoy:
Same Game Parlays, player props and live, in-game betting. Seamless betting integration with theScore's trusted sports news, scores and data. Hollywood Casino's extensive portfolio of slots, table games and live dealer experiences, including Blue Jays Blackjack, the Dancing Drums series, and Sweet Bonanza series. To celebrate the launch, theScore Bet is introducing a series of fan experiences throughout the summer, including its popular Toronto Blue Jays Jersey Swap event. Additional details are available at theScore.bet/alberta.
About theScore Bet Sportsbook, theScore Casino & Hollywood Casino
theScore Bet Sportsbook & Casino, theScore Casino and Hollywood Casino are PENN Entertainment's leading online gaming brands in Canada, offering premium sports betting and online casino experiences powered by PENN's proprietary technology platform. theScore Bet Sportsbook & Casino uniquely integrates with theScore to deliver a connected sports media and betting experience, while Hollywood Casino and theScore Casino provide players with a comprehensive portfolio of slots, table games, live dealer experiences and exclusive content.
About PENN Entertainment, Inc.
PENN Entertainment, Inc., together with its subsidiaries (“PENN,” or the “Company,” “we,” “our,” or “us”), operates in 28 jurisdictions throughout North America, with a broadly diversified portfolio of casinos, racetracks, and online sports betting and iCasino offerings. PENN’s focus is on organic cross-sell opportunities, reinforced by its market-leading retail casinos, sports media assets and technology, including a proprietary state-of-the-art, fully integrated digital sports betting and iCasino platform, and an in-house iCasino content studio. The Company’s portfolio is further bolstered by its industry-leading PENN Play™ customer loyalty program, offering its approximately 34 million members a unique set of rewards and experiences.
Forward Looking Statement
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as “expects,” “believes,” “estimates,” “projects,” “intends,” “plans,” “goal,” “seeks,” “may,” “will,” “should,” “look forward to,” or “anticipates” or the negative or other variations of these or similar words, or by discussions of future events, strategies or risks and uncertainties. These statements are based upon management's current expectations, assumptions and estimates and are not guarantees of timing, future results, or performance. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. Actual results may differ materially from those contemplated in these statements due to a variety of risks, uncertainties and other factors, including those factors described in PENN Entertainment’s filings with the Securities and Exchange Commission (the “SEC”), including PENN Entertainment's current reports on Form 8-K, quarterly reports on Form 10-Q and its annual report on Form 10-K for the year ended December 31, 2025. Forward-looking statements speak only as of the date they are made and, except for PENN Entertainment’s ongoing obligations under the U.S. federal securities laws, PENN Entertainment undertakes no obligation to publicly update any forward-looking statements whether as a result of new information, future events or otherwise.
Key Takeaways State Street's Q2 earnings is estimated at $3.30, up 30.4%, while sales are seen rising 11.5%.NII is projected to climb 14.4% to $833.8 million, supported by robust lending and stable funding costs.Total fee revenues are expected to rise 12.6%, led by management, servicing and securities finance fees. State Street (STT - Free Report) is slated to report second-quarter 2026 results on July 16, before market open. The company’s quarterly revenues and earnings are expected to have risen year over year.
In the first quarter of 2026, STT’s earnings outpaced the Zacks Consensus Estimate. Results were aided by growth in fee revenues and net interest income (NII). Also, the company witnessed improvements in the total assets under custody and administration (AUC/A) and assets under management (AUM) balances. However, higher expenses and provisions were undermining factors.
State Street has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering a surprise of 6.97%, on average.
Major Q2 Factors & Estimates for State StreetNII: In the quarter, the Federal Reserve kept interest rates unchanged and signaled a hike later in the year. Further, a solid lending scenario (per the Fed’s latest data, overall loan growth was robust in the quarter) and stabilizing funding/deposit costs are expected to have offered the much-needed support to STT’s NII growth.
The Zacks Consensus Estimate for State Street’s average interest-earning assets is pegged at $294.8 billion, which implies a 3.2% decline from the prior-year quarter.
The consensus estimate for NII (on a fully taxable-equivalent basis) of $833.8 million indicates a 14.4% year-over-year rise.
Fee Revenues: Supported by solid inflows, the company’s AUM and AUC/A balances are expected to have increased in the to-be-reported quarter. Thus, management fees are likely to have benefited. The consensus estimate for management fees of $747.6 million implies a 33% year-over-year jump.
The consensus estimate for securities finance revenues of $133.9 million implies a 6.2% increase.
At the end of the first quarter, STT reported $315 million of servicing fee revenues to be installed. Hence, the metric is likely to have grown in the second quarter. The Zacks Consensus Estimate for servicing fees of $1.48 billion indicates a 13.1% improvement.
The Zacks Consensus Estimate for FX trading services income is pegged at $404.6 million, suggesting a 6.1% year-over-year decline. The consensus estimate for software services fees suggests a 22.8% decrease to $177.6 million.
Overall, the Zacks Consensus Estimate for total fee revenues of $3.06 billion indicates 12.6% year-over-year growth.
Expenses: Total expenses at State Street are expected to have increased in the second quarter, primarily due to higher information systems and communication costs, as well as spending on strategic acquisitions, expansion efforts and franchise investments.
While the company has been taking steps to enhance operating efficiency, ongoing investments in growth initiatives, infrastructure and technology are likely to have exerted upward pressure on costs in the to-be-reported quarter.
What the Zacks Model Unveils for State StreetPer our model, the likelihood of State Street beating the Zacks Consensus Estimate this time around is high. This is because the company has the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: The Earnings ESP for State Street is +0.35%.
Zacks Rank: STT currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
State Street’s Q2 Earnings & Sales EstimatesThe Zacks Consensus Estimate for State Street’s earnings of $3.30 per share has been revised 2.8% higher over the past seven days. The figure suggests a 30.4% surge from the year-ago quarter.
The consensus estimate for quarterly sales of $3.85 billion indicates an 11.5% increase.
State Street’s Peers Worth a LookHere are STT’s peers that you may want to consider, as our model shows that these, too, have the right combination of elements to post an earnings beat this time:
The Bank of New York Mellon Corporation (BNY - Free Report) is slated to report second-quarter 2026 results on July 15. The company has a Zacks Rank #2 at present and an Earnings ESP of +0.05%.
Quarterly earnings estimates for BNY have been moved north to $2.20 over the past week.
The Earnings ESP for Northern Trust (NTRS - Free Report) is +0.50% and it carries a Zacks Rank of 2 at present. The company is slated to report second-quarter 2026 results on July 22.
Over the past seven days, the Zacks Consensus Estimate for Northern Trust’s quarterly earnings has been revised upward to $2.68.
Cloudflare zpřístupnila Precursor, nástroj pro průběžné behaviorální ověřování proti botům v reálném čase bez zásahů do běžných uživatelů. Funguje jedním kliknutím a sleduje celou relaci v prohlížeči.
Built on one of the world’s largest networks, Precursor is the only defense of its kind to replace disruptive checkpoints to stop evasive bots without slowing down users
SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced the general availability of Precursor, a next-generation, continuous behavioral validation engine for bot management. Built directly on Cloudflare’s edge, Precursor runs seamlessly inside web browsers to monitor entire user sessions in order to detect bot automation. Unlike traditional, static CAPTCHAs, it analyzes ongoing interactions in real time to catch advanced bots, improving detection precision without interrupting legitimate users.
For the first time, automated bot traffic has eclipsed human activity on the Internet, now generating roughly 57% of all web requests. This milestone emphasizes a seismic evolution from an Internet built for human clicks to a digital landscape now dominated by AI agents. For organizations and everyday consumers, this means that legacy defenses are blind to a new breed of automated threats that drive up infrastructure costs, manipulate inventory, and compromise data. While a modern bot can easily fake a single action to pass a one-time security check, replicating an entire human journey remains a massive engineering hurdle. To protect the integrity of the global Internet, organizations must move away from static, point-in-time defenses and embrace continuous behavioral validation—analyzing telemetry across an entire session to unmask automated imposters trying to blend into the crowd.
"Traditional security checks look at a single moment in time, but modern bots have gotten smart enough to fake their way through the front door," said Dane Knecht, CTO of Cloudflare. "Instead of just checking an ID at the gate, we are looking at behavior over the entire visit. This makes life seamless for real users, while making it incredibly difficult and expensive for bad actors to fake human behavior. Cloudflare already protects users billions of times a day at critical moments like login and checkout, but until now, the space between those moments was a black box. With Precursor, we’re now eliminating that blindspot."
Now generally available, Precursor provides a session-level view of site activity by continuously collecting robust browser signals to block unwanted automated traffic through:
Privacy-Led Defense: Built to protect end user confidentiality, Precursor logs aggregate behavioral patterns rather than recording specific user inputs. For example, keyboard activity is recorded exclusively as timing rhythm and cadence—never capturing actual keystrokes. Zero-Code, One-Click Setup: Precursor is enabled with one click, automatically allowing Cloudflare to inject a compact, dynamic script passing through the network, requiring no modifications to underlying code. The script evaluates interaction trail dimensions such as mouse movement, scrolling rhythm, typing cadence, clipboard activity, and page visibility duration. A Real-Time Analysis Engine: Cloudflare's servers instantly unpack the telemetry data sent from a user's browser and scan it for signs of faked or computer-generated activity. We then validate whether interaction streams map rationally to human behavior, such as cross-referencing that pointer activity aligns with page visibility or text fields are focused during typing events. Session-Long Security Measures: Unlike traditional defense challenges that reset per every request, Precursor continuously evaluates the visitor’s user journey across a web or single page application. Automated agents cannot reset their behavioral signatures by refreshing a page, allowing defensive algorithms to adjust a session's Bot Score with compounding context. To learn more, please check out the resources below:
Blog: Introducing Precursor: detecting agentic behavior with continuous client-side signals Cloudflare Precursor About Cloudflare
Cloudflare, Inc. (NYSE: NET) is the leading connectivity cloud company. It empowers organizations to make their employees, applications and networks faster and more secure everywhere, while reducing complexity and cost. Cloudflare’s connectivity cloud delivers the most full-featured, unified platform of cloud-native products and developer tools, so any organization can gain the control they need to work, develop, and accelerate their business.
Powered by one of the world’s largest and most interconnected networks, Cloudflare blocks billions of threats online for its customers every day. It is trusted by millions of organizations – from the largest brands to entrepreneurs and small businesses to nonprofits, humanitarian groups, and governments across the globe.
Learn more about Cloudflare’s connectivity cloud at cloudflare.com/connectivity-cloud. Learn more about the latest Internet trends and insights at radar.cloudflare.com.
Follow us: Blog | X | LinkedIn | Facebook | Instagram
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expect,” “explores,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these words, or other similar terms or expressions that concern Cloudflare’s expectations, strategy, plans, or intentions. However, not all forward-looking statements contain these identifying words. Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding the capabilities and effectiveness of Cloudflare Precursor and Cloudflare’s other products and technology, the benefits to Cloudflare’s customers from using Cloudflare Precursor and Cloudflare’s other products and technology, the timing of when Cloudflare Precursor or any of its related features will be generally available to all current and potential Cloudflare customers, Cloudflare’s technological development, future operations, growth, initiatives, or strategies, and comments made by Cloudflare’s CTO. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in Cloudflare’s filings with the Securities and Exchange Commission (SEC), including Cloudflare’s Quarterly Report on Form 10-Q filed on May 8, 2026, as well as other filings that Cloudflare may make from time to time with the SEC.
The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Cloudflare undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Cloudflare may not actually achieve the plans, intentions, or expectations disclosed in Cloudflare’s forward-looking statements, and you should not place undue reliance on Cloudflare’s forward-looking statements.
SLB OneSubsea získala od Eni velkou EPC zakázku na 3. fázi hlubokomořského projektu Baleine na Pobřeží slonoviny. Kontrakt pokrývá kompletní subsea systémy pro 13 vrtů.
Integrated subsea production system and local capabilities enable accelerated deepwater development
HOUSTON--(BUSINESS WIRE)--Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire.
Under the contract, SLB OneSubsea will deliver complete subsea production systems (SPS) for 13 wells, reinforcing its role as a core technology and execution partner on one of the most strategically significant offshore developments currently underway in the region.
The EPC scope includes subsea trees, umbilical, manifolds, multiphase flowmeters and control systems, along with installation, commissioning and life-of-field support. The integrated delivery model is designed to streamline execution and support the project’s fast-track development schedule.
"Baleine Phase 3 brings together scale and execution certainty," said Mads Hjelmeland, chief executive officer of SLB OneSubsea. "Through our subsea production system technology and by leveraging our established local presence, we are supporting Eni’s efforts to advance a complex, deepwater project efficiently while contributing to the long-term development of offshore resources in Côte d’Ivoire."
Project execution will be supported by SLB OneSubsea’s in-country presence and local capabilities, contributing to efficient delivery across the life of the project.
Key points
Eni has awarded SLB OneSubsea a multi-well EPC contract for the Baleine Phase 3 development. The SPS contract covers 13 wells and includes subsea trees, umbilicals, manifolds, flowmeters and control systems, along with installation and commissioning. SLB OneSubsea will execute the project through its established in-country presence and local capabilities, supporting efficient project delivery. About SLB
SLB (NYSE: SLB) is a global technology company that has driven energy innovation for 100 years. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at SLB.com.
About SLB OneSubsea
SLB OneSubsea is driving the new subsea era that leverages digital and technology innovation to optimize our customers’ oil and gas production, decarbonize subsea operations and unlock the large potential of subsea solutions to accelerate the energy transition. OneSubsea is a joint venture backed by SLB, Aker Solutions and Subsea7 headquartered in Oslo and Houston, with 10,000 employees across the world. Find out more at onesubsea.com.
This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws — that is, statements about the future, not about past events. Such statements often contain words such as “expect,” “may,” “can,” “estimate,” “intend,” “anticipate,” “will,” “potential,” “projected" and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as forecasts or expectations regarding the deployment of, or anticipated benefits of, SLB’s new technologies and partnerships; and improvements in operating procedures and technology. These statements are subject to risks and uncertainties, including, but not limited to, the inability to recognize intended benefits of SLB’s strategies, initiatives or partnerships; and other risks and uncertainties detailed in SLB’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes), or should underlying assumptions prove incorrect, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, and SLB disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.
T. Rowe Price Group oznámila k 30. červnu 2026 aktiva pod správou ve výši 1,893 bilionu USD. V červnu přiteklo čistě 0,8 miliardy USD, za čtvrtletí ale firma vykázala čistý odliv 6,5 miliardy USD.
, /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced June month-end assets under management of $1.89 trillion. Net inflows for June 2026 were $0.8 billion, including a large subadvised equity inflow. Net outflows for the quarter-ended June 2026 were $6.5 billion. Quarterly net flows include $0.5 billion of manager-driven distributions.
The below table shows the firm's assets under management as of June 30, 2026, and for the prior month-, quarter- and year-end by asset class and in the firm's target date retirement portfolios.
As of
(in billions)
6/30/2026
5/31/2026
3/31/2026
12/31/2025
Equity
$ 919
$ 919
$ 810
$ 879
Fixed income, including money market
222
221
215
212
Multi-asset
690
691
625
627
Alternatives
62
61
60
58
Total assets under management
$ 1,893
$ 1,892
$ 1,710
$ 1,776
Target date retirement portfolios
$ 622
$ 623
$ 561
$ 561
Q2 2026 EARNINGS RELEASE AND EARNINGS CALL
T. Rowe Price will release Q2 2026 earnings on Friday, July 31, 2026 at 7:00 AM ET. The company will host an earnings call from 8:00 – 8:45 AM ET that day. To access the webcast and accompanying materials, visit the company's investor relations website at: investors.troweprice.com.
OTHER MATTERS
T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm, entrusted with managing $1.89 trillion in client assets as of June 30, 2026, about two-thirds of which are retirement-related. Renowned for over 85 years of investment excellence, retirement leadership, and independent proprietary research, the firm leverages its long-standing expertise to ask better questions that can drive better investment decisions. Built on a culture of integrity and prioritizing client interests, T. Rowe Price empowers millions of investors worldwide to thrive amidst evolving markets. Visit troweprice.com/newsroom for news and public policy commentary.
Workhorse jmenovala Jody Davis novou finanční ředitelkou, která nahradí odcházejícího Boba Ginnana. Firma uvedla, že má pomoci se zajištěním růstového kapitálu a snižováním nákladů.
DETROIT, July 13, 2026 (GLOBE NEWSWIRE) -- Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse”), a North American OEM and provider of all-electric trucks, step vans, shuttles and buses, today announced the appointment of Jody Davis as Chief Financial Officer (CFO), replacing current CFO Bob Ginnan, who is retiring.
Davis is a finance executive with approximately 15 years of finance leadership experience across manufacturing, energy storage, aerospace, and technology companies, with a track record of closing large capital rounds and guiding development-stage businesses into full production. His experience includes roles in strategic finance, capital formation, capital markets, treasury, financial planning & analytics, as well as building the finance infrastructure needed to support capital intensive companies as they move from development into commercialization and production.
“Jody is a company-builder who has deep and direct experience in numerous areas that are critical to Workhorse at this stage in our journey,” said Scott Griffith, CEO of Workhorse. “His experience raising later-stage growth capital combined with experience developing relationships with analysts and investors will be a strong addition to the Workhorse leadership team. We believe he’s the right CFO for where we are and where we’re going.”
Immediately prior to joining Workhorse, Davis served as Vice President of Strategic Finance at Unimacts, where he led financing initiatives across multiple entities within a complex capital structure. Previously, he served as Chief Financial Officer of Evio, formerly EOS Aircraft Inc., a hybrid-electric regional aircraft program, where he led the strategic repositioning of the business to Montreal, Canada as part of an Industrial and Technological Benefits (ITB) partnership with Boeing Canada. In connection with that transition, he built integrated financial models linking design, production and certification milestones to capital deployment.
Davis was part of the founding team and served as Chief Financial Officer of Our Next Energy, Inc., (ONE), a Michigan-based LFP battery innovator. During his time with the company, ONE scaled from pre-seed stage to production while expanding to approximately 500 employees, and Davis built the finance, human resources, financial planning & analytics functions needed to support this rapid growth. He played a key role across capital formation, various debt structures, investor diligence, board reporting, treasury, working capital discipline, and manufacturing scale-up.
“Workhorse is at an inflection point. I believe it has something rare: a product that already wins on real operator economics, a commercial-grade manufacturing facility, and a customer base that includes many of the largest medium-duty fleets in North America,” said Davis. “Workhorse is in the early stages of an exciting growth plan, and with the right capital partners, I believe there is significant upside ahead. My focus will be to bring in those partners and work to maintain a financial architecture that keeps pace with the opportunity: the right capital structure, rigorous cost management, and the systems that give Workhorse’s team, customers and investors the visibility they need. I’m thrilled to join the Workhorse team and look forward to getting to work.”
The Company believes Davis’ background is well-suited to help Workhorse achieve its near-term priorities, including securing additional growth capital, developing relationships with analysts and institutional investors, and accelerating cost reductions on the W56 and next-generation Class 5–6 platforms. Davis replaces current CFO Bob Ginnan, who is retiring. Ginnan served as CFO at Workhorse since January, 2022, helping the company navigate through several key corporate financial events, including capital raises, a divestiture and the merger with Motiv Electric Trucks.
“I want to thank Bob for his years of leadership and tireless work, including his most recent efforts to assist with finalizing and closing the Workhorse-Motiv merger and his efforts to lead several key aspects of integration,” said Griffith. “We all wish him well.”
About Workhorse Group Inc.
Headquartered in the Detroit area with a commercial-scale manufacturing plant in Union City, Indiana, Workhorse (Nasdaq: WKHS) is redefining what a medium-duty truck should be. Workhorse builds software-first, electric trucks, shuttles and buses that are powerful, cost-efficient, reliable, safe and comfortable — all with zero tailpipe emissions. Our deep experience building electric vehicles at scale drives intentional innovations designed to help customers lower operating costs, improve fleet performance, enhance the driver experience, and maximize uptime without compromise. More information is available at www.workhorse.com.
Media Relations Contacts:
Workhorse
John Williams, Communications
+1-206-660-5503, [email protected]
This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that are not historical facts, including statements regarding the impact of Mr. Davis’ appointment, and those regarding the Company's achievement of its priorities and its other plans, objectives, expectations, business strategies, future operations, financial performance, prospects, and other future events or developments, are forward-looking statements. These forward-looking statements are based on management's current expectations, assumptions, and estimates as of the date of this press release and are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties are described in greater detail under the caption "Risk Factors" in the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by applicable law.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/92a2014d-8229-4cbb-a588-2b25e1a0886b
Jody Davis, Chief Financial Officer at Workhorse Jody Davis joins Workhorse as CFO, replacing current CFO Bob Ginnan, who is retiring.
Williams získá od skupiny vedené Blackstone investici 5,34 miliardy USD za 49% nekontrolní podíl v pěti projektech výroby elektřiny za měřičem. Součástí jsou i Apollo a vozidla a účty spravované KKR.
A logo of Blackstone is pictured in Manhattan, New York City, U.S. July 29, 2025. REUTERS/Mike Segar/File Photo Purchase Licensing Rights, opens new tab
CompaniesJuly 13 (Reuters) - U.S. pipeline operator Williams (WMB.N), opens new tab said on Monday a consortium led by Blackstone (BX.N), opens new tab will invest $5.34 billion for a 49% noncontrolling stake in five of its behind-the-meter power generation projects.
The consortium, which also includes Apollo and insurance vehicles and accounts managed by KKR (KKR.N), opens new tab, will provide $4.4 billion representing 49% of expected growth capital expenditures for the projects, along with about $900 million of additional consideration to Williams.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
The transaction covers the company's Socrates, Apollo, Aquila, Socrates the Younger and Neo projects, part of a broader pipeline of more than 6 gigawatts of power projects that Williams is developing.
Reporting by Sumit Saha in Bengaluru; Editing by Maju Samuel
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Enphase Energy uvedla na trh v Austrálii a na Novém Zélandu nové mikroinvertory IQ9N pro rezidenční solární systémy s technologií GaN. Jsou zpětně kompatibilní s mikroinvertory IQ7 a IQ8 a kompatibilní s bateriemi IQ Batteries.
FREMONT, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced the launch of the new IQ9N™ Microinverter for residential solar in Australia and New Zealand, continuing the product's global rollout following recent launches across Europe and the United States. Built with gallium nitride (GaN) technology, IQ9N Microinverters are designed for the latest high-power solar panels and backed by an industry-leading 25-year limited warranty.
IQ9N Microinverters support 16 A of continuous DC current and 427 VA of continuous output power to help maximize energy production from each module. They are backward compatible with IQ7™ and IQ8™ Series Microinverters and compatible with IQ® Batteries, enabling homeowners and installers to expand existing Enphase systems using similar installation methods and accessories. GaN technology enables peak efficiency of up to 97.95% and cooler operation.
IQ9N Microinverters optimize energy from each panel across partial shading, complex roof layouts, and high-temperature conditions, making them well suited to the Australian climate. Enphase’s GaN architecture reduces conduction losses and heat while supporting long-term reliability and consistent performance across seasons. Read the technical white paper, "Enphase Adoption of GaN Bi-Directional Switch Technology for Distributed Power Electronics," for more details.
Like all Enphase microinverters, IQ9N Microinverters convert DC to AC at each panel, eliminating long high-voltage DC runs used in traditional string inverter designs and delivering a safer, all-AC architecture on the roof. Per-panel power conversion also keeps the rest of the system producing even if one panel is shaded, soiled, or offline.
“With some of the highest rooftop solar penetration anywhere in the world, Australian homeowners expect their systems to turn every available ray of sunshine into real savings,” said Kallan Smith, director at GoSolar Newcastle, an installer of Enphase products in the Hunter region of New South Wales, Australia. “IQ9N Microinverters bring Enphase’s latest GaN-based technology to the roof, helping maximize production from each panel while pairing seamlessly with Enphase IQ Batteries to create a truly state-of-the-art, unified home energy system.”
“New Zealand homes need solar technology that can handle real-world conditions – coastal air, fast-changing weather, complex rooflines, and the growing use of higher-power panels,” said James Reid, solar team leader at ElectraServe, an installer of Enphase products in Canterbury, New Zealand. "IQ9N Microinverters let us pair the latest panels with per-panel optimization that captures energy other architectures leave on the roof. Additionally, they enable simple expansion and coupling to the latest technologies."
"Homeowners here want solar that performs for decades, not just on day one," said Luke Rose, director at Helcro Solar, an installer of Enphase products in Greater Melbourne in Victoria, Australia. "The efficiency, reliability, and 25-year warranty of IQ9N Microinverters give us complete confidence in every system we design."
IQ9N Microinverters meet rigorous grid compliance standards, including AS/NZS 4777.2:2020, and are CEC listed. A double-insulated, corrosion-resistant polymer housing and -40°C to +65°C operating range enable them to withstand extreme weather conditions. Built-in rapid shutdown capability helps reduce risk to utility workers and first responders. Homeowners can monitor system performance at the panel level, receive real-time alerts, and benefit from over-the-air software updates through the Enphase® App.
"Australia is one of the world’s most advanced rooftop solar markets and a natural next step in the global expansion of IQ9N Microinverters," said Ken Fong, senior vice president and general manager for Americas and Asia Pacific at Enphase Energy. "IQ9N Microinverters combine our proven distributed architecture with GaN technology in a compact form factor for residential solar.”
IQ9N Microinverters are currently available through Enphase distribution partners in Australia and New Zealand. Learn more about IQ9N Microinverters on the Enphase website.
About Enphase Energy, Inc.
Enphase Energy, a global energy technology company based in Fremont, CA, is the world's leading supplier of microinverter-based solar and battery systems, EV chargers, home energy management systems, and virtual power plant (VPP) solutions. Enphase products enable people to harness the sun to make, use, save, and sell their own power, all controlled through the Enphase App. The company revolutionized the solar industry with its microinverter-based technology and has shipped approximately 87.8 million microinverters, with more than 5.2 million Enphase-based systems deployed in over 165 countries. For more information, visit https://enphase.com/.
This press release contains forward-looking statements, including statements related to the expected capabilities and performance of Enphase Energy's IQ9N Microinverters and related technology, including safety, quality, and reliability; the suitability of IQ9N Microinverters for residential solar applications and the latest high-power residential solar panels; the expected benefits of gallium nitride-based technology, including higher efficiency, cooler operation, and optimized performance across conditions; the expected benefits of Enphase's distributed microinverter architecture; the availability and timing of IQ9N Microinverter shipments in Australia and globally; the compatibility of IQ9N Microinverters with existing Enphase systems and IQ Batteries; anticipated homeowner and installer adoption of IQ9N Microinverters in Australia and New Zealand; and the scope and terms of Enphase's limited warranty. These forward-looking statements are based on Enphase Energy's current expectations and assumptions and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those contemplated by these forward-looking statements. Such risks include, but are not limited to, market demand; competitive developments; changes in incentive programs and regulatory or compliance requirements; the pace of residential solar adoption in Australia, New Zealand, and other markets; manufacturing and supply chain constraints; and other factors discussed in Enphase Energy's filings with the Securities and Exchange Commission, including those risks described in more detail in Enphase Energy's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other filings made from time to time with the Securities and Exchange Commission. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations, except as required by law.
Kratos získal zakázku v hodnotě přibližně 100 milionů USD na výrobu pozemního modulárního systému pro sledování vesmírného prostoru. Program přechází do výroby.
Ground Based Modular System Recently Demonstrated Mission Effectiveness July 13, 2026 08:00 ET | Source: Kratos Defense & Security Solutions, Inc.
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, today announced that the company has recently received an approximate $100 million sole source prime contract award for the production of a ground-based modular space domain awareness system. Kratos is an industry leader in space domain awareness, directed energy and other relevant national security systems. Work under this new program award will be performed at secure Kratos production and integration facilities.
Mike Johns, Kratos Senior Vice President, said, “Kratos is proud to have developed, tested and demonstrated this true technology-leading space domain awareness system, which will now be entering production. Our entire organization is extremely proud to have the confidence with our customer to move forward with this mission critical national security system. Based on customer feedback, we believe that this program could in the future become one of the most important for our DRSS business.”
Eric Demarco, Kratos’ President and CEO, said, “We believe that across our company, Kratos has the right, relevant products, at the right time, at the right cost points—products which can be rapidly mass produced and fielded now. There is a generational rebuild and recapitalization of the U.S. defense industrial base under way, including for strategic space systems, to deter and defeat our enemies, and Kratos is committed to supporting the Department of War and the success of its mission.”
Due to security related, competitive and other considerations, no additional information will be provided.
About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low-cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command & control (C2) and telemetry, tracking and control (TT&C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual & augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on LinkedIn and X.
Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 28, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.
Chesapeake Utilities a Peninsula Pipeline oznámily projekt Florida Energy Pathway, nový intrastátní plynovod v jižní Floridě s investicí kolem 1,2 miliardy USD. Má být uveden do provozu v roce 2030 a podpořit kapacitu i spolehlivost dodávek.
, /PRNewswire/ -- Chesapeake Utilities Corporation (NYSE: CPK) (the "Company" or "Chesapeake Utilities") and its subsidiary, Peninsula Pipeline Company ("PPC"), today announced the Florida Energy Pathway ("FEP"), a new intrastate natural gas infrastructure project in south Florida. This project will be developed, constructed and operated by PPC in order to expand natural gas transportation capacity to address regional supply constraints, enhance system reliability and extend natural gas infrastructure to serve homes and businesses.
FEP is anticipated to be a 24-inch intrastate natural gas pipeline originating in Palm Beach County and terminating in Miami-Dade County. The project is anchored by firm commitments totaling nearly 250,000 dekatherms per day from multiple investment grade shippers. Upstream capacity will be supplied by Florida Gas Transmission in conjunction with its Phase IX expansion. PPC is also accepting binding commitments with additional shippers for firm transportation service.
Total project investment is estimated to be approximately $1.2 billion, pending finalization of design and development activities. The project is anticipated to be in service in 2030, subject to final commissioning. Chesapeake Utilities is evaluating options for financing the project and intends to partner with one or more third parties to invest in and own up to 49% of the total project.
"Florida continues to lead the nation in population and economic growth, which drives increasing energy demand. In the south Florida area, this has led to significant energy supply constraints. Natural gas infrastructure expansions, including the Florida Energy Pathway project, play an important role in enabling regional growth, increasing natural gas capacity and supporting long-term energy independence," said Jeff Householder, Chesapeake Utilities chair of the board, president and chief executive officer.
"Florida Energy Pathway represents a long-term, regulated, organic growth opportunity and aligns strategically with our natural gas transportation expertise, above-average growth expectations and increased presence in south Florida following the acquisition of Florida City Gas. We are excited to bring this project online to serve our customers' needs and deliver energy that strengthens our local economies and communities."
Chesapeake Utilities will discuss this project in further detail and address its long-term capital investment expectations on its second quarter earnings call in August.
About Chesapeake Utilities Corporation
Chesapeake Utilities Corporation is a diversified energy delivery company, listed on the New York Stock Exchange. Chesapeake Utilities Corporation offers sustainable energy solutions through its natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions, and other businesses. For more information, visit www.chpk.com.
About Peninsula Pipeline Company
Peninsula Pipeline Company (PPC) is Chesapeake Utilities' intrastate transmission business in Florida. PPC provides transportation service that links interstate pipelines to local distribution systems, industrial customers and power generation facilities. For more information, visit www.peninsula-pipeline.com/.
Forward-Looking Statements
Matters included in this release may include forward-looking statements that involve risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding project investment, timeline and financing. Actual results may differ materially from those in the forward-looking statements due to a number of factors, including uncontrollable authorization and construction impediments. Please refer to the Safe Harbor for Forward-Looking Statements in the Company's 2025 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the first quarter of 2026 for further information on the risks and uncertainties related to the Company's forward-looking statements.
Media
Alexander Nye
Director, Strategic Communications
727.754.0136
[email protected]
Investors
Lucia Dempsey
Head of Investor Relations
347.804.9067
[email protected]
, /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second quarter of 2026 before the Nasdaq market opens on Wednesday, August 5, 2026.
InMode is currently finalizing its financial results for the second quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results such period, subject to final adjustments and other developments that may arise between now and the time such financial results are finalized. Based on preliminary results, management expects:
Revenue for the second quarter of 2026 to be in the range of $95.2 million to $95.4 million Full year 2026 revenue to be in the range of $365 million to $375 million As the Company's Special Committee continues its evaluation of strategic proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
First Hawaiian se dohodla na převzetí TriCo v čistě akciové transakci; kombinovaná banka bude mít zhruba 34 miliard USD aktiv a vznikne 6. největší banka se sídlem na západě USA.
HONOLULU and CHICO, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) ("First Hawaiian"), parent company of First Hawaiian Bank, and TriCo Bancshares (NASDAQ: TCBK) ("TriCo"), parent company of Tri Counties Bank, today announced they have entered into a definitive agreement pursuant to which First Hawaiian will acquire TriCo in an all-stock transaction.
This partnership combines two culturally aligned, relationship-driven banking franchises with attractive deposit bases, disciplined credit cultures and deep local market positions. On a combined basis, the company will have approximately $34 billion of assets and be the 6th largest bank headquartered in the Western U.S. This partnership will increase First Hawaiian’s presence on the mainland and offer customers the full suite of banking capabilities and expand the combined bank’s market areas to include a more diverse geography. The combined bank is expected to leverage its strong capital position, liquidity profile and credit quality to deliver enhanced earnings and generate long-term value to shareholders.
“This partnership creates a broader platform for long-term growth,” said Bob Harrison, Chairman, President and CEO of First Hawaiian. “TriCo is an ideal partner to execute this next phase of our growth: a well-managed, relationship-focused bank in California with a strong deposit franchise, disciplined credit culture, experienced local leadership and deep commitment to its communities. Together, we will preserve what has made both companies successful while creating a stronger and more diversified bank. I could not be more excited to partner with TriCo.”
“TriCo has built its franchise around long-term customer relationships, local decision-making and a commitment to the communities we serve,” said Rick Smith, Chairman, President and CEO of TriCo. “First Hawaiian shares those values and brings the scale, capital strength and broader product capabilities to help us do even more for our customers and communities. We are excited for our employees and shareholders to participate in the future of the combined company, and we look forward to working closely with Bob and the First Hawaiian team.”
Pursuant to the terms of the agreement, TriCo’s shareholders will receive 2.095 First Hawaiian shares for each TriCo share, representing $63.12 per share as of First Hawaiian’s closing stock price on July 10, 2026. Upon closing of the transaction, First Hawaiian and TriCo shareholders are expected to own approximately 65% and 35%, respectively, of the combined company. Four current TriCo directors, including Rick Smith, will join the First Hawaiian and First Hawaiian Bank Boards of Directors, with the remaining three to be mutually agreed upon by First Hawaiian and TriCo prior to the closing. To ensure business and client continuity, leadership will include representation from both organizations and First Hawaiian will retain Tri Counties Bank branding on the mainland. There are no expected branch closings associated with the transaction and TriCo’s commitment to its communities is not expected to change.
The Boards of Directors of First Hawaiian and TriCo unanimously approved the definitive agreement and the parties expect to close the transaction by the end of 2026, subject to the receipt of required regulatory approvals, approval by First Hawaiian and TriCo shareholders and the satisfaction of customary closing conditions.
Second Quarter 2026 Financial Highlights
The announcement precedes First Hawaiian’s release of its financial results for the second quarter ended June 30, 2026. The following are key highlights of the results the company expects to report on July 24, 2026:
Continued earnings growth, with net income of $73.4 million and diluted EPS of $0.60, compared to net income of $67.8 million and diluted EPS of $0.55 in the prior quarterCost of deposits improved 2 basis points to 1.20% from 1.22% in the prior quarterNet interest margin expanded by 6 bps QoQ to 3.25%Return on average assets improved to 1.23%, up 9 bps from 1.14% in the prior quarterReturn on average tangible common equity of 16.3%, compared to 15.3% in the prior quarter*Gross loans increased to $14.6 billion, compared to $14.4 billion in the prior quarterBook value per share increased to $23.22, up from $22.75 in the prior quarterTangible book value per share of $15.04, reflecting 3% QoQ growth* * Return on average tangible common equity and tangible book value per share are non-GAAP financial measures. Refer to the appendix to the investor presentation furnished by FHI as an exhibit to Form 8-K with the U.S. Securities and Exchange Commission on the date of this release for further information, including a reconciliation of those measures to the comparable GAAP measurements.
These preliminary results are estimates based on information available to management of FHI as of the date of this release and are subject to change upon completion of FHI's standard closing procedures and review by its independent registered public accounting firm. As a result, there can be no assurance that FHI's final results will not differ from these preliminary estimates.
Advisors
Evercore served as financial advisor and Sullivan & Cromwell LLP served as legal counsel to First Hawaiian.
Keefe, Bruyette & Woods, A Stifel Company served as financial advisor and Holland & Knight LLP served as legal counsel to TriCo.
Conference Call Information
First Hawaiian and TriCo will host a conference call today to discuss the transaction at 8:30 a.m. Eastern Time, 5:30 a.m. Pacific Time and 2:30 a.m. Hawaii Time.
To access the call by phone, please register via the following link: https://register-conf.media-server.com/register/BI2891c10b1f314068b969f7a768bfea65, and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.
A live webcast of the conference call, including a slide presentation, will be available at the following link: https://edge.media-server.com/mmc/p/zk2u4mjj. The archive of the webcast will be available at the same location.
First Hawaiian, Inc.
First Hawaiian, Inc. (NASDAQ: FHB) is a bank holding company headquartered in Honolulu, Hawaii. Its principal subsidiary, First Hawaiian Bank, founded in 1858 under the name Bishop & Company, is Hawaii’s oldest and largest financial institution with branch locations throughout Hawaii, Guam and Saipan. The company offers a comprehensive suite of banking services to consumer and commercial customers including deposit products, loans, wealth management, insurance, trust, retirement planning, credit card and merchant processing services. Customers may also access their accounts through ATMs, online and mobile banking channels. For more information about First Hawaiian, Inc., visit the Company’s website, www.fhb.com.
TriCo Bancshares
Established in 1975, Tri Counties Bank is a wholly-owned subsidiary of TriCo Bancshares (NASDAQ: TCBK) headquartered in Chico, California, providing services in traditional stand-alone and in-store bank branches and loan production offices in communities throughout California. Tri Counties Bank provides an extensive and competitive breadth of consumer, small business and commercial banking financial services, along with convenient around-the-clock ATMs, online and mobile banking access. Brokerage services are provided by Tri Counties Advisors through affiliation with Raymond James Financial Services, Inc. Visit www.TriCountiesBank.com to learn more.
Forward-Looking Statements
This communication may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements regarding the expected timing, completion and effects of the proposed business combination transaction between First Hawaiian, Inc. (“FHI”) and TriCo Bancshares (“TriCo”) (the “Transaction”), and the plans, objectives, expectations and intentions of FHI and TriCo. Any statement that does not describe historical or current facts is a forward-looking statement. Forward-looking statements are often, but not always, made through the use of words or phrases such as “annualized,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “goal,” “intend,” “may,” “might,” “outlook,” “plan,” “potential,” “predict,” “projection,” “seek,” “should,” “target,” “will,” “would” or the negative version of those words or other comparable words or phrases of a future or forward-looking nature.
FHI and TriCo caution that the forward-looking statements in this communication are not guarantees of future performance and involve a number of known and unknown risks, uncertainties and assumptions that are difficult to assess and are subject to change based on factors which are, in many instances, beyond FHI’s and TriCo’s control. A number of important factors could cause actual results to differ materially from those indicated in these forward-looking statements, including the following: changes in general economic, political, or industry conditions, and in conditions impacting the banking industry specifically; uncertainty in U.S. fiscal, monetary and trade policy, including the interest rate policies of the Federal Reserve Board or the effects of any declines in housing and commercial real estate prices, high or increasing unemployment rates, continued or renewed inflation, the impact of proposed or imposed tariffs by the U.S. government or retaliatory tariffs proposed or imposed by U.S. trading partners that could have an adverse impact on customers or any recession or slowdown in economic growth particularly in the markets in which FHI and TriCo conduct business, including Hawaii, Guam, Saipan and California; volatility and disruptions in global capital and credit markets; the impact of bank failures or adverse developments at other banks on general investor sentiment regarding the stability and liquidity of banks; changes in interest rates that could significantly reduce net interest income and negatively affect asset yields and valuations and funding sources, including impacts on prepayment speeds; competitive pressures among financial institutions and nontraditional providers of financial services, including on product pricing and services; concentrations within FHI’s or TriCo’s loan portfolio (including commercial real estate loans) or other asset classes, and the parties’ ability to attract and retain customer deposits, large loans to certain borrowers, access liquidity and capital, and manage deposit costs and funding sources; the success, impact, and timing of FHI’s and TriCo’s respective business strategies, including market acceptance of any new products or services and FHI’s and TriCo’s ability to successfully implement strategic, operational, technology and integration initiatives; the failure to properly use and protect customer and employee information and data; cybersecurity risks, including the occurrence of fraudulent activity or a material breach of, or disruption to, the security of FHI’s, TriCo’s or their vendors’ systems; risks related to the development, implementation, use and management of artificial intelligence and other emerging technologies; the effects of failures or interruptions of information, communications or third-party service-provider systems; the nature, extent, timing, and results of governmental actions, examinations, reviews, reforms, regulations, and interpretations; changes in laws or regulations; adverse weather conditions, natural disasters and other catastrophic events such as wildfires; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the parties to terminate the merger agreement to which FHI and TriCo are parties; the outcome of any legal proceedings that may be instituted against FHI or TriCo, including potential litigation relating to the Transaction; delays in completing the Transaction; the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the Transaction); the failure to obtain stockholder or shareholder approvals, as applicable, or to satisfy any of the other conditions to the closing of the Transaction on a timely basis or at all; changes in FHI’s or TriCo’s share price before closing, including as a result of the financial performance of the other party prior to closing, or more generally due to broader stock market movements, and the performance of financial companies and peer group companies; the possibility that the anticipated benefits of the Transaction are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where FHI and TriCo do business; certain restrictions during the pendency of the proposed Transaction that may impact the parties’ ability to pursue certain business opportunities or strategic Transactions; the possibility that the Transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management’s attention from ongoing business operations and opportunities; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Transaction; the ability to complete the Transaction and integration of FHI and TriCo promptly and successfully; the dilution caused by FHI’s issuance of additional shares of its capital stock in connection with the Transaction; and other factors that may affect the future results of FHI and TriCo.
The foregoing factors should not be considered an exhaustive list and should be read together with the other cautionary statements set forth in FHI’s Annual Report on Form 10-K for the year ended December 31, 2025 and its latest Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission (the “SEC”) and available on FHI’s investor relations website, https://ir.fhb.com, under the heading “SEC Filings,” and in other documents FHI files with the SEC, and in TriCo’s Annual Report on Form 10-K for the year ended December 31, 2025 and its latest Quarterly Report on Form 10-Q, which are on file with the SEC and available on TriCo’s website, www.tcbk.com, under the “About” tab and the “Investor Relations” link and then under the heading “SEC Filings” and in other documents TriCo files with the SEC. If one or more events related to these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may differ materially from what we anticipate. Accordingly, you should not place undue reliance on any such forward-looking statements.
Any forward-looking statement speaks only as of the date on which it is made, and neither FHI nor TriCo undertakes any obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by applicable law.
Important Additional Information and Where to Find It
In connection with the proposed Transaction, FHI will file with the SEC a Registration Statement on Form S-4 that will include a Joint Proxy Statement of FHI and TriCo and a Prospectus of FHI, as well as other relevant documents concerning the Transaction. Certain matters in respect of the Transaction involving FHI and TriCo will be submitted to FHI’s stockholders and TriCo’s shareholders, as applicable, for their consideration.
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. INVESTORS, FHI STOCKHOLDERS AND TRICO SHAREHOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT AND THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE TRANSACTION WHEN THEY BECOME AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
Stockholders or shareholders, as applicable, will be able to obtain a free copy of the definitive joint proxy statement/prospectus, as well as other filings containing information about the Transaction, FHI and TriCo, without charge, at the SEC’s website, www.sec.gov. Copies of the joint proxy statement/prospectus and the filings with the SEC that will be incorporated by reference in the joint proxy statement/prospectus can also be obtained, without charge, by directing a request to First Hawaiian, Inc., Attention: Secretary, 999 Bishop Street, Honolulu, HI 96813, (808) 525-7000 or to TriCo Bancshares, Attention: Shareholder Services, 63 Constitution Drive, Chico, CA 95973, (530) 898-0300.
Participants in the Solicitation
FHI, TriCo, and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from FHI stockholders or TriCo shareholders in connection with the Transaction under the rules of the SEC. Information regarding FHI's directors and executive officers is available in the sections entitled “Directors, Executive Officers and Corporate Governance” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in FHI's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on February 27, 2026 (available at https://www.sec.gov/ix?doc=/Archives/edgar/data/36377/000110465926021544/fhb-20251231x10k.htm); in the sections entitled “Corporate Governance and Board Matters,” “Compensation Discussion and Analysis,” “Executive Compensation Tables,” “Biographies of Executive Officers” and “Security Ownership of Certain Beneficial Owners, Directors and Management” in FHI's definitive proxy statement relating to its 2026 Annual Meeting of Stockholders, which was filed with the SEC on March 12, 2026 (available at https://www.sec.gov/ix?doc=/Archives/edgar/data/36377/000110465926026700/tm2532317-1_def14a.htm); and other documents filed by FHI with the SEC. Information regarding TriCo's directors and executive officers is available in the sections entitled “Directors, Executive Officers and Corporate Governance” and “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters;” in TriCo's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 2, 2026 (available at https://www.sec.gov/ix?doc=/Archives/edgar/data/356171/000035617126000010/tcbk-20251231.htm); in the sections entitled “Board of Directors,” “Corporate Governance, Board Nominations and Board Committees,” “Compensation of Directors,” “Ownership of Voting Securities,” “Compensation Discussion and Analysis” and “Compensation of Named Executive Officers” in TriCo's definitive proxy statement relating to its 2026 Annual Meeting of Shareholders, which was filed with the SEC on April 17, 2026 (available at https://www.sec.gov/ix?doc=/Archives/edgar/data/356171/000035617126000033/tcbk-20260417.htm); and other documents filed by TriCo with the SEC. To the extent holdings of FHI common stock by the directors and executive officers of FHI or holdings of TriCo common stock by directors and executive officers of TriCo have changed from the amounts held by such persons as reflected in the documents described above, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus relating to the Transaction. Free copies of this document, when available, may be obtained as described in the preceding paragraph.
Contacts
First Hawaiian Investor Relations: Kevin Haseyama, CFA, (808) 525-6268, [email protected]
First Hawaiian Media Relations: Bill Weeshoff, (808) 525-6229, [email protected]
TriCo Investor Contact: Peter G. Wiese, (530) 898-0300 [email protected]
